<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6272852</article-id><article-id pub-id-type="doi">10.3390/molecules21050529</article-id><article-id pub-id-type="publisher-id">molecules-21-00529</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Weng-Keong</given-names></name><xref ref-type="aff" rid="af1-molecules-21-00529">1</xref><xref ref-type="aff" rid="af2-molecules-21-00529">2</xref></contrib><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Loh Teng-Hern</given-names></name><xref ref-type="aff" rid="af1-molecules-21-00529">1</xref><xref ref-type="aff" rid="af2-molecules-21-00529">2</xref></contrib><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Kok-Gan</given-names></name><xref ref-type="aff" rid="af3-molecules-21-00529">3</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Learn-Han</given-names></name><xref ref-type="aff" rid="af1-molecules-21-00529">1</xref><xref ref-type="aff" rid="af2-molecules-21-00529">2</xref><xref ref-type="aff" rid="af4-molecules-21-00529">4</xref><xref rid="c1-molecules-21-00529" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Goh</surname><given-names>Bey-Hing</given-names></name><xref ref-type="aff" rid="af1-molecules-21-00529">1</xref><xref ref-type="aff" rid="af2-molecules-21-00529">2</xref><xref ref-type="aff" rid="af4-molecules-21-00529">4</xref><xref rid="c1-molecules-21-00529" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Forti</surname><given-names>Luca</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-21-00529"><label>1</label>School of Pharmacy, Monash University Malaysia, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia; <email>wkcha29@student.monash.edu</email> (W.-K.C.); <email>lttan13@student.monash.edu</email> (L.T.-H.T.)</aff><aff id="af2-molecules-21-00529"><label>2</label>Biomedical Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia</aff><aff id="af3-molecules-21-00529"><label>3</label>Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia; <email>kokgan@um.edu.my</email></aff><aff id="af4-molecules-21-00529"><label>4</label>Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao, 56000 Phayao, Thailand</aff><author-notes><corresp id="c1-molecules-21-00529"><label>*</label>Correspondence: <email>lee.learn.han@monash.edu</email> or <email>leelearnhan@yahoo.com</email> (L.-H.L.); <email>goh.bey.hing@monash.edu</email> (B.-H.G.); Tel.: +60-3-5514-5887 or +60-3-5514-4887 (L.-H.L. &#x00026; B.-H.G.); Fax: +60-3-5514-6364 (L.-H.L. &#x00026; B.-H.G.)</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2016</year></pub-date><volume>21</volume><issue>5</issue><elocation-id>529</elocation-id><history><date date-type="received"><day>24</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>14</day><month>4</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 by the authors.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Nerolidol (3,7,11-trimethyl-1,6,10-dodecatrien-3-ol) is a naturally occurring sesquiterpene alcohol that is present in various plants with a floral odor. It is synthesized as an intermediate in the production of (3<italic>E</italic>)-4,8-dimethy-1,3,7-nonatriene (DMNT), a herbivore-induced volatile that protects plants from herbivore damage. Chemically, nerolidol exists in two geometric isomers, a <italic>trans</italic> and a <italic>cis</italic> form. The usage of nerolidol is widespread across different industries. It has been widely used in cosmetics (e.g., shampoos and perfumes) and in non-cosmetic products (e.g., detergents and cleansers). In fact, U.S. Food and Drug Administration (FDA) has also permitted the use of nerolidol as a food flavoring agent. The fact that nerolidol is a common ingredient in many products has attracted researchers to explore more medicinal properties of nerolidol that may exert beneficial effect on human health. Therefore, the aim of this review is to compile and consolidate the data on the various pharmacological and biological activities displayed by nerolidol. Furthermore, this review also includes pharmacokinetic and toxicological studies of nerolidol. In summary, the various pharmacological and biological activities demonstrated in this review highlight the prospects of nerolidol as a promising chemical or drug candidate in the field of agriculture and medicine.</p></abstract><kwd-group><kwd><italic>cis</italic>-nerolidol</kwd><kwd><italic>trans</italic>-nerolidol</kwd><kwd>sesquiterpene</kwd><kwd>essential oil</kwd><kwd>pharmacological activities</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-21-00529"><title>1. Introduction</title><p>Ever since ancient times, medicinal plants have been explored and used as herbal medicines to treat many diseases [<xref rid="B1-molecules-21-00529" ref-type="bibr">1</xref>]. With the advancement of technology, research on herbal medicine has intensified on the efforts to identify the bioactive compounds in medicinal plants that are responsible for their pharmacological and biological activities. Essential oils (EOs) are volatile, natural and complex bioactive compounds which are characterized by a strong odour, and their biological effects are known to be associated to a series of complex interactions with cells, tissues and whole organisms [<xref rid="B2-molecules-21-00529" ref-type="bibr">2</xref>]. Besides its well-known application in aromatherapy [<xref rid="B3-molecules-21-00529" ref-type="bibr">3</xref>], the uses of EO have been extended into the food, agriculture and pharmaceutical industries [<xref rid="B4-molecules-21-00529" ref-type="bibr">4</xref>,<xref rid="B5-molecules-21-00529" ref-type="bibr">5</xref>,<xref rid="B6-molecules-21-00529" ref-type="bibr">6</xref>]. Among the plants that are rich in EOs are <italic>Baccharis dracunculifolia</italic> DC, <italic>Elettaria cardamomum</italic> (L.) Maton, <italic>Momordica charantia</italic> L., <italic>Piper aleyreanum</italic> C. DC and <italic>Piper claussenianum</italic> (Miq.) C. DC [<xref rid="B7-molecules-21-00529" ref-type="bibr">7</xref>,<xref rid="B8-molecules-21-00529" ref-type="bibr">8</xref>,<xref rid="B9-molecules-21-00529" ref-type="bibr">9</xref>,<xref rid="B10-molecules-21-00529" ref-type="bibr">10</xref>,<xref rid="B11-molecules-21-00529" ref-type="bibr">11</xref>]. </p><p>Nerolidol (3,7,11-trimethyl-1,6,10-dodecatrien-3-ol), also known as peruviol, is a naturally occurring sesquiterpene alcohol present in the EO of various plants with a floral odour [<xref rid="B12-molecules-21-00529" ref-type="bibr">12</xref>,<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>]. Nerolidol was found to exist as one of the bioactive compounds responsible for the biological activities demonstrated by the EOs of the aforementioned plants.</p><p>Statistics showed that the global usage of nerolidol <italic>per annum</italic> ranges from 10 to 100 metric tonnes [<xref rid="B14-molecules-21-00529" ref-type="bibr">14</xref>]. For instance, nerolidol is frequently incorporated in cosmetics (e.g., shampoos and perfumes) and non-cosmetic products (e.g., detergents and cleansers) [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>]. Besides, nerolidol is also widely used in the food industry as a flavor enhancer in many food products since its approval by U.S. Food and Drug Administration as a safe food flavoring agent.</p><p>Principally, this article aims to review the diverse range of pharmacological and biological activities of nerolidol which include antioxidant, anti-microbial, anti-biofilm, anti-parasitic, insecticidal, anti-ulcer, skin penetration enhancer, anti-tumor, anti-nociceptive and anti-inflammatory properties. The review also covers the chemical structure, physical properties, and the biosynthesis pathway of nerolidol as the intermediate involved in the mechanisms responsible for protection of plants against herbivores and plant pathogens. This article also highlights the pharmacokinetic and toxicological properties of nerolidol in both <italic>in vitro</italic> and <italic>in vivo</italic> experimental models.</p></sec><sec id="sec2-molecules-21-00529"><title>2. Chemical Structure and Physical Properties</title><p>Nerolidol has four different isomeric forms which consist of two enantiomers and two geometric isomers [<xref rid="B15-molecules-21-00529" ref-type="bibr">15</xref>]. The existence of these isomeric forms is due to the presence of a double bond at the C-6 position and the asymmetric center at the C-3 position. These isomeric forms of <italic>cis</italic>- and <italic>trans</italic>-nerolidol are illustrated in <xref ref-type="fig" rid="molecules-21-00529-f001">Figure 1</xref>. Besides, the synonyms for <italic>cis</italic>- and <italic>trans</italic>-nerolidol are listed in <xref rid="molecules-21-00529-t001" ref-type="table">Table 1</xref>.</p><p>Like other sesquiterpene compounds, nerolidol has high hydrophobicity, thereby allowing easier penetration across the plasma membrane and interaction with intracellular proteins and/or intra-organelle sites [<xref rid="B16-molecules-21-00529" ref-type="bibr">16</xref>]. The physical properties of nerolidol (isomer not specified) have been described by Lapczynski <italic>et al.</italic> [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>] as follows:</p><list list-type="simple"><list-item><label>(i)</label><p>Physical description: A clear pale yellow to yellow liquid having a faint floral odor reminiscent of rose and apple.</p></list-item><list-item><label>(ii)</label><p>Chemical formula: C<sub>15</sub>H<sub>26</sub>O</p></list-item><list-item><label>(iii)</label><p>Flash point: &#x0003e;212&#x000b0; F; CC.</p></list-item><list-item><label>(iv)</label><p>Boiling point: 276 &#x000b0;C.</p></list-item><list-item><label>(v)</label><p>LogK<sub>ow</sub> (calculated): 5.68.</p></list-item><list-item><label>(vi)</label><p>Vapor pressure (calculated): 0.1 mm Hg 20 &#x000b0;C.</p></list-item><list-item><label>(vii)</label><p>Specific gravity: 0.8744.</p></list-item><list-item><label>(viii)</label><p>Water solubility (calculated): 1.532 mg/L at 25 &#x000b0;C.</p></list-item></list></sec><sec id="sec3-molecules-21-00529"><title>3. Sources, Extraction and Analytical Methods of Nerolidol</title><p>Numerous extraction methods have been employed for extracting EOs from various plant samples [<xref rid="B2-molecules-21-00529" ref-type="bibr">2</xref>]. The hydrodistillation method using the Clevenger-type apparatus appears as the most common method used for extracting nerolidol. <xref rid="molecules-21-00529-t002" ref-type="table">Table 2</xref> summarizes the different extraction methods and the yield of nerolidol from various parts of plants such as leaves, flowers, seeds, fruits, resins, twigs and woods. Based on the literature references, leaves are the most common source for extraction of nerolidol. In terms of the percentage of nerolidol in the leaf EO among different plant species, <italic>Piper claussenianum</italic> (Miq.) C. DC. has the highest percentage of <italic>trans-</italic>nerolidol (81.4%), followed by <italic>Zanthoxylum hyemale</italic> A.St.-Hil. (51.0%), <italic>Zornia brasiliensis</italic> Vogel (48.0%) and <italic>Swinglea glutinosa</italic> (Blanco) Merr. (28.4%) (<xref rid="molecules-21-00529-t002" ref-type="table">Table 2</xref>).</p><p>Microclimatic and environmental factors such as species, season, location, climate, soil type, age of the leaves and the extraction method may influence the concentration of each constituents in EOs [<xref rid="B17-molecules-21-00529" ref-type="bibr">17</xref>]. Seasonal variation is one of the main factors that influences the composition of EOs in plants [<xref rid="B18-molecules-21-00529" ref-type="bibr">18</xref>,<xref rid="B19-molecules-21-00529" ref-type="bibr">19</xref>,<xref rid="B20-molecules-21-00529" ref-type="bibr">20</xref>] including the concentration of nerolidol. It was reported by Marques and Kaplan [<xref rid="B19-molecules-21-00529" ref-type="bibr">19</xref>] that the harvested leaves from <italic>Piper claussenianum</italic> (Miq.) C. DC. yielded variable amounts of nerolidol during the year of 2009. The content of <italic>trans-nerolidol</italic> was higher during the Brazilian spring collection period (September, October and November, 87.0%, 94.0%, 92.0%, respectively) as compared to that during autumn collection period (March, April and May, 78.0%; 77.0%; 80.0%, respectively). Another study conducted by de Sousa <italic>et al.</italic> [<xref rid="B20-molecules-21-00529" ref-type="bibr">20</xref>] has shown that the mean concentration of <italic>trans</italic>-nerolidol in the leaves of <italic>Baccharis dracunculifolia</italic> DC. was five fold higher in March 2005 (136.53 mg/100 g of plant) than that in July 2004 (25.03 mg/100 g of plant). All these findings provide important information to identify and determine the most appropriate harvest period to obtain the highest yield of nerolidol from different plants.</p><p>Gas chromatography-mass spectrometry (GC-MS) is the analytical method that is most commonly used to detect nerolidol [<xref rid="B21-molecules-21-00529" ref-type="bibr">21</xref>]. This is because the boiling points of sesquiterpenes range from ~250 to 280 &#x000b0;C in which suitable for the gas-phase separation technique employed by GC-MS analysis [<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>,<xref rid="B23-molecules-21-00529" ref-type="bibr">23</xref>]. Apart from GC-MS, liquid chromatography-mass spectrometry (LC-MS) method is also widely used due to its high sensitivity and high accuracy [<xref rid="B24-molecules-21-00529" ref-type="bibr">24</xref>]. Recently, He <italic>et al.</italic> [<xref rid="B25-molecules-21-00529" ref-type="bibr">25</xref>] suggested that LC-MS could be used for <italic>in vivo</italic> pharmacokinetic analysis of nerolidol due to its convenience and stability features. The study demonstrated that the lower limit lower quantification (LLOQ) of nerolidol using LC-MS was reported as 10 ng/mL [<xref rid="B25-molecules-21-00529" ref-type="bibr">25</xref>]. On the other hand, another study reported the LLOQ of nerolidol as 3.5 ng/mL by using GC-MS [<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>]. These results suggest that GC-MS may be a more preferable detection method as it was shown to have higher sensitivity than LC-MS in detecting nerolidol.</p><p>In order to differentiatie the <italic>cis</italic>- and <italic>trans</italic>-isomers of nerolidol, the retention time of different LC-MS and GC-MS chromatography columns as well as the major peaks of the mass spectra (<italic>m</italic>/<italic>z</italic>) are the parameters used (<xref rid="molecules-21-00529-t003" ref-type="table">Table 3</xref>). According to <xref rid="molecules-21-00529-t003" ref-type="table">Table 3</xref>, <italic>cis</italic>-nerolidol displayed shorter retention times than <italic>trans</italic>-nerolidol regardless of the type of GC or LC column used. Besides retention time, one can also discriminate <italic>cis</italic>- from <italic>trans</italic>-nerolidol by referring to the retention indices (RIs) and RIs can be used for comparison across different chromatographic systems [<xref rid="B53-molecules-21-00529" ref-type="bibr">53</xref>]. RIs, also known as Kov&#x000e1;ts retention indices, are frequently used along with mass spectrometry because the combination provides a more accurate identification of isomers, which is often difficult to be achieved by mass spectrometry alone [<xref rid="B54-molecules-21-00529" ref-type="bibr">54</xref>]. The retention indices of different chromatographic columns of GC are shown in <xref rid="molecules-21-00529-t003" ref-type="table">Table 3</xref>.</p></sec><sec id="sec4-molecules-21-00529"><title>4. Industrial Synthesis of Nerolidol</title><p>Chemical synthesis of nerolidol is required to increase its production in order to meet the growing industrial demand for nerolidol. Initially, nerolidol was synthesized as an intermediate in the chemical synthesis of geranyl esters from linalool [<xref rid="B59-molecules-21-00529" ref-type="bibr">59</xref>]. The process began with the treatment of linalool with diketene or ethyl acetoacetate by the Carroll reaction to yield a mixture of (<italic>E</italic>)- and (<italic>Z</italic>)-geranylacetone [<xref rid="B59-molecules-21-00529" ref-type="bibr">59</xref>]. Addition of acetylene to both (<italic>E</italic>)- and (<italic>Z</italic>)-geranylacetone led to the production of (<italic>E</italic>)- and (<italic>Z</italic>)-dehydronerolidol, respectively, which were selectively hydrogenated to <italic>trans</italic>- and <italic>cis</italic>-nerolidol, respectively, using a Lindlar catalyst [<xref rid="B60-molecules-21-00529" ref-type="bibr">60</xref>]. The overall chemical synthesis of (<italic>E</italic>)- and (<italic>Z</italic>)-nerolidol is illustrated as shown in <xref ref-type="scheme" rid="molecules-21-00529-sch001">Scheme 1</xref> as described by Nigmatov <italic>et al.</italic> [<xref rid="B59-molecules-21-00529" ref-type="bibr">59</xref>].</p><p>Although nerolidol can be obtained via the aforementioned chemical reaction or isolation from natural sources, both methods suffer from the disadvantages that they are expensive and produce low yields of end products. In order to overcome these limitations, researchers have utilized eukaryotes such as yeast to produce higher yields of nerolidol. Therefore, a new method of nerolidol production has been developed and patented [<xref rid="B61-molecules-21-00529" ref-type="bibr">61</xref>]. The method involved the cultivation of a yeast strain (particularly <italic>Saccharomyces cerevisiae</italic>, as it is a natural producer of farnesyl diphosphate (FDP)) lacking functional squalene synthase by modifying one <italic>ERG9</italic> squalene synthase gene. This was because the absence of functional squalene synthase prevented the conversion of FDP to squalene, therefore causing FDP to accumulate. The next step involved modifying the yeast to overexpress 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase using an inducible promoter such as <italic>GAL1</italic> HMG CoA reductase, leading to a higher throughput of FDP. The last step involved growing the yeast in a synthetic medium which is lacking of uracil so that FDP can be fully hydrolyzed into nerolidol. Further shifting towards nerolidol production can be also enhanced by adjusting the pH of the medium to be more acidic either at the start, during or at the end of the growth cycle.</p></sec><sec id="sec5-molecules-21-00529"><title>5. The Ecological Role and Biosynthesis of Nerolidol</title><p>Plant secondary metabolites (PSMs) are organic compounds that do not interfere with the primary metabolism of plants. Given that they mediate many ecological functions, PSMs are mainly secreted as plant defenses against herbivore and pathogen damages [<xref rid="B62-molecules-21-00529" ref-type="bibr">62</xref>]. PSMs are stored either constitutively in inactive forms or induced in response to insect or microbe attack. To thwart off pathogens and herbivores, PSMs employ different chemical defensive strategies involving secondary metabolite pathways [<xref rid="B62-molecules-21-00529" ref-type="bibr">62</xref>]. The first strategy consists of an indirect defense mechanism in which the plants confront herbivores indirectly by secreting herbivore-induced plant volatiles (HIPVs) to attract parasitoids and natural enemies of herbivores [<xref rid="B63-molecules-21-00529" ref-type="bibr">63</xref>]. On the other hand, the direct defense mechanism employs another strategy, that is, toxic, volatile and non-volatile metabolites which are stored in specialized cells to be released or activated when plants are attacked by pathogens [<xref rid="B64-molecules-21-00529" ref-type="bibr">64</xref>].</p><p>Among PSMs, terpenoids are the most structurally diverse group. For instance, monoterpenes and sesquiterpenes are the major volatile terpenoids released from plants [<xref rid="B65-molecules-21-00529" ref-type="bibr">65</xref>]. Their function are diverse ranging from basic plant functions such as photosynthesis, respiration, growth and development, to playing role in plant defense mechanism to protect plants against herbivore and pathogen attacks [<xref rid="B66-molecules-21-00529" ref-type="bibr">66</xref>].</p><p>In general, terpenoids are formed from the universal C5 precursor isopentenyl diphosphate (IPP) and its allylic isomer dimethylallyl diphosphate (DMAPP) [<xref rid="B67-molecules-21-00529" ref-type="bibr">67</xref>]. Subsequently, condensation of IPP and DMAPP by prenyltransferases leads to the production of linear isoprenyl diphosphate precursors of many chain lengths such as geranyl diphosphate (GDP), FDP and geranylgeranyl diphosphate (GGDP). The allylic prenyldiphosphates of GDP, FDP and GGDP are then converted by terpene synthases (TPSs) to form monoterpenes (C<sub>10</sub>), sesquiterpenes (C<sub>15</sub>) and diterpenes (C<sub>20</sub>), respectively [<xref rid="B68-molecules-21-00529" ref-type="bibr">68</xref>].</p><p>With regard to the production of nerolidol, (<italic>E</italic>)-nerolidol synthase was recently found to be responsible for the conversion of FDP, the universal precursor of sesquiterpenes to (3<italic>S</italic>)-(<italic>E</italic>)-nerolidol. In snapdragon (<italic>Antirrhinum majus</italic> L.), Nagegowda <italic>et al.</italic> have recently purified two nerolidol/linalool synthases (AmNES/LIS-1/-2) that are responsible for the production of nerolidol and linalool. AmNES/LIS-1 is found in the cytosol and is responsible for nerolidol biosynthesis, whereas AmNES/LIS-2 is located in the plastids and is responsible for the formation of linalool [<xref rid="B69-molecules-21-00529" ref-type="bibr">69</xref>]. Similar to snapdragon, (3<italic>S</italic>)-(<italic>E</italic>)-nerolidol synthase activities were demonstrated in maize [<xref rid="B70-molecules-21-00529" ref-type="bibr">70</xref>]. Schnee <italic>et al.</italic> isolated the terpene synthase 1 (TPS1) enzyme, which is encoded by the maize <italic>TPS1</italic> gene to produce both 3<italic>R</italic>- and 3<italic>S</italic>-enantiomer of (<italic>E</italic>)-nerolidol [<xref rid="B71-molecules-21-00529" ref-type="bibr">71</xref>]. Due to the stimulation of herbivore damage, the expression of <italic>tps1</italic> was increased by almost 8-fold, followed by the conversion of (<italic>E</italic>)-nerolidol to (3<italic>E</italic>)-4,8-dimethyl-1,3,7-nonatriene (DMNT). Taken all together, the conversion of (<italic>E</italic>)-nerolidol to DMNT is crucial due to the fact that DMNT acts as an herbivore-induced volatile to protect the plant against herbivore damage. The overall biosynthesis mechanism of nerolidol is illustrated in <xref ref-type="scheme" rid="molecules-21-00529-sch002">Scheme 2</xref> as described by Bouwmeester <italic>et al.</italic> [<xref rid="B72-molecules-21-00529" ref-type="bibr">72</xref>].</p></sec><sec id="sec6-molecules-21-00529"><title>6. Pharmacological and Biological Activities of Nerolidol</title><p>With the knowledge that nerolidol plays a very active role in the defense system of some plants, researchers have been interested to further explore various aspects of its pharmacological and biological activities. To date, various pharmacological and biological activities of nerolidol have been reported such as anti-microbial, anti-biofilm, anti-oxidant, anti-parasitic, skin-penetration enhancer, skin-repellent, anti-nociceptive, anti-inflammatory and anti-cancer. <xref rid="molecules-21-00529-t004" ref-type="table">Table 4</xref> summarizes the important information on the pharmacological and biological activities of nerolidol in different <italic>in vitro</italic> and <italic>in vivo</italic> models. Besides the pharmacological and biological activities of nerolidol, the sources of nerolidol extraction from various parts of plants are illustrated as well (<xref ref-type="fig" rid="molecules-21-00529-f002">Figure 2</xref>).</p><sec id="sec6dot1-molecules-21-00529"><title>6.1. Antioxidant Activity</title><p>Reactive oxygen species (ROS) are formed by the incomplete reduction of oxygen during aerobic metabolism [<xref rid="B110-molecules-21-00529" ref-type="bibr">110</xref>]. Superoxide anion (O<sub>2</sub><sup>&#x02013;</sup>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), and hydroxyl radicals (OH&#x02022;) are some examples of ROS. Under normal circumstance or low level of oxidative stress, an in-built antioxidant defense system in the body helps the cells to counteract with any potential damages by detoxifying ROS with appropriate enzymes such as glutathione (GSH) reductase, GSH peroxidase, superoxide dismutase (SOD) and catalase. However, an imbalance in the antioxidant defense system or overproduction of free radicals which exceeds the detoxification capacity of cell may contribute to the onset of oxidative stress [<xref rid="B111-molecules-21-00529" ref-type="bibr">111</xref>]. During oxidative stress, an elevation of intracellular levels of ROS was found to cause damage on biomolecules (lipids, proteins and DNA) [<xref rid="B112-molecules-21-00529" ref-type="bibr">112</xref>]. Thus, high level of ROS is detrimental to cells. It is mainly due to the formation and accumulation of cellular damage resulted from oxidative stress and subsequently leading to the loss of cellular functions. If left untreated, it will result in many complications such as cancer, cardiovascular diseases and neurodegenerative disorders [<xref rid="B113-molecules-21-00529" ref-type="bibr">113</xref>].</p><p>Given the fact that chemical compounds belonging to the sesquiterpene group are well known for their antioxidant properties [<xref rid="B113-molecules-21-00529" ref-type="bibr">113</xref>,<xref rid="B114-molecules-21-00529" ref-type="bibr">114</xref>], perhaps antioxidant activity may be expected from nerolidol. Furthermore, EOs containing nerolidol derived from medicinal plants were found to exhibit antioxidant activity, suggesting its plausible utilization as an antioxidant agent. Indeed, it has been demonstrated that nerolidol exhibits potent antioxidant properties in counterbalancing the effect of ROS by protecting the cells against oxidative damage to lipids, proteins and DNA [<xref rid="B73-molecules-21-00529" ref-type="bibr">73</xref>,<xref rid="B74-molecules-21-00529" ref-type="bibr">74</xref>,<xref rid="B75-molecules-21-00529" ref-type="bibr">75</xref>]. According to a study conducted by Vinholes <italic>et al.</italic>, the antioxidant activity of <italic>cis</italic>-nerolidol was evaluated using 1,1-diphenyl-2-picrylhydrazine (DPPH) radical scavenging assay. The study revealed that <italic>cis</italic>-nerolidol exhibited DPPH scavenging activity [<xref rid="B73-molecules-21-00529" ref-type="bibr">73</xref>]. In another study, <italic>cis</italic>-nerolidol was found to possess higher scavenging activity towards hydroxyl radicals with IC<sub>50</sub> measured at 1.48 mM [<xref rid="B73-molecules-21-00529" ref-type="bibr">73</xref>]. Due to the ability in scavenging several types of free radicals, <italic>cis</italic>-nerolidol was evidenced to protect Caco-2 cells against oxidative stress induced by tert-butyl hydroperoxide (tert-BuOOH), suggesting that nerolidol is a good antioxidant that exerts protection against oxidative damage [<xref rid="B73-molecules-21-00529" ref-type="bibr">73</xref>]. Another study conducted by Vinholes <italic>et al.</italic> reported that <italic>cis-</italic>nerolidol mediated its strong antioxidant activity in protecting the hepatocytes through the inhibition of lipid peroxidation induced by tert-BuOOH, thereby 1mM of <italic>cis</italic>-nerolidol resulted in 36.50% &#x000b1; 4.47% of malonaldehyde (MDA) reduction [<xref rid="B74-molecules-21-00529" ref-type="bibr">74</xref>]. </p><p>Besides the <italic>in vitro</italic> evidences displaying the antioxidant properties of nerolidol, an <italic>in vivo</italic> study by Nogueira Neto <italic>et al.</italic> demonstrated the neuroprotective effects of nerolidol (a mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol) in adult male <italic>Swiss</italic> albino mice hippocampus against neuronal damages induced by oxidative stress [<xref rid="B75-molecules-21-00529" ref-type="bibr">75</xref>]. The study demonstrated that significant decrease in MDA and nitrite levels were observed for the nerolidol group at doses of 25, 50 and 75 mg/kg when compared to saline, the negative control. Beside that, nerolidol also increased the antioxidant enzymatic activities of superoxide dismutase and catalase at doses of 25, 50 and 75 mg/kg. These observations suggest that nerolidol mediates a potent antioxidant activity by scavenging free radicals, preventing lipid peroxidation and enhancing the production of antioxidant enzymes in cells for protection against oxidative stress [<xref rid="B115-molecules-21-00529" ref-type="bibr">115</xref>,<xref rid="B116-molecules-21-00529" ref-type="bibr">116</xref>].</p></sec><sec id="sec6dot2-molecules-21-00529"><title>6.2. Antibacterial Activity</title><p>The decrease in the effectiveness of many antibiotics due to the rise of antimicrobial resistance is a global concern faced by the pharmaceutical, medical and food industries. Consequently, the number of infections caused by multidrug-resistant bacteria is increasing globally, leading to increased risk of mortality and morbidity [<xref rid="B117-molecules-21-00529" ref-type="bibr">117</xref>]. Due to this, a large proportion of investments by pharmaceutical industries are being put into drug discovery research of new inhibitory compounds of microbiological, plant, or animal origin to be developed into potentially new anti-microbial drugs.</p><p>The studies showed that nerolidol exhibited potent antimicrobial activity against <italic>Staphylococcus aureus</italic> FDA 209P, 14 strains of methicillin-susceptible <italic>S. aureus</italic> (MSSA) and 20 strains of methicillin-resistant <italic>S. aureus</italic> (MRSA) with MIC values ranging from 512 to over 1024 &#x003bc;g/mL [<xref rid="B76-molecules-21-00529" ref-type="bibr">76</xref>]. Besides, nerolidol possessed antibacterial activity against various strains of <italic>Staphylococcus aureus</italic> including MRSA by disrupting the cell membranes as indicated by the increased leakage of K<sup>+</sup> ions from the bacterial cells [<xref rid="B76-molecules-21-00529" ref-type="bibr">76</xref>,<xref rid="B77-molecules-21-00529" ref-type="bibr">77</xref>,<xref rid="B78-molecules-21-00529" ref-type="bibr">78</xref>]. The observed effects could be due to the presence of the long aliphatic chain in chemical structure of nerolidol. The hypothesis may comply with the findings of Togashi <italic>et al.</italic> [<xref rid="B118-molecules-21-00529" ref-type="bibr">118</xref>] that the terpene alcohols with carbon chains of C10 to C12 (the numbering is started from the carbon atom connected to a hydroxyl group) was found to exhibit a strong antibacterial activity against <italic>S. aureus</italic> FDA209P. Since the carbon chain length of nerolidol is C12, it was shown to cause damage to the cell membrane, leading to the leakage of macromolecules and eventually cell lysis [<xref rid="B78-molecules-21-00529" ref-type="bibr">78</xref>]. Besides causing membrane disruption, nerolidol was also found to interfere with genes which regulate the pathogenicity of the pathogens. For example, a study conducted by Lee <italic>et al.</italic> reported that <italic>cis-</italic>nerolidol present in the black pepper oil was responsible for the down-regulation of the &#x003b1;-hemolysin gene <italic>hla</italic> expression in <italic>S. aureus</italic> via quantitative real-time PCR analyses [<xref rid="B45-molecules-21-00529" ref-type="bibr">45</xref>]<italic>.</italic></p><p>In a similar way, EOs of <italic>Momordica charantia</italic> L. seed was found to exhibit strong antibacterial activity against <italic>S. aureus</italic> ATCC 6538 with MIC value of 125 &#x003bc;g/mL. The high content of <italic>trans</italic>-nerolidol was suggested to be responsible for the antibacterial activity demonstrated by the EOs of <italic>Momordica charantia</italic> L. seed [<xref rid="B7-molecules-21-00529" ref-type="bibr">7</xref>]. Likewise, the study conducted on the antimicrobial activity of green tea flavor components by Kubo [<xref rid="B79-molecules-21-00529" ref-type="bibr">79</xref>] has also shown that nerolidol as one of the ten major green tea flavor compounds, exhibited anti-microbial activity against <italic>S. aureus</italic> with MIC values of 200 &#x003bc;g/mL. Besides, nerolidol was also found to exert the strongest antibacterial activity against <italic>Streptococcus mutans</italic> when compared among the ten green tea flavor compounds with a MIC value of 25 &#x003bc;g/mL [<xref rid="B79-molecules-21-00529" ref-type="bibr">79</xref>]. Meanwhile, nerolidol derived from the leaf EO of <italic>Ginkgo biloba</italic> (L.) demonstrated the highest antibacterial activity against <italic>Salmonella enterica</italic>, and <italic>S. aureus</italic> when compared to other EOs (isophytol, linalool, &#x003b2;-sitosterol acetate, &#x003b2;-sitosterol, stigmasterol, ergosterol, &#x003b2;-sitosterol-3-<italic>O</italic>-&#x003b2;-<sc>d</sc>-gluco-pyranoside and <italic>Ginkgo biloba</italic> polyprenols (GBP)) [<xref rid="B31-molecules-21-00529" ref-type="bibr">31</xref>]. The evidences presented above may suggest nerolidol can be a good antibacterial agent particularly against <italic>S. aureus</italic>.</p><p>Besides the direct antibacterial action of nerolidol, nerolidol (<italic>cis</italic>-nerolidol and the racemic mixture of cis- and <italic>trans</italic>-isomers (1:1)) was found to potentiate the action of antibiotics, namely amoxicilline/clavulanic acid against <italic>S. aureus</italic> and amoxicilline/clavulanic acid, ceftadizine and imipenem against <italic>Escherichia coli</italic> [<xref rid="B80-molecules-21-00529" ref-type="bibr">80</xref>]. The sensitization effect was also observed when nerolidol enhanced the susceptibility of <italic>S. aureus</italic> to ciprofloxacin, clindamycin, erythromycin, gentamicin, tetracycline, and vancomycin. Other than <italic>S. aureus,</italic> nerolidol was also found to enhance the susceptibility of <italic>E. coli</italic> ATCC 25922 to polymyxin B [<xref rid="B81-molecules-21-00529" ref-type="bibr">81</xref>]. These findings were further supported by the experiment conducted by Sim&#x000f5;es <italic>et al.</italic> as it revealed that the treatment of nerolidol (racemic mixture of the <italic>cis</italic>- and <italic>trans</italic>-nerolidol) (1:1) potentiated the susceptibility of <italic>E. coli</italic> and <italic>S. aureus</italic> towards the antibiotics (ciprofloxacin, erythromycin, gentamicin and vancomycin), thereby resulted in significantly lower MIC concentrations [<xref rid="B82-molecules-21-00529" ref-type="bibr">82</xref>]. Moreover, the study also demonstrated a moderate correlation between cell killing and permeabilization effects of nerolidol against both <italic>S. aureus</italic> and <italic>E. coli</italic>, suggesting that nerolidol exerted its action by modifying the bacterial outer layer as evidenced by the increased propidium iodide uptake [<xref rid="B82-molecules-21-00529" ref-type="bibr">82</xref>]. All these observations suggest that nerolidol provides an alternative therapeutic option for the development of drug combinations that may be more effective in controlling multi-drug resistant bacteria. </p></sec><sec id="sec6dot3-molecules-21-00529"><title>6.3. Anti-Biofilm Activity</title><p>Many bacteria are known to possess the ability to produce biofilm, which is defined as a community of microorganisms held together by a self-produced extracellular matrix and attached to living or inert surfaces such as polystyrene, glass, stainless steel and blood components in different environments [<xref rid="B119-molecules-21-00529" ref-type="bibr">119</xref>]. Due to the complexity of the biofilm structure formation, microbial biofilms represent a significant challenge to the medical and pharmaceutical industries. The formation of biofilm induces microbial resistance to anti-microbial agents as well as to the body&#x02019;s immune system. It has also been associated with the increased antibiotic resistance, thereby leading to biofilm-associated infections which complicate the treatment procedure. Therefore, there is a new trend in recent studies focusing on the evaluation of essential oils as potential inhibitors of biofilm formation. In the meantime, nerolidol was found to exhibit anti-biofilm activity against a number of pathogens. For example, a study conducted by Lee <italic>et al.</italic> has revealed that the EO of <italic>Cananga odorata</italic> (Lam.) Hook.f. &#x00026; Thomson exhibited strong biofilm activity in a dose-dependent manner against the biofilm formation of <italic>S. aureus</italic> ATCC 6538 [<xref rid="B45-molecules-21-00529" ref-type="bibr">45</xref>]. The anti-biofilm activity was attributed to the presence of <italic>cis</italic>- and <italic>trans</italic>-nerolidol in the essential oil of <italic>C. odorata</italic>. It was demonstrated that the <italic>cis</italic>-nerolidol at 0.01% (<italic>v</italic>/<italic>v</italic>) inhibited <italic>S. aureus</italic> biofilm formation by more than 80%, whereas <italic>trans</italic>-nerolidol at similar concentration exerted 45% inhibition. Another study conducted by Curvelo <italic>et al.</italic> revealed that the EO of <italic>Piper claussenianum</italic> (Miq.) C. DC., Piperaceae leaf (<italic>trans</italic>-nerolidol identified as the main component (81.4%) in this EO) decreases the formation of biofilm by <italic>Candida albicans</italic> for 30% and 50% after 24 and 48 incubation hours, respectively [<xref rid="B32-molecules-21-00529" ref-type="bibr">32</xref>]. The same study also compared the anti-biofilm activities of the <italic>cis,trans-</italic>nerolidol and <italic>cis-</italic>nerolidol on the pre-formed biofilm by <italic>C. albicans</italic>. The study indicated that <italic>cis,trans-</italic>nerolidol resulted a stronger reduction in the viability of the mature biofilm than that of <italic>cis</italic>-nerolidol. Thus, it was suggested that <italic>trans</italic>-nerolidol, which was the main constituent in EO of Piper claussenianum (Miq.) C. DC., Piperaceae leaf, may responsible for the observed anti-biofilm activity in reducing the viability of the pre-formed biofilms.</p></sec><sec id="sec6dot4-molecules-21-00529"><title>6.4. Anti-Fungal Activity</title><p>Various anti-fungal agents have been developed to control the spread of fungal diseases such as candidiasis [<xref rid="B120-molecules-21-00529" ref-type="bibr">120</xref>]. However, there are serious questions concerning the safety of these drugs due to their well-known side-effects as well as the possible development of antifungal drug resistance [<xref rid="B121-molecules-21-00529" ref-type="bibr">121</xref>]. Therefore, the attention has been shifted to bio-prospecting the natural products to overcome or control fungal infections. In fact, EOs have been extensively studied and have been proven to be effective against fungal infections [<xref rid="B122-molecules-21-00529" ref-type="bibr">122</xref>]. </p><p>There are many evidences that support the effectiveness of nerolidol in exhibiting anti-fungal activity. <italic>Trans</italic>-nerolidol, which is a major component of leaf EO of <italic>Piper claussenianum</italic> (Miq.) C. DC., Piperaceae (81.4%), has been shown to exhibit fungicidal activity against <italic>Candida albicans</italic> with MIC values measured ranging from 0.24%&#x02013;1.26% [<xref rid="B32-molecules-21-00529" ref-type="bibr">32</xref>]. Similarly, the leaf EO also exerted a strong activity in the inhibition of germ-tube transformation of <italic>Candida albicans</italic> by 81% [<xref rid="B32-molecules-21-00529" ref-type="bibr">32</xref>]. In another study, nerolidol has also been found to possess strong antifungal activity by distorting the hyphal growth of <italic>Trichophyton mentagrophytes</italic> at the concentration of 0.4 mg/mL [<xref rid="B16-molecules-21-00529" ref-type="bibr">16</xref>]. Also, the growth of <italic>T. mentagrophyte</italic><italic>s</italic> was inhibited by nerolidol derived from green tea flavor with MIC value measured at 12.5 &#x003bc;g/mL [<xref rid="B79-molecules-21-00529" ref-type="bibr">79</xref>].</p><p>Lee <italic>et al.</italic> reported a strong anti-fungal effect of nerolidol against <italic>Microsporum gypseum</italic> that causes dermatophytosis, a superficial infection in keratinized tissues including hair, nail and stratum corneum of skin [<xref rid="B83-molecules-21-00529" ref-type="bibr">83</xref>]. Although nerolidol (0.5%&#x02013;2%) was found to exhibit lower anti-fungal activity as compared to eugenol (0.01%&#x02013;0.03%), the study showed that nerolidol was more effective in reducing the skin lesion than eugenol in guinea pig model. Moreover, histopathologic analysis revealed that animals treated with nerolidol had a lower degree of hyperkeratosis and inflammatory cell infiltration than non-treated animals.</p><p>Besides its anti-fungal effect against human pathogens, nerolidol also shows promising outcomes in controlling fungal infections in plants caused by phytopathogenic fungi. <italic>Trans</italic>-nerolidol, extracted from EO of <italic>Lantana radula</italic> Sw., has demonstrated to exhibit stronger fungistatic activity against the the phytopathogenic fungi <italic>Corynespora cassiicola</italic> than the EO extracted from <italic>Lantana camara</italic> [<xref rid="B33-molecules-21-00529" ref-type="bibr">33</xref>]. Similarly, the leaf EO of <italic>Piper chaba</italic> Hunter which contained the <italic>trans</italic>-nerolidol as one of the major constituents, exhibited antifungal activity against phytopathogenic fungi such as <italic>Fusarium oxysporum</italic>, <italic>Phytophthora capsici</italic>, <italic>Colletotrichum capsici</italic>, <italic>Fusarium solani</italic> and <italic>Rhizoctonia solani</italic> with 55.1 to 70.3% growth inhibition and a MIC ranging from 125 and 500 &#x000b5;g/mL [<xref rid="B34-molecules-21-00529" ref-type="bibr">34</xref>].</p><p>Znini <italic>et al.</italic> have also reported strong anti-fungal activity of <italic>trans</italic>-nerolidol extracted from EOs of aerial parts of <italic>Warionia saharae</italic> ex Benth. &#x00026; Coss. against the three apple phytopathogenic fungi, <italic>Alternaria</italic> sp., <italic>Penicillium expansum</italic> and <italic>Rhizopus stolonifer</italic> causing the deterioration of apple by significantly inhibiting the mycelial growth of all strains tested. It was also found to inhibit the fungal spore production of <italic>Alternaria</italic> sp., <italic>P. expansum</italic> and <italic>R. stolonifera</italic> at the dosage of 1, 2 and 2 &#x000b5;L/mL air, respectively [<xref rid="B26-molecules-21-00529" ref-type="bibr">26</xref>]. Besides this result, another study conducted by Pontin <italic>et al.</italic> has revealed strong antifungal activity of nerolidol in inhibiting mycelial growth and sclerotial production by ~85% and ~ 84%, respectively [<xref rid="B84-molecules-21-00529" ref-type="bibr">84</xref>]. Nerolidol was also found to cause alterations in hyphal morphology and membrane permeability as demonstrated by hyphal shrinkage and partial distortion [<xref rid="B84-molecules-21-00529" ref-type="bibr">84</xref>]. In addition, the study revealed an increase in the level of nerolidol in garlic (<italic>Allium sativum</italic> L.) tissues in response to fungal attack by <italic>Sclerotium cepivorum</italic> [<xref rid="B84-molecules-21-00529" ref-type="bibr">84</xref>]. Based on the number of studies reported on the anti-fungal activity of <italic>trans</italic>-nerolidol, it could be suggested that <italic>trans</italic>-nerolidol is a good candidate for the development of anti-fungal drugs.</p></sec><sec id="sec6dot5-molecules-21-00529"><title>6.5. Anti-Parasitic Activity</title><p>Parasitic diseases such as malaria, leishmaniasis, sleeping sickness and Chagas&#x02019; disease continue to affect hundreds of millions of people around the world with a majority of them living in tropical regions [<xref rid="B123-molecules-21-00529" ref-type="bibr">123</xref>]. However, most of them live in countries where the prospects of any financial return on investment are too low to support market-driven drug discovery and development of new drugs on parasitic diseases. Moreover, the emergence of parasites resistant to current anti-parasitic drugs thwarts the effort in treating the parasitic diseases. All these challenges underline the importance of plant EO as potential novel anti-parasitic agents [<xref rid="B89-molecules-21-00529" ref-type="bibr">89</xref>,<xref rid="B124-molecules-21-00529" ref-type="bibr">124</xref>].</p><sec id="sec6dot5dot1-molecules-21-00529"><title>6.5.1. Anti-Leishmaniasis</title><p>Leishmaniasis is a vector-borne infection caused by protozoan parasites from the genus of <italic>Leishmania</italic>. Leishmaniasis affects approximately 350 million people in 88 tropical and subtropical countries. The clinical syndromes and manifestations of leishmaniasis vary widely but are often divided into the three clinically distinct syndromes, the visceral leishmaniasis, cutaneous leishmaniasis (CL), and mucosal leishmaniasis (ML), depending on the parasite species and the host&#x02019;s immune response [<xref rid="B125-molecules-21-00529" ref-type="bibr">125</xref>]. CL has affected mankind for centuries, mainly affecting the skin or mucous membranes and is distinguished by the presence of ulcerative skin lesions. On the other hand, VL is fatal if left untreated and the cutaneous forms are disfiguring and mutilating. Although pentavalent antimonials are still widely used to treat leishmaniasis, they are toxic, poorly tolerated and become increasingly ineffective to cure drug-resistant parasites [<xref rid="B126-molecules-21-00529" ref-type="bibr">126</xref>]. Therefore, the search of alternative drugs continues.</p><p>Recently, <italic>trans</italic>-nerolidol purified from the leaf EO of <italic>Baccharis dracunculifolia</italic> DC has been found to mediate strong anti-leishmanial activity against promastigotes of <italic>Leishmania</italic> (<italic>L.</italic>) <italic>donovani</italic> with an IC<sub>50</sub> and IC<sub>90</sub> values of 42 and 85 &#x000b5;g/mL, respectively [<xref rid="B8-molecules-21-00529" ref-type="bibr">8</xref>]. Besides this study, nerolidol also exhibited anti-leishmaniasis activity by inhibiting the growth of <italic>L. amazonensis</italic>, <italic>L. braziliensis</italic>, and <italic>L. chagasi</italic> promastigotes and <italic>L. amazonensis</italic> amastigotes with <italic>in vitro</italic> IC<sub>50</sub> of 85, 74, 75, and 67 &#x000b5;M, respectively. Moreover, <italic>L. amazonensis</italic>-infected macrophages treated with 100 &#x000b5;M nerolidol resulted in 95% reduction in the rate of infection. Arruda <italic>et al.</italic> suggested that nerolidol at 30 &#x003bc;M mediated anti-leishmaniasis activity through the inhibition of isoprenoid biosynthesis in <italic>L. amazonensis</italic>, as demonstrated by the reduced incorporation of [2-<sup>14</sup>C] mevalonic acid or [1-<sup>14</sup>C] acetic acid precursors into dolichol, ergosterol and ubiquinone in the mevalonate pathway [<xref rid="B86-molecules-21-00529" ref-type="bibr">86</xref>]. However, nerolidol did not reduce the incorporation of [1(<italic>n</italic>)-<sup>3</sup>H] farnesyl pyrophosphate into dolichol and ergosterol, suggesting that nerolidol could be an inhibitor at the early step in the mevalonate pathway [<xref rid="B86-molecules-21-00529" ref-type="bibr">86</xref>]. Previously, the inhibition of isoprenoid biosynthesis pathway was shown to result in the arrest of development of <italic>Plasmodium falciparum</italic> during the intraerythrocytic stages [<xref rid="B127-molecules-21-00529" ref-type="bibr">127</xref>]. Marques <italic>et al.</italic> have also observed similar growth inhibition of promastigotes of <italic>L. amazonensis</italic> after being treated with <italic>trans</italic>-nerolidol purified from the leaves of <italic>Piper claussenianum</italic> (Miq.) C. DC., Piperaceae [<xref rid="B9-molecules-21-00529" ref-type="bibr">9</xref>]. <italic>Trans</italic>-nerolidol was also found to induce (1) a significant inhibition (62.17%) on the arginase activity of <italic>L. amazonensis</italic> and (2) an increase in the production of nitric oxide (NO) in <italic>L. amazonensis</italic>-infected macrophages. These results indicated that <italic>trans</italic>-nerolidol was able to interfere with parasite-host cell interaction, thus reducing the percentage of infected cells. Another study conducted by Camargos <italic>et al.</italic> have shown that through electron paramagnetic resonance (EPR) spectroscopy, nerolidol was able to increase the molecular dynamics of the lipid component in the <italic>Leishmania</italic> plasma membrane at IC<sub>50</sub> of 0.008 &#x000b5;M [<xref rid="B87-molecules-21-00529" ref-type="bibr">87</xref>]. This could be possibly due to the insertion of nerolidol into the lipid bilayer that act as spacers to increase the fluidity of membranes since nerolidol has high hydrophobicity, thus causing major reorganization in cell membranes [<xref rid="B128-molecules-21-00529" ref-type="bibr">128</xref>]. Subsequently, this will lead to an increase in the overall molecular dynamics of the membrane, causing leakage of cytoplasmic content and eventually the death of <italic>Leishmania</italic> cells.</p></sec><sec id="sec6dot5dot2-molecules-21-00529"><title>6.5.2. Anti-Trypanosomal Activity</title><p>Trypanosomiasis, also known as sleeping sickness, is caused by protozoan parasites of African trypanosomes (e.g., <italic>Trypanosoma brucei</italic> subspecies) and is fatal if left untreated. Its symptoms include swollen lymph nodes, fever, extreme fatigue and rash. <italic>Trans</italic>-nerolidol purified from the aerial part of <italic>Leonotis ocymifolia</italic> (Burm.f.) Iwarsson and leaves of <italic>Strychnos spinosa</italic> Lam. showed anti-trypanosomal activity with IC<sub>50</sub> of 15.78 &#x000b5;g/mL and 1.7 &#x000b5;g/mL, respectively on bloodstream forms of <italic>T. brucei brucei</italic> [<xref rid="B27-molecules-21-00529" ref-type="bibr">27</xref>,<xref rid="B35-molecules-21-00529" ref-type="bibr">35</xref>]. Mohd-Shukri <italic>et al.</italic> conducted an in-depth study about the effects of nerolidol (containing the mixture of &#x000b1;40% <italic>cis</italic>-nerolidol and &#x000b1;55% of <italic>trans</italic>-nerolidol) compared to a positive control, berenil (a standard anti-trypanosomal drug) on the morphological changes of a protozoan parasite <italic>Trypanosoma evansi</italic> in mice by using light and electron microscopy [<xref rid="B85-molecules-21-00529" ref-type="bibr">85</xref>]. Berenil elicited immediate adverse morphological changes after 2&#x02013;3 h post-treatment as demonstrated by stiffening and tapering at both ends of the parasite as well as distorted flagella and loss of undulating membranes. On the other hand, nerolidol only induced adverse morphological changes beginning from 23rd to 25th day post-treatment when the parasites became stiff, lost their undulating membrane. At the 27th day post-treatment, total disfigurement was observed, indicating that nerolidol exhibited promising trypanosomatidal activity against the morphology of <italic>T. evansi</italic> in mice. </p></sec><sec id="sec6dot5dot3-molecules-21-00529"><title>6.5.3. Anti-Schistosomal Activity</title><p>Schistosomiasis is caused by a trematode blood fluke of the genus <italic>Schistosoma</italic> and is one of the most significantly neglected tropical diseases in the world [<xref rid="B129-molecules-21-00529" ref-type="bibr">129</xref>]. Schistosome transmission involves the contamination of water by faeces or urine containing eggs with a specific freshwater snail as intermediate host, followed by human contact with water inhabited by the freshwater snail [<xref rid="B130-molecules-21-00529" ref-type="bibr">130</xref>]. Its acute symptoms include fever, urticaria, diarrhea and eosinophilia. However, schistosomiasis, if left untreated, can progress to its chronic stage, leading to inflammatory and obstructive disease in the urinary system (<italic>S. haematobium</italic>) or intestinal disease, hepatosplenic inflammation, and liver fibrosis [<xref rid="B130-molecules-21-00529" ref-type="bibr">130</xref>]. According to a study by Parreira <italic>et al.</italic>, the EO of <italic>Baccharis dracunculifolia</italic> DC. (Asteraceae) possessed high schistosomicidal activity since all pairs of <italic>Schistosoma mansoni</italic> adult worms were dead after 24 h incubation with the EO at concentrations of 10, 50, and 100 &#x000b5;g/mL [<xref rid="B8-molecules-21-00529" ref-type="bibr">8</xref>]. However, <italic>trans</italic>-nerolidol did not display any significant schistosomicidal activity in the tested assays with the concentration ranging from 10 to 100 &#x000b5;M. In contrast, another experiment conducted by Silva <italic>et al.</italic> have revealed that nerolidol in the form of <italic>cis</italic>- and <italic>trans</italic>-nerolidol racemic mixture (1:1) exerted anti-schistosomal activity by reducing worm motor activity and causing the death of all male and female schistosomes of <italic>Schistosoma mansoni</italic> at concentrations of 31.2 and 62.5 &#x000b5;M, respectively [<xref rid="B88-molecules-21-00529" ref-type="bibr">88</xref>]. The differences between these two results could be due to the fact that <italic>trans</italic>-nerolidol isomer is less active than the racemic mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol [<xref rid="B88-molecules-21-00529" ref-type="bibr">88</xref>]. The study also found that nerolidol induced (1) severe tegumental damage in adult schistosomes and (2) alterations on the tubercles of male parasites in a concentration-dependent manner. With the available findings, a mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol was shown to be a promising candidate to treat schistosomiasis.</p></sec><sec id="sec6dot5dot4-molecules-21-00529"><title>6.5.4. Anti-Malarial Activity</title><p>Malaria is an infection caused by the protozoan parasites belonging to the genus of <italic>Plasmodium</italic> and is transmitted via the bite of <italic>Anopheles</italic> mosquito [<xref rid="B131-molecules-21-00529" ref-type="bibr">131</xref>]. Its symptoms are fever, headache, vomiting, sweating and fatigue. If left untreated, it can cause organ failure, abnormal blood coagulation and ultimately death. According to a study conducted by Lopes <italic>et al.</italic>, nerolidol was found to exhibit strong anti-malarial activity since treatment of <italic>Plasmodium falciparum</italic> with 100 mg/mL of nerolidol extracted from the leaf EO of <italic>Virola surinamensis</italic> (Rol. ex Rottb.) Warb. for 48 h resulted in 100% of the inhibition on the development of young trophozoite to the schizont stage without pigment formation [<xref rid="B29-molecules-21-00529" ref-type="bibr">29</xref>]. Similarly, nerolidol (23.7%), which is one of the major volatile components extracted from inflorescences oil of <italic>Piper claussenianum</italic> (Miq.) C. DC., has been demonstrated to exert anti-malarial activity with IC<sub>50</sub> of 11.1 &#x003bc;g/mL whereas the crude oil of <italic>P. claussenianum</italic> showed IC<sub>50</sub> of 7.9 &#x003bc;g/mL [<xref rid="B89-molecules-21-00529" ref-type="bibr">89</xref>]. The study suggested that nerolidol may exert the inhibition of glycoprotein biosynthesis by repressing the biosynthesis of N-glycoproteins that are otherwise observable in <italic>P. falciparum</italic> mainly at the ring and young trophozoite stages of the intra-erythrocytic cycles [<xref rid="B29-molecules-21-00529" ref-type="bibr">29</xref>]. Besides this mechanism of action, another study conducted by Rodrigues Goulart <italic>et al.</italic> has shown that the nerolidol inhibited the biosynthesis of the isoprenoid chain attached to the benzoquinone ring in the intraethryocytic stages of <italic>Plasmodium falciparum</italic> [<xref rid="B90-molecules-21-00529" ref-type="bibr">90</xref>]. It was evidenced that nerolidol interfered with isoprenoid biosynthesis of apicoplast by disrupting the elongation of isoprenic chains via inhibition of isoprenyl diphosphate synthases, an enzyme that is responsible for the formation of isoprenoid compounds such as dolichols. Beside isoprenyl diphosphate synthase, nerolidol also inhibited the enzyme octaprenyl phosphate/phytoene synthase which is localized in the cytoplasm and also in mitochondria at the intra-erythrocytic stages of <italic>P. falciparum</italic> [<xref rid="B132-molecules-21-00529" ref-type="bibr">132</xref>]. Moreover, treatment with nerolidol at doses 2.2 times below the IC<sub>50</sub> of 0.12 &#x003bc;M was shown to inhibit the production of isoprenic chain attached to coenzyme Q at all intraerythrocytic stages of <italic>P. falciparum</italic> [<xref rid="B91-molecules-21-00529" ref-type="bibr">91</xref>]. These findings indicated that nerolidol possesses strong anti-malarial activity by inhibiting the development of the intraerythrocytic stages of the parasites.</p><p>Besides displaying anti-malarial activity alone, nerolidol has also been found to exhibit a synergistic effect with either fosmidomycin or squalestatin against malarial parasites. The combination of nerolidol with either fosmidomycin or squalestatin resulted in strong supra-additive (the sum of the fractions of IC<sub>50</sub> of &#x0003c;1) interaction in mediating inhibition of plasmodial isoprenoid pathway against <italic>P. falciparum</italic> with strong combinatorial IC<sub>50</sub> of 0.57 and 0.54 &#x003bc;M respectively [<xref rid="B92-molecules-21-00529" ref-type="bibr">92</xref>]. </p></sec><sec id="sec6dot5dot5-molecules-21-00529"><title>6.5.5. Other Anti-Parasitic Activities</title><p>Nerolidol demonstrated strong nematicidal activity against a nematode, <italic>Caenorhabditis elegans</italic> with its LC<sub>50</sub> value of 12 &#x000b5;g/mL as well as 74.0% mortality at 50 &#x000b5;g/mL [<xref rid="B94-molecules-21-00529" ref-type="bibr">94</xref>]. Besides nematicidal activity, nerolidol (a mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol) inhibited the <italic>in vitro</italic> growth of four <italic>Babesia</italic> species with IC<sub>50</sub> values of 21 &#x000b1; 1, 29.6 &#x000b1; 3, 26.9 &#x000b1; 2, and 23.1 &#x000b1; 1 &#x000b5;M for <italic>B. bovis</italic>, <italic>B. bigemina, B. ovata,</italic> and <italic>B. caballi</italic>, respectively. This anti-parasitic activity could be due to inhibition of the isoprenoid pathway by nerolidol by a similar mechanism similar to that found with <italic>Plasmodium falciparum</italic> [<xref rid="B93-molecules-21-00529" ref-type="bibr">93</xref>]. Nerolidol was also found to be the most active compound among the tested sesquiterpenes (nerolidol, farnesol and elemol) that caused the death of nematodes, L<sub>3</sub> larvae of <italic>Anisakis simplex</italic> type I with the mortality at 4 hours of 100% at the concentrations of 31.5 and 62.5 &#x000b5;g/mL [<xref rid="B95-molecules-21-00529" ref-type="bibr">95</xref>]. Moreover, only 20% of nerolidol-treated rats were affected by gastric wall lesions caused by <italic>Anisakis</italic> larvae in comparison to 86% of the control rats [<xref rid="B95-molecules-21-00529" ref-type="bibr">95</xref>].</p></sec></sec><sec id="sec6dot6-molecules-21-00529"><title>6.6. Insect Repellent Activity</title><p>There is a growing concern about the usage of current commercial synthetic insecticides due to the increasing difficulty in the management of pesticide resistance [<xref rid="B133-molecules-21-00529" ref-type="bibr">133</xref>]. For this reason, the researchers have focused on research of EOs that have been traditionally used as repellants. Studies in several countries have shown that certain plant EOs are effective not only in repelling insects, but have contact and fumigant insecticidal activity against specific pests without harmful side-effects to humans and animals [<xref rid="B134-molecules-21-00529" ref-type="bibr">134</xref>,<xref rid="B135-molecules-21-00529" ref-type="bibr">135</xref>]. </p><p>The combination of nerolidol and linalool (that are purified from EO of <italic>Capparis tomentosa</italic> fresh leaves) showed significant repellence activity against maize weevil <italic>Sitophilus zeamais</italic> at all tested doses (0.002, 0.02, 0.2 and 2 &#x000b5;L) [<xref rid="B30-molecules-21-00529" ref-type="bibr">30</xref>]. In another study, <italic>trans</italic>-nerolidol derived from the EO of Siam-wood (<italic>Fokienia hodginsii</italic> (Dunn) A.Henry &#x00026; H H.Thomas) was shown to possess insecticidal activity with LD<sub>50</sub> value at 0.17 &#x000b5;mol/fly [<xref rid="B51-molecules-21-00529" ref-type="bibr">51</xref>]. </p><p>A mixture of nerolidol and tea tree oil with a ratio of 2:1 (tea tree oil 0.5% plus nerolidol 1%) was shown to exert insecticidal and ovicidal activity against <italic>Pediculus capitis</italic> (head lice) and its eggs [<xref rid="B96-molecules-21-00529" ref-type="bibr">96</xref>]. Besides, nerolidol purified from the seeds of <italic>Magnolia denudata</italic> Desr. also showed larvacidal activity against third-instar larvae of insecticide-susceptible <italic>Culex pipiens pallens</italic> and <italic>Aedes aegypti</italic> as well as the wild <italic>Aedes albopictus</italic> and <italic>Anopheles sinensis</italic> with lethal dose (LD)<sub>50</sub> values of 9.84, 13.85, 16.34 and 20.84 mg/L respectively [<xref rid="B47-molecules-21-00529" ref-type="bibr">47</xref>]. Similarly, <italic>trans</italic>-nerolidol, which is one of the components of EO from the leaves of <italic>Melaleuca quinquenervia</italic> (Cav.) S.T.Blake, at its concentration of 0.1 mg/mL exhibited strong larvicidal activity with &#x02265; 95% mortality against <italic>Aedes aegypti</italic> [<xref rid="B36-molecules-21-00529" ref-type="bibr">36</xref>]. </p><p>Meanwhile, the <italic>trans</italic>-nerolidol that was purified from the leaves of <italic>Piper aduncum</italic> L. possessed strong acaricidal activity due to its highest repellency of 83.2% &#x000b1; 0.59% compared to &#x003b1;-humulene (73.3% &#x000b1; 0.83%) and &#x003b2;-caryophyllene (70.7% &#x000b1; 0.88%) against the two-spotted spider mite, <italic>Tetranychus urticae</italic> Koch that causes damage to many agricultural crops [<xref rid="B37-molecules-21-00529" ref-type="bibr">37</xref>]. The EO of aerial parts of <italic>Baccharis dracunculifolia</italic> DC. containing nerolidol as one of the major components was discovered to demonstrate strong acaricidal activity by causing 100% mortality of <italic>Rhipicephalus microplus</italic> larvae (cattle tick that infests cattle) at 20.0 mg/mL [<xref rid="B97-molecules-21-00529" ref-type="bibr">97</xref>]. Meanwhile, a 100% mortality of <italic>Rhipicephalus microplus</italic> larvae was achieved at a lower concentration of nerolidol (15.0mg/mL). The study also demonstrated that nerolidol reduced the quality of the egg and larval hatching rate with increasing concentration from 20 to 50mg/mL [<xref rid="B97-molecules-21-00529" ref-type="bibr">97</xref>].</p></sec><sec id="sec6dot7-molecules-21-00529"><title>6.7. Anti-Ulcer Activity</title><p>Gastric ulcer affects thousands of people around the world and is known to be caused by an imbalance between aggressive (acid, pepsin) and protective factor (secretion and action of mucus and bicarbonate) in the stomach [<xref rid="B98-molecules-21-00529" ref-type="bibr">98</xref>]. It is induced by several factors, such as stress, smoking, nutritional deficiencies and ingestion of non-steroidal anti-inflammatory drugs (NSAIDs). The current therapy for ulcers usually involves the use of histamine H<sub>2</sub>-antagonists, proton pump inhibitors and anti-muscarinics for the inhibition of gastric acid secretion. However, these drugs pose severe side-effects, particularly hypersensitivity, arrhythmia and impotence [<xref rid="B136-molecules-21-00529" ref-type="bibr">136</xref>]. With this in mind, plant EOs have recently been exploited as they have been shown to produce promising results for alternative therapies to treat gastric ulcers with lesser side-effects. </p><p>A study has been conducted by Klopell <italic>et al.</italic> on the anti-ulcer property of nerolidol using different experimental models such as ethanol-, indomethacin- and stress-induced ulceration in rat [<xref rid="B98-molecules-21-00529" ref-type="bibr">98</xref>]. In the stress-induced ulceration model of experiment, nerolidol treatment at 50, 250 and 500 mg/k caused a significant reduction in the ulcerative lesion index (ULI) by 41.22, 51.31 and 56.57, respectively when compared to the control group animals. With regard to the ethanol-induced ulceration model of experiment, treatment with nerolidol at 250 and 500 mg/kg significantly inhibited the formation of ulcer at 52.63% and 87.63%, respectively as compared to the control group. On the other hand, indomethacin-induced ulceration model of experiment, the treatment at 250 and 500 mg/kg of nerolidol had significantly inhibited the gastric ulcer for 51.02% and 46.93%. These findings indicate that nerolidol could be used as an active component in gastroprotective and anti-ulcer treatments.</p></sec><sec id="sec6dot8-molecules-21-00529"><title>6.8. Skin Penetration Enhancer Activity</title><p>Transdermal delivery has gained a lot of attention as an attractive alternative route to intravenous and oral drug delivery systems [<xref rid="B137-molecules-21-00529" ref-type="bibr">137</xref>]. However, the application of transdermal delivery is limited by poor drug permeability as the stratum corneum plays as a rate-limiting lipophilic barrier against the uptake of chemical and biological agents [<xref rid="B138-molecules-21-00529" ref-type="bibr">138</xref>]. Therefore, terpenes are often used as topical skin penetration enhancers due to their wide range of physicochemical properties such as low cutaneous irritancy and good toxicological profile as well as adsorption enhancement ability [<xref rid="B139-molecules-21-00529" ref-type="bibr">139</xref>]. </p><p>Nerolidol has been found to be a potent skin penetration enhancer. It was found to increase the diffusion rate by over 20-fold for transdermal delivery of several drugs especially on 5-fluorouracil [<xref rid="B99-molecules-21-00529" ref-type="bibr">99</xref>]. This high permeation-enhancing ability was attributed to the structure of nerolidol which is suitable for the alignment within lipid lamellae of the stratum corneum in order to disrupt the organization of stratum corneum. This view has been further supported by Prasanthi and Lakshmi [<xref rid="B100-molecules-21-00529" ref-type="bibr">100</xref>] who reported that nerolidol with highest lipophilicity (log P = 5.36 &#x000b1; 0.38) have the highest enhancement effect with its rank of order of nerolidol &#x0003e; farnesol &#x0003e; limonene &#x0003e; linalool &#x0003e; geraniol &#x0003e; carvone &#x0003e; fenchone &#x0003e; menthol in facilitating transdermal delivery of alfuzosin hydrochloride. Similarly, nerolidol has the highest permeation enhancing ability with a 3.2-fold increase in permeation of selegiline hydrochloride across the rat skin, followed by carvone (2.8-fold increase) and anethole (2.6-fold increase) [<xref rid="B101-molecules-21-00529" ref-type="bibr">101</xref>]. Another study conducted by El-Kattan <italic>et al.</italic> has shown that nerolidol was the most effective percutaneous permeation enhancer for four model drugs (nicardipine hydrochloride, hydrocortisone, carbamazepine, and tamoxifen) when compared to other terpenes (fenchone, thymol, nerolidol and <sc>d</sc>-limonene) [<xref rid="B102-molecules-21-00529" ref-type="bibr">102</xref>]. </p></sec><sec id="sec6dot9-molecules-21-00529"><title>6.9. Anti-Nociceptive and Anti-Inflammatory Activity</title><p>Pain is an unpleasant sensation and emotional experience that is associated with actual or potential tissue damage [<xref rid="B140-molecules-21-00529" ref-type="bibr">140</xref>]. On the other hand, the stimulation of nociception is associated with the detection of real tissue injury or a potentially damaging event by nociceptors as a stimuli (transduction) followed by its transmission of encoded information to the brain [<xref rid="B141-molecules-21-00529" ref-type="bibr">141</xref>]. Under normal circumstances, the presence of an injury activates the inflammatory response as follows: firstly the inflammatory mediators are released from damaged cells such as ions (K<sup>+</sup>, H<sup>+</sup>), bradykinin, histamine, 5-hydroxytryptamine (5-HT), ATP and nitric oxide. Subsequent activation of arachidonic acid pathway leads to the production of prostanoids and leukotrienes that would then lead to the release of more inflammatory mediators such as cytokines and growth factors. These mediators will ultimately activate peripheral nociceptors directly, resulting in spontaneous pain. Beside this action, they also act to convert responses of primary afferent neurons to subsequent stimuli (peripheral sensitization) to be transmitted to the brain. Due to exacerbated physiological response, chronic exposure to pain is very harmful to an individual as it can cause organ damage and ultimately death, if left untreated [<xref rid="B142-molecules-21-00529" ref-type="bibr">142</xref>].</p><p>Non-steroid anti-inflammatory drugs (NSAIDs) are well-known analgesic drugs that act to reduce inflammation and pain by acting as an inhibitor of cyclooxygenases (COXs) in the arachidonic acid pathway. However, one major disadvantage of administration of NSAIDs is their serious side-effects such as significant gastrointestinal upset, gastritis, ulceration, hemorrhage, and even death [<xref rid="B143-molecules-21-00529" ref-type="bibr">143</xref>]. In order to address this issue, EOs extracted from various medicinal plants have been increasingly explored as alternative traditional medicines to treat inflammation and pain without posing harmful side-effects.</p><p>Pinheiro <italic>et al.</italic> investigated the anti-nociceptive and anti-inflammatory effects of EO of <italic>Peperomia serpens</italic> (Sw.) Loudon in rodents [<xref rid="B38-molecules-21-00529" ref-type="bibr">38</xref>]. The EO has been found to possess anti-inflammatory and anti-nociceptive activities which could possibly be mediated by one of its major compounds, <italic>trans</italic>-nerolidol (38.0%). In a similar experiment, Lima <italic>et al.</italic> reported anti-nociceptive and anti-inflammatory activities of the EO of the aerial parts of <italic>Piper aleyreanum</italic> C. DC which is attributable to the presence of <italic>trans</italic>-nerolidol (1.2%) [<xref rid="B10-molecules-21-00529" ref-type="bibr">10</xref>]. In order to strengthen the findings, Fons&#x000ea;ca <italic>et al.</italic> investigated the anti-nociceptive and anti-inflammatory activities of nerolidol using mouse models of pain [<xref rid="B103-molecules-21-00529" ref-type="bibr">103</xref>]. The study found that nerolidol has no effect on the locomotor activity. Meanwhile, anti-nociceptive activity was evaluated via acetic acid-induced writhing and the formalin tests. The results demonstrated that oral administration of nerolidol was able to cause lesser acetic acid-induced abdominal contractions and also inhibition in paw licking behavior in the respective tests when compared to the control group (<xref rid="molecules-21-00529-t004" ref-type="table">Table 4</xref>). These results implied that nerolidol modulates its effect on neuropathic pain and inflammatory processes as demonstrated by the formalin test [<xref rid="B103-molecules-21-00529" ref-type="bibr">103</xref>]. However, the anti-nociceptive effect of nerolidol did not involve the thermal stimulation of centrally mediated nociception as shown by the negative hot-plate test result. In addition, the researchers also further elucidated the possible anti-nociceptive mechanisms of nerolidol by examining its effects on the parameters GABAergic system, opioidergic and ATP-sensitive K+ channels. The results have shown a positive association of nerolidol with the GABAergic system but not with opioidergic or ATP-sensitive K+ channels, implying that the anti-nociceptive activtity of nerolidol is mediated through GABA<sub>A</sub> receptors [<xref rid="B103-molecules-21-00529" ref-type="bibr">103</xref>]. In order to evaluate the anti-inflammatory activity of nerolidol, carrageenan-induced paw edema was used as a model of inflammation. It was found that nerolidol exhibited inhibitory effect on inflammation. Further investigation of carrageenan-induced peritonitis model revealed that nerolidol decreased the levels of polymorphonuclear cells and tumor necrosis factor (TNF-&#x003b1;) in peritoneal lavage as well as interleukin 1 beta (IL-1b) in LPS-stimulated, peritoneal macrophages (<xref rid="molecules-21-00529-t004" ref-type="table">Table 4</xref>) [<xref rid="B103-molecules-21-00529" ref-type="bibr">103</xref>]. Taken these results together, nerolidol has been shown to demonstrate promising analgesic and anti-inflammatory activities.</p></sec><sec id="sec6dot10-molecules-21-00529"><title>6.10. Anti-Cancer and Anti-Tumor Activity</title><p>Cancer is one of the most alarming causes of death, with an estimated over six million deaths have been reported around the world annually. It is a multifactorial disease that leads to uncontrolled growth and invasion of abnormal cells, ultimately leading to the formation of tumor. Chemotherapy, radiosurgery and surgery are some of the effective treatments against various type of tumors. Despite that, these treatments still pose many side-effects that lead to acute and chronic organ damage such as bone marrow suppression, hepatic, pulmonary, cardiac, renal and gastrointestinal toxicities [<xref rid="B144-molecules-21-00529" ref-type="bibr">144</xref>,<xref rid="B145-molecules-21-00529" ref-type="bibr">145</xref>]. Moreover, the development of drug resistance in tumors have also been reported during the courses of chemotherapy. This may be due to the occurrence of mutations in the tumor cells that negates the apoptotic pathway during cancer treatment [<xref rid="B146-molecules-21-00529" ref-type="bibr">146</xref>]. These drawbacks of chemotherapy treatment have urged researchers to find alternative treatments without harming the growth of normal cells and triggering anti-tumor drug resistance. Among the alternative approaches, plant phytochemicals have been recently explored for their possible beneficial (anti-proliferative and cytotoxic) effects on cancer cells <italic>in vitro</italic> or <italic>in vivo</italic> models [<xref rid="B147-molecules-21-00529" ref-type="bibr">147</xref>,<xref rid="B148-molecules-21-00529" ref-type="bibr">148</xref>].</p><sec id="sec6dot10dot1-molecules-21-00529"><title>6.10.1. <italic>In Vitro</italic> Studies</title><p>Several studies have shown anti-tumor properties of nerolidol on cancer cell lines. A study conducted by Ryabchenko <italic>et al.</italic> has demonstrated strong anti-tumor effects of nerolidol (a combination of <italic>cis</italic>-nerolidol 40.7%, <italic>trans</italic>-nerolidol 58.3%, <italic>cis</italic>-dihydronerolidol 0.4% and <italic>trans</italic>-dihydronerolidol). It was found to reduce the viability of HeLa cells at its concentration (CC<sub>50</sub>) of less than 5 &#x000b5;M (1.5 &#x000b1; 0.7 &#x000b5;M) [<xref rid="B104-molecules-21-00529" ref-type="bibr">104</xref>]. Beside this study, nerolidol (isomer not specified), which is one of the ten major compounds found in the green tea flavor, exhibited strong cytotoxicity effect with an IC<sub>50</sub> value of 2.96 and 3.02 &#x000b5;g/mL against BT-20 breast carcinoma cells and HeLa cells, indicating that nerolidol potentially exhibit strong anti-cancer activity against the two tumor cell lines [<xref rid="B106-molecules-21-00529" ref-type="bibr">106</xref>]. This has been further supported by the fact that <italic>trans</italic>-nerolidol, which was purified from the leaf EO of <italic>Zornia brasiliensis</italic> Vogel, had a strong cytotoxicity activity against cancer cell lines such as B16-F10 (mouse melanoma), HepG2 (human hepatocellular carcinoma), HL-60 (human promyelocytic leukemia) and K562 (human chronic myelocytic leukemia) with IC<sub>50</sub> values of &#x0003e;25, &#x0003e;25, 21.99 and 17.58 &#x000b5;g/mL, respectively using Alamar blue assay [<xref rid="B39-molecules-21-00529" ref-type="bibr">39</xref>]. The study also reported no cytotoxicity effect of <italic>trans</italic>-nerolidol on non-tumor cells, particularly the peripheral blood mononuclear cells (PBMCs) [<xref rid="B39-molecules-21-00529" ref-type="bibr">39</xref>]. Another study conducted by Boris <italic>et al.</italic> have shown that <italic>cis</italic>-nerolidol exhibited the strongest cytotoxic activity (16.5 &#x000b1; 6.7 &#x003bc;M) against HeLa cells among other sesquiterpene alcohols such as &#x003b1;-bisabolol, cedrol, patchoulol, and santalol [<xref rid="B105-molecules-21-00529" ref-type="bibr">105</xref>]. Beside green tea, <italic>trans</italic>-nerolidol extracted from leaf EO of <italic>Comptonia peregrina</italic> (L.) Coult. has been found to induce strong cytotoxic effect against human lung carcinoma A-549 and colon adenocarcinoma DLD-1 cell lines with IC<sub>50</sub> values of 6.4 &#x000b1; 0.4 and 5.8 &#x000b1; 0.4 &#x000b5;g/mL, respectively [<xref rid="B149-molecules-21-00529" ref-type="bibr">149</xref>]. Another anti-proliferative study conducted by Ambro&#x0017e; <italic>et al.</italic> has shown that <italic>trans</italic>-nerolidol potentiated the action of doxorubicin, an anticancer drug, by increasing killing of CaCo-2 cancer cells [<xref rid="B40-molecules-21-00529" ref-type="bibr">40</xref>]. The study also reported no cytotoxicity effect of <italic>trans</italic>-nerolidol on rat hepatocytes that serve as non-tumor cells [<xref rid="B145-molecules-21-00529" ref-type="bibr">145</xref>]. Based on the literature, it can be suggested nerolidol is a good candidate for the development of anticancer agent that selectively targets specific cancerous cells with no cytotoxicity towards PBMCs and rat hepatocytes. </p><p>When examining the cytotoxic effect of nerolidol with regard to the apoptotic pathway, the combination of two acylic isoprenoids, farnesol and nerolidol was found to suppress the proliferation of human HL-60 acute promyelocytic leukemia (HL-60) cells by 20%, which was slightly synergistic (slightly exceeding the 13% suppression obtained from the sum of both compounds); farnesol isomers (2.5 &#x000b5;mol/L) and nerolidol (5 &#x000b5;mol/L) individually suppressed the proliferation of HL-60 cells by 4% and 9%, respectively [<xref rid="B108-molecules-21-00529" ref-type="bibr">108</xref>]. The mechanism of action involved prolonging the cell cycle arrest of HL-60 cells at the G<sub>0</sub>-G<sub>1</sub>/S interphase and lead to apoptotic cell death. Another study conducted by Hanu&#x00161;ov&#x000e1; <italic>et al.</italic> focused on the anti-proliferative effect of EO from leaves of <italic>Myrica rubra</italic> (Lour.) Siebold &#x00026; Zucc. (MEO) and its major compound, <italic>trans</italic>-nerolidol on the adhesion, expression of adhesion molecules (ICAM-1; <italic>E</italic>-cadherin; &#x003b2;-catenin and apoptotic molecules (NF-&#x003ba;B, caspases) in colorectal cancer cell line HT29 [<xref rid="B147-molecules-21-00529" ref-type="bibr">147</xref>]. The study showed that only the MEO reduced the cell adhesion to collagen. Meanwhile, both MEO and <italic>trans</italic>-nerolidol (30 &#x000b5;g/mL) significantly suppressed cell adhesion of HT29 cells in the presence of TNF&#x003b1; and it was suggested due to the down-regulation of ICAM-1 [<xref rid="B109-molecules-21-00529" ref-type="bibr">109</xref>]. Besides, <italic>trans</italic>-nerolidol (30 &#x000b5;g/mL) also significantly increased the expression of E-cadherin [<xref rid="B109-molecules-21-00529" ref-type="bibr">109</xref>], a cell adhesion molecule that mediates the suppression of epithelial cell tumor invasiveness [<xref rid="B150-molecules-21-00529" ref-type="bibr">150</xref>]. MEO and <italic>trans</italic>-nerolidol were also found to decrease the phosphorylation of NF-&#x003ba;B and activate caspases activity in TNF&#x003b1;-induced HT29, thereby leading to apoptosis of cancer cells [<xref rid="B109-molecules-21-00529" ref-type="bibr">109</xref>].</p></sec><sec id="sec6dot10dot2-molecules-21-00529"><title>6.10.2. <italic>In Vivo</italic> Studies</title><p>In animal studies, nerolidol has been found to possess strong anti-tumor activity by inhibiting the intestinal carcinogenesis induced by azoxymethane (15 mg/kg body weight) administered twice per week for a duration of three weeks in male F344 rats [<xref rid="B107-molecules-21-00529" ref-type="bibr">107</xref>]. The result showed the reduction of incidence of intestinal neoplasia from 82% to 33% in rats fed with nerolidol. Moreover, the number of tumors/rat was reduced from 1.5 to 0.7 in rats fed with nerolidol. The improvement of intestinal carcinogenesis was possibly due to the modulatory effect nerolidol on protein prenylation, a post-translational process that is required to cause cancer [<xref rid="B151-molecules-21-00529" ref-type="bibr">151</xref>]. Another study conducted by Costa <italic>et al.</italic> has demonstrated that the EO of <italic>Zornia brasiliensis</italic> Vogel leaf at dose of 100 mg/kg containing <italic>trans</italic>-nerolidol as major constituent reduced the weight of tumor in mice injected with B16-F10 melanoma by 38.61% when compared to the untreated group [<xref rid="B39-molecules-21-00529" ref-type="bibr">39</xref>]. </p></sec></sec></sec><sec id="sec7-molecules-21-00529"><title>7. Pharmacokinetic Studies</title><p>Although there is an increasing popularity of herbal medicines and essential oils, they are not properly screened for purity and potency which may raise serious questions regarding their possible herb-drug interaction with conventional medicine that may cause serious adverse effects on human health [<xref rid="B152-molecules-21-00529" ref-type="bibr">152</xref>]. In order to address this issue, more pharmacokinetic and toxicological research have been conducted to examine the efficacy and safety of essential oils.</p><sec id="sec7dot1-molecules-21-00529"><title>7.1. In Vitro Studies</title><p>In order to determine the recovery of nerolidol, <italic>Saccharomyces cerevisiae</italic> prototrophic haploid strain IWD72 was incubated in YEPD medium comprised of yeast extract, bacteriological peptone, glucose, adenine, and uracil. Nerolidol (100 &#x003bc;g/mL) was subsequently added to the 50 mL bacteria culture in YEPD medium. The aerobic culture cells were harvested by centrifugation after 24 h, and the cells were collected for the recovery of nerolidol. Residual nerolidol recovered at 24 h was 79.0 &#x000b5;g/mL [<xref rid="B14-molecules-21-00529" ref-type="bibr">14</xref>,<xref rid="B153-molecules-21-00529" ref-type="bibr">153</xref>].</p></sec><sec id="sec7dot2-molecules-21-00529"><title>7.2. In Vivo Studies</title><p>Rats were fed 20 and 40 mg of nerolidol that were mixed with 1 mL of cottonseed oil and 30&#x02013;35 mL of evaporated milk per day, for eight days. The average daily excretion on the 1st to 4th and 4th to 8th day was monitored. Rats fed with 20 mg/day of nerolidol excreted 0.3 and 0.7 mg of nerolidol per day with a maximum average of 0.9 mg. On the other hand, the rats fed with 40 mg/day of nerolidol excreted 1.0 and 1.6 mg per day with a maximum average of 2.1 mg [<xref rid="B14-molecules-21-00529" ref-type="bibr">14</xref>,<xref rid="B154-molecules-21-00529" ref-type="bibr">154</xref>]. </p><p>Based on a recent <italic>in vivo</italic> pharmacokinetic study conducted by Saito <italic>et al.</italic>, nerolidol (<italic>cis</italic>-<italic>/trans</italic>-nerolidol, 1:3; <italic>w</italic>/<italic>w</italic>) was quantitatively determined in mouse plasma using GC-MS method [<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>]. Three BALB/c mice weighing 20 &#x000b1; 2 g were firstly fed orally with a single oral dose of 1000 mg/kg of nerolidol. Blood samples were then taken at 30 min, 1, 2, 3, 4, 5, 6, 8, and 12 h after oral administration, followed by separation of plasma from blood via centrifugation and GC-MS analysis. The level of nerolidol was observed in the plasma with its maximum concentration of &#x0223c;0.27 &#x000b1; 0.07 &#x003bc;g/mL within 30 min after oral administration and remained constant for up to 3 h after administration, reaching a maximum concentration of ~0.35 &#x000b1; 0.05 &#x003bc;g/mL after 6 h of administration. The concentration of nerolidol in plasma after 6 hours was twice the IC<sub>50</sub> concentration of <italic>in vitro</italic> nerolidol administration on <italic>P. falciparum</italic> (0.169 &#x003bc;g/mL) [<xref rid="B155-molecules-21-00529" ref-type="bibr">155</xref>]. Moreover, this maximum concentration was detected to be ~1460 times lower than the concentration required to induce 50% hemolysis (&#x0223c;511 &#x003bc;g/mL). The concentration of nerolidol in plasma decreased to near zero 12 h after oral administration. These results indicated that the maximum concentration in mouse plasma after oral administration was below the hemolytic concentration, thus the safe oral dose is up to 1000 mg/kg. </p><p>In another recent study, He <italic>et al.</italic> utilized LC-MS instead of GC-MS method to quantitatively determine the <italic>in vivo</italic> pharmacokinetics of nerolidol (<italic>cis</italic>-/<italic>trans</italic>-nerolidol, 2:3) in rat plasma [<xref rid="B25-molecules-21-00529" ref-type="bibr">25</xref>]. Sprague-Dawley rats weighing 250&#x02013;300 g were firstly administered only once with 25 mg/kg of nerolidol via intraperitoneal injection. Blood samples were then collected at 10, 20, 30, 60, 90, 120, 240 and 360 min after injection, followed by separation of plasma from blood via centrifugation. Through the LC-MS analysis, they revealed that the maximum concentration of nerolidol observed in rat plasma was 8.30 &#x000b1; 1.07 &#x003bc;g/mL at 20 min after single intraperitoneal injection. The concentration of nerolidol in plasma decreased to near zero two hours after intraperitoneal injection.</p><p>A comparative pharmacokinetic study between work by Saito <italic>et al.</italic> [<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>] and He <italic>et al.</italic> [<xref rid="B25-molecules-21-00529" ref-type="bibr">25</xref>] revealed that the oral administration of nerolidol exhibited lower peak plasma concentration than that of intraperitoneal administration (<xref rid="molecules-21-00529-t005" ref-type="table">Table 5</xref>). This is because orally administered nerolidol must first undergo first-pass effect by which it must pass through the intestinal wall and then to the portal circulation and liver [<xref rid="B157-molecules-21-00529" ref-type="bibr">157</xref>]. As a result, a portion of the oral dose of nerolidol was lost during the first pass metabolism in the liver, thus contributing to low bioavailability as compared to that of intraperitoneal injection [<xref rid="B158-molecules-21-00529" ref-type="bibr">158</xref>]. Another key point of the pharmacokinetic comparison between the two studies is that the human equivalent doses (HEDs) of both administration calculated in <xref rid="molecules-21-00529-t005" ref-type="table">Table 5</xref> can be used as appropriate starting doses of nerolidol in human clinical trials.</p></sec><sec id="sec7dot3-molecules-21-00529"><title>7.3. Toxicological Studies</title><p>Despite the long history of therapeutic uses of EOs and its general acknowledgment by the public, the assumption that the HEDs can be used for the first clinical trial has however seldom been verified, thus raising the concern of safety issues pertaining the usage of EOs [<xref rid="B159-molecules-21-00529" ref-type="bibr">159</xref>]. For that reason, toxicological screenings are required to assess the potential toxicities induced by the EOs.</p><sec id="sec7dot3dot1-molecules-21-00529"><title>7.3.1. Acute Toxicity</title><p>The dermal LD<sub>50</sub> values of nerolidol (isomer not specified) in rabbit was found to be higher than 2000 mg/kg body weight, thus indicating low acute toxicity via transdermal route [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>]. In terms of oral administration, the oral LD<sub>50</sub> values of nerolidol in rats and mice were higher than 2000 mg/kg body weight (&#x0003e;5000 and 9976 mg/kg body weight, respectively), indicating low acute toxicity via oral route [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>].</p></sec><sec id="sec7dot3dot2-molecules-21-00529"><title>7.3.2. Skin Irritation and Sensitization Studies</title><p>In human studies, 4% nerolidol (isomer not specified) administration in a pre-test for a maximization study with single occlusive application for 48 h did not cause skin irritation [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>]. On the other hand, the application of undiluted nerolidol (isomer not specified) on intact and abraded skin caused well-defined erythema or slight edema in rabbits after 48 h, whereas 5% nerolidol in diethylphthalate caused very slight edema in one animal and was cleared after 48 h [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>]. With regard to skin sensitization, human studies have shown that nerolidol (isomer not specified) (4%) did not cause any positive reactions in maximization tests or repeated insult patch tests. In animal studies, the administration of nerolidol in guinea pigs resulted in weak reactions in two adjuvant tests with concentrations of 3% and 10% [<xref rid="B160-molecules-21-00529" ref-type="bibr">160</xref>,<xref rid="B161-molecules-21-00529" ref-type="bibr">161</xref>]. However, no cross-sensitization was observed when guinea pigs induced with farnesyl acetate were cross-sensitized with nerolidol.</p></sec><sec id="sec7dot3dot3-molecules-21-00529"><title>7.3.3. Mucous Membrane Irritation</title><p>No human data is available for mucous membrane irritation studies [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>]. However, in animal studies, undiluted nerolidol initially caused very slight redness, but was cleared by 2 h. On the other hand, 5% nerolidol in DEP poses no mucous membrane irritation [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>]. </p></sec><sec id="sec7dot3dot4-molecules-21-00529"><title>7.3.4. Phototoxicity and Photoallergenicity</title><p>UV spectra for nerolidol indicated that it did not absorb UVB light (290&#x02013;320 nm) [<xref rid="B162-molecules-21-00529" ref-type="bibr">162</xref>]. However, nerolidol peaked at the UVC range (220&#x02013;240 nm) with a very slight absorption at 250&#x02013;300 nm range, thus do not possibly induce phototoxicity or photoallergy under the current conditions of use as fragrance ingredients [<xref rid="B13-molecules-21-00529" ref-type="bibr">13</xref>].</p></sec><sec id="sec7dot3dot5-molecules-21-00529"><title>7.3.5. Reproductive and Developmental Toxicity</title><p>In order to investigate the development of fetal epidermal permeability barrier <italic>in vitro</italic>, the activators of the receptors for vitamin D<sub>3</sub> and retinoids, and of the peroxisome proliferator activated receptors (PPARs) and the farnesoid X-activated receptor (FXR) were examined. Sprague-Dawley rats were firstly impregnated (plug date = day 0) in order for the skin of 17-day old fetus to be cultured for the measurement of barrier function. The effect of activators of FXR, isoprenoid precursors and metabolites on the development of epidermal barrier was monitored. Explants were incubated in the presence of 100 &#x003bc;M nerolidol for two days. Full-thickness flank skin was excised from fetal rats for skin analysis with light and electron microscopy. The results have shown that nerolidol did not activate the FXR, thus did not alter the epidermal barrier during skin development [<xref rid="B14-molecules-21-00529" ref-type="bibr">14</xref>,<xref rid="B163-molecules-21-00529" ref-type="bibr">163</xref>].</p></sec><sec id="sec7dot3dot6-molecules-21-00529"><title>7.3.6. Cytotoxicity and Genotoxicity</title><sec id="sec7dot3dot6dot1-molecules-21-00529"><title>7.3.6.1. In Vitro <italic>Studies</italic></title><p>Due to nerolidol being used as a potent skin permeation enhancer with low toxicity, a number of studies were conducted on the toxicological properties of nerolidol. Mendanha <italic>et al.</italic> compared the hemolytic and toxic effects of nerolidol and various monoterpenes on fibroblast cells as well as their effect on erythrocyte membrane fluidity [<xref rid="B155-molecules-21-00529" ref-type="bibr">155</xref>]. By using the 3T3 NRU assay to evaluate the cytotoxicity of nerolidol and various monoterpenes (&#x003b1;-terpineol, <sc>l</sc>-(&#x02212;)-carvone, (+)-limonene, <sc>l</sc>-menthone, <sc>d</sc>,<sc>l</sc>-menthol, pulegone and 1,8-cineole) on fibroblast cells, nerolidol was found to be the most cytotoxic with its IC<sub>50</sub> value of 0.06 &#x000b1; 0.01 mM. Besides, nerolidol caused 50% hemolysis at 2.3 &#x000b1; 0.8 mM and induced a significant increase in the fluidity of erythrocyte membrane at 2.5 &#x000d7; 10<sup>9</sup> molecules/cell, indicating that the nerolidol possessed the highest hemolytic effect on erythrocyte membrane fluidity when compared to terpenes. In addition, electron paramagnetic resonance (EPR) spectroscopy of the spin label 5-doxyl stearic acid (5-DSA) was used to investigate the effect of terpenes on membrane fluidity in erythrocyte and fibroblast cells. Nerolidol was found to be more potent than terpenes that caused an increase in the membrane fluidity. The results implied that nerolidol was able to increase membrane fluidity but also had increased ability to disrupt the membrane and had higher cytotoxic potential.</p><p>Ferreira <italic>et al.</italic> further examined the toxicity of nerolidol (a racemic mixture of <italic>cis</italic>- and <italic>trans</italic>-isomers) (1:1) on mitochondrial and cellular energetics in <italic>in vivo</italic> model using Wister rat liver mitochondria and <italic>in vitro</italic> model using HepG2 (human hepatocellular liver carcinoma) cells [<xref rid="B12-molecules-21-00529" ref-type="bibr">12</xref>]. In the <italic>in vitro</italic> study, nerolidol exertes hepatic cell cytotoxicity due to a decrease in ATP/ADP levels by negatively interfering with hepatic mitochondrial bioenergetics in concentrations lower than 2.4 &#x003bc;M. Consequently, nerolidol induced cell arrest and cell death which is possibly due to the inhibition of F<sub>0</sub>F<sub>1</sub>-ATP synthase in a concentration-dependent manner. In the <italic>in vivo</italic> study, nerolidol (low doses up to 2.4 &#x003bc;M) induced a decrease in transmembrane electric potential in the mitochondrial membrane isolated from rat liver in a concentration-dependent manner [<xref rid="B12-molecules-21-00529" ref-type="bibr">12</xref>]. By decreasing transmembrane electric potential, nerolidol could negatively affect the hepatic mitochondrial bioenergetics as it would cause mitochondrial dysfunction, thus leading to hepatic cell cytotoxicity and eventually cell death [<xref rid="B164-molecules-21-00529" ref-type="bibr">164</xref>].</p><p>Marques <italic>et al.</italic> investigated the cytotoxicity effect of EO extracted from leaves of <italic>P. claussenianum</italic> and reported no toxicity effect in the fibroblasts nor macrophages cell lines in any concentration tested (ranging from 40 to 0.56 mg/mL) [<xref rid="B9-molecules-21-00529" ref-type="bibr">9</xref>]. Similarly, the EO extracted from leaves of <italic>P. claussenianum</italic> did not induce toxicity on the L929 mouse fibroblast cells [<xref rid="B78-molecules-21-00529" ref-type="bibr">78</xref>]. Peres <italic>et al.</italic> investigated the cytotoxicity effect of EO purified from <italic>Piper gaudichaudianum</italic> Kunth in which its major compounds were <italic>trans</italic>-nerolidol, &#x003b1;-humulene, (<italic>E</italic>)-caryophyllene and bicyclogermacrene [<xref rid="B165-molecules-21-00529" ref-type="bibr">165</xref>]. Although dose-dependent cytotoxicity effect of the EO as well as single-strand DNA breakage were observed in the Chinese hamster lung fibroblast cells (V79 cells), however, no double-strand breaks occurred. Furthermore, the EO induced a significant increase in lipid peroxidation at higher dose. The results indicated that the EO possessed strong cytotoxicity, genotoxic and mutagenic effects which were attributed to the role of nerolidol. Due to this reason, Sperotto <italic>et al.</italic> further investigated the cytotoxic and mutagenic properties of the EO of <italic>P. gaudichaudianum</italic> as well as its major compound <italic>trans</italic>-nerolidol using <italic>Saccharomyces cerevisiae</italic> as a model organism [<xref rid="B166-molecules-21-00529" ref-type="bibr">166</xref>]. <italic>P. gaudichaudianum</italic> EO was found to induce cytotoxic effects in the XV185-14c and N123 strains of <italic>S. cerevisiae</italic> but induced mutagenesis only at the <italic>lys1</italic> locus at the highest concentration of 100 &#x000b5;g/mL. On the other hand, nerolidol (a racemic mixture of <italic>cis</italic>- and <italic>trans</italic>-isomers) (1:1) was found to be cytotoxic in XV185-14c at concentration of 25, 50 and 100 &#x000b5;g/mL and did not significantly cause any induction of mutagenicity at the three loci evaluated. Moreover, EO and nerolidol were discovered to generate ROS via DCF-DA probing assay in superoxide dismutase (Sod)-deficient strains. Based on these findings, Sperotto <italic>et al.</italic> [<xref rid="B166-molecules-21-00529" ref-type="bibr">166</xref>] claimed that nerolidol shows a weak mutagenic effect but exerts strong cytotoxicity effect which could be attributed to the formation of reactive oxygen species (ROS) and the formation of single-strand breaks. Despite that, more in depth analysis involving molecular techniques could be conducted to elucidate the mechanisms that are responsible for the strong cytotoxic but weak mutagenic effects of nerolidol. Furthermore, toxicogenomics could be an option to be considered in further evaluating the safety of nerolidol. Briefly, toxicogenomic is based on the integration of genomics and toxicology with the aim of studying the toxicity of xenobiotics on the biological systems via global analysis of genome-wide mRNA expression (transcriptomics), protein (proteomics) and metabolite patterns (metabonomics) [<xref rid="B167-molecules-21-00529" ref-type="bibr">167</xref>]. Due to its wide usage in the research of plant-based medicinal natural products, particularly in traditional Chinese medicine (TCM) [<xref rid="B168-molecules-21-00529" ref-type="bibr">168</xref>], toxicogenomics could perhaps be an effective tool in evaluating the safety of nerolidol at the genomic level to ensure that it is safe for humans. Besides that, more <italic>in vitro</italic> experiments investigating the induction of micronuclei, chromosome aberration or telomere shortening effect of nerolidol may also be performed in order to confirm the genotoxicity status of nerolidol in human or mammalian cells.</p></sec><sec id="sec7dot3dot6dot2-molecules-21-00529"><title>7.3.6.2. In Vivo <italic>Studies</italic></title><p>P&#x000ed;culo <italic>et al.</italic> had investigated the genotoxicity and clastogenicity (ability to cause DNA damage by inducing chromosomal aberrations) effects of <italic>trans</italic>-nerolidol in blood and liver cells of 12-week-old male Swiss albino mice (<italic>Mus musculus</italic>) using comet and micronucleus assays respectively [<xref rid="B169-molecules-21-00529" ref-type="bibr">169</xref>]. The experiment was based on the cytotoxicity effect analysis by scoring 200 consecutive total polychromatic (PCE) and normochromatic (NCE) erythrocytes (PCE:NCE ratio) in bone marrow cells and no significant decrease in PCEs:NCEs ratios at the three doses tested (250, 500 and 2000 mg kg<sup>&#x02212;1</sup>) was observed, indicating the absence of cytotoxic effects of <italic>trans</italic>-nerolidol at these doses. Nevertheless, weak genotoxic effects of <italic>trans</italic>-nerolidol in the blood and liver cells were observed and a slight increase in the DNA damage at higher doses. Based on the available studies, it can be deduced that the non-toxic dose of <italic>trans</italic>-nerolidol for animal is up to 2000 mg/kg. Moreover, no DNA damage was observed in the peripheral blood cells and liver of the animals. In order to determine the safety of nerolidol consumption in humans, more clinical trials should be conducted to assess and validate the toxicity and side effects of nerolidol in humans. </p></sec></sec></sec></sec><sec id="sec8-molecules-21-00529"><title>8. Conclusions</title><p>Nerolidol is one of the common components found in the essential oil of various medicinal plants. A majority of the studies reveal that nerolidol is the major constituent in many plants that accounts for their pharmacological and biological activities such as anti-microbial, anti-parasitic, anti-biofilm, anti-oxidant, anti-nociceptive, anti-inflammatory, anti-ulcer, skin penetration enhancer, insect repellent and anti-cancer properties. Based on pharmacokinetic and toxicological data available, the dosage of nerolidol is considered safe to be translated from animal to clinical studies in order to evaluate its efficacy. Taken all together, nerolidol has a great potential to be used as a new chemical or therapeutic drug in the field of agriculture and medicine, respectively and sufficient baseline information is available for guiding future works and commercial exploitation.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the Monash University Malaysia ECR Grant (5140077-000-00), Ministry of Science, Technology and Innovation Malaysia (MOSTI), eScience Funds (02-02-10-SF0215 &#x00026; 06-02-10-SF0300), University of Malaya for High Impact Research Grant (UM-MOHE HIR Nature Microbiome Grant No. H-50001-A000027 and No.A000001-50001), External Industry Grants from Biotek Abadi Sdn Bhd (vote no. GBA-808138 and GBA-808813).</p></ack><notes><title>Author Contributions</title><p>All authors contributed equally.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. </p></notes><ref-list><title>References</title><ref id="B1-molecules-21-00529"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petrovska</surname><given-names>B.B.</given-names></name></person-group>
<article-title>Historical review of medicinal plants&#x02019; usage</article-title>
<source>Pharmacogn. Rev.</source>
<year>2012</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.4103/0973-7847.95849</pub-id>
<?supplied-pmid 22654398?><pub-id pub-id-type="pmid">22654398</pub-id></element-citation></ref><ref id="B2-molecules-21-00529"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bakkali</surname><given-names>F.</given-names></name><name><surname>Averbeck</surname><given-names>S.</given-names></name><name><surname>Averbeck</surname><given-names>D.</given-names></name><name><surname>Idaomar</surname><given-names>M.</given-names></name></person-group>
<article-title>Biological effects of essential oils&#x02014;A review</article-title>
<source>Food Chem. Toxicol.</source>
<year>2008</year>
<volume>46</volume>
<fpage>446</fpage>
<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2007.09.106</pub-id>
<?supplied-pmid 17996351?><pub-id pub-id-type="pmid">17996351</pub-id></element-citation></ref><ref id="B3-molecules-21-00529"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ali</surname><given-names>B.</given-names></name><name><surname>Al-Wabel</surname><given-names>N.A.</given-names></name><name><surname>Shams</surname><given-names>S.</given-names></name><name><surname>Ahamad</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>S.A.</given-names></name><name><surname>Anwar</surname><given-names>F.</given-names></name></person-group>
<article-title>Essential oils used in aromatherapy: A systemic review</article-title>
<source>Asian Pac. J. Trop. Biomed.</source>
<year>2015</year>
<volume>5</volume>
<fpage>601</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="doi">10.1016/j.apjtb.2015.05.007</pub-id>
</element-citation></ref><ref id="B4-molecules-21-00529"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perricone</surname><given-names>M.</given-names></name><name><surname>Arace</surname><given-names>E.</given-names></name><name><surname>Corbo</surname><given-names>M.R.</given-names></name><name><surname>Sinigaglia</surname><given-names>M.</given-names></name><name><surname>Bevilacqua</surname><given-names>A.</given-names></name></person-group>
<article-title>Bioactivity of essential oils: A review on their interaction with food components</article-title>
<source>Front. Microbiol.</source>
<year>2015</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.00076</pub-id>
<?supplied-pmid 25709605?><pub-id pub-id-type="pmid">25709605</pub-id></element-citation></ref><ref id="B5-molecules-21-00529"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Isman</surname><given-names>M.B.</given-names></name></person-group>
<article-title>Botanical insecticides, deterrents, and repellents in modern agriculture and an increasingly regulated world</article-title>
<source>Annu. Rev. Entomol.</source>
<year>2006</year>
<volume>51</volume>
<fpage>45</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.ento.51.110104.151146</pub-id>
<?supplied-pmid 16332203?><pub-id pub-id-type="pmid">16332203</pub-id></element-citation></ref><ref id="B6-molecules-21-00529"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Edris</surname><given-names>A.E.</given-names></name></person-group>
<article-title>Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: A review</article-title>
<source>Phytother. Res.</source>
<year>2007</year>
<volume>21</volume>
<fpage>308</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1002/ptr.2072</pub-id>
<?supplied-pmid 17199238?><pub-id pub-id-type="pmid">17199238</pub-id></element-citation></ref><ref id="B7-molecules-21-00529"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braca</surname><given-names>A.</given-names></name><name><surname>Siciliano</surname><given-names>T.</given-names></name><name><surname>D&#x02019;Arrigo</surname><given-names>M.</given-names></name><name><surname>German&#x000f2;</surname><given-names>M.P.</given-names></name></person-group>
<article-title>Chemical composition and antimicrobial activity of <italic>Momordica charantia</italic> seed essential oil</article-title>
<source>Fitoterapia</source>
<year>2008</year>
<volume>79</volume>
<fpage>123</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/j.fitote.2007.11.002</pub-id>
<?supplied-pmid 18164872?><pub-id pub-id-type="pmid">18164872</pub-id></element-citation></ref><ref id="B8-molecules-21-00529"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parreira</surname><given-names>N.A.</given-names></name><name><surname>Magalhaes</surname><given-names>L.G.</given-names></name><name><surname>Morais</surname><given-names>D.R.</given-names></name><name><surname>Caixeta</surname><given-names>S.C.</given-names></name><name><surname>de Sousa</surname><given-names>J.P.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>Cunha</surname><given-names>W.R.</given-names></name><name><surname>Silva</surname><given-names>M.L.</given-names></name><name><surname>Nanayakkara</surname><given-names>N.P.</given-names></name><name><surname>Rodrigues</surname><given-names>V.</given-names></name><etal/></person-group>
<article-title>Antiprotozoal, schistosomicidal, and antimicrobial activities of the essential oil from the leaves of <italic>Baccharis dracunculifolia</italic></article-title>
<source>Chem. Biodivers.</source>
<year>2010</year>
<volume>7</volume>
<fpage>993</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.1002/cbdv.200900292</pub-id>
<?supplied-pmid 20397234?><pub-id pub-id-type="pmid">20397234</pub-id></element-citation></ref><ref id="B9-molecules-21-00529"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marques</surname><given-names>A.M.</given-names></name><name><surname>Barreto</surname><given-names>A.L.S.</given-names></name><name><surname>Curvelo</surname><given-names>J.A.d.R.</given-names></name><name><surname>Romanos</surname><given-names>M.T.V.</given-names></name><name><surname>Soares</surname><given-names>R.M.d.A.</given-names></name><name><surname>Kaplan</surname><given-names>M.A.C.</given-names></name></person-group>
<article-title>Antileishmanial activity of nerolidol-rich essential oil from <italic>Piper claussenianum</italic></article-title>
<source>Rev. Bras. Farmacogn.</source>
<year>2011</year>
<volume>21</volume>
<fpage>908</fpage>
<lpage>914</lpage>
<pub-id pub-id-type="doi">10.1590/S0102-695X2011005000157</pub-id>
</element-citation></ref><ref id="B10-molecules-21-00529"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lima</surname><given-names>D.K.S.</given-names></name><name><surname>Ballico</surname><given-names>L.J.</given-names></name><name><surname>Rocha Lapa</surname><given-names>F.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>H.P.</given-names></name><name><surname>de Souza</surname><given-names>L.M.</given-names></name><name><surname>Iacomini</surname><given-names>M.</given-names></name><name><surname>Werner</surname><given-names>M.F.d.P.</given-names></name><name><surname>Baggio</surname><given-names>C.H.</given-names></name><name><surname>Pereira</surname><given-names>I.T.</given-names></name><name><surname>da Silva</surname><given-names>L.M.</given-names></name><etal/></person-group>
<article-title>Evaluation of the antinociceptive, anti-inflammatory and gastric antiulcer activities of the essential oil from <italic>Piper aleyreanum</italic> C.DC in rodents</article-title>
<source>J. Ethnopharmacol.</source>
<year>2012</year>
<volume>142</volume>
<fpage>274</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2012.05.016</pub-id>
<?supplied-pmid 22588049?><pub-id pub-id-type="pmid">22588049</pub-id></element-citation></ref><ref id="B11-molecules-21-00529"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tan</surname><given-names>L.T.</given-names></name><name><surname>Lee</surname><given-names>L.H.</given-names></name><name><surname>Yin</surname><given-names>W.F.</given-names></name><name><surname>Chan</surname><given-names>C.K.</given-names></name><name><surname>Abdul Kadir</surname><given-names>H.</given-names></name><name><surname>Chan</surname><given-names>K.G.</given-names></name><name><surname>Goh</surname><given-names>B.H.</given-names></name></person-group>
<article-title>Traditional uses, phytochemistry, and bioactivities of <italic>Cananga odorata</italic> (ylang-ylang)</article-title>
<source>Evid. Based Complement. Altern. Med.</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.1155/2015/896314</pub-id>
<?supplied-pmid 26294929?><pub-id pub-id-type="pmid">26294929</pub-id></element-citation></ref><ref id="B12-molecules-21-00529"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>F.M.</given-names></name><name><surname>Palmeira</surname><given-names>C.M.</given-names></name><name><surname>Oliveira</surname><given-names>M.M.</given-names></name><name><surname>Santos</surname><given-names>D.</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>A.M.</given-names></name><name><surname>Rocha</surname><given-names>S.M.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Peixoto</surname><given-names>F.</given-names></name></person-group>
<article-title>Nerolidol effects on mitochondrial and cellular energetics</article-title>
<source>Toxicol. In Vitro</source>
<year>2012</year>
<volume>26</volume>
<fpage>189</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1016/j.tiv.2011.11.009</pub-id>
<?supplied-pmid 22138475?><pub-id pub-id-type="pmid">22138475</pub-id></element-citation></ref><ref id="B13-molecules-21-00529"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lapczynski</surname><given-names>A.</given-names></name><name><surname>Bhatia</surname><given-names>S.P.</given-names></name><name><surname>Letizia</surname><given-names>C.S.</given-names></name><name><surname>Api</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Fragrance material review on nerolidol (isomer unspecified)</article-title>
<source>Food Chem. Toxicol.</source>
<year>2008</year>
<volume>46</volume>
<fpage>S247</fpage>
<lpage>S250</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2008.06.063</pub-id>
<?supplied-pmid 18640205?><pub-id pub-id-type="pmid">18640205</pub-id></element-citation></ref><ref id="B14-molecules-21-00529"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGinty</surname><given-names>D.</given-names></name><name><surname>Letizia</surname><given-names>C.S.</given-names></name><name><surname>Api</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Addendum to fragrance material review on nerolidol (isomer unspecified)</article-title>
<source>Food Chem. Toxicol.</source>
<year>2010</year>
<volume>48</volume>
<issue>Suppl. 3</issue>
<fpage>S43</fpage>
<lpage>S45</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2009.11.008</pub-id>
<?supplied-pmid 20141875?><pub-id pub-id-type="pmid">20141875</pub-id></element-citation></ref><ref id="B15-molecules-21-00529"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schubert</surname><given-names>V.</given-names></name><name><surname>Dietrich</surname><given-names>A.</given-names></name><name><surname>Ulrich</surname><given-names>T.</given-names></name><name><surname>Mosandl</surname><given-names>A.</given-names></name></person-group>
<article-title>The stereoisomers of nerolidol: Separation, analysis and olfactoric properties</article-title>
<source>Z. Naturforsch. C</source>
<year>1992</year>
<volume>47</volume>
<fpage>304</fpage>
<lpage>307</lpage>
</element-citation></ref><ref id="B16-molecules-21-00529"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>M.J.</given-names></name><name><surname>Gwak</surname><given-names>K.S.</given-names></name><name><surname>Yang</surname><given-names>I.</given-names></name><name><surname>Kim</surname><given-names>K.W.</given-names></name><name><surname>Jeung</surname><given-names>E.B.</given-names></name><name><surname>Chang</surname><given-names>J.W.</given-names></name><name><surname>Choi</surname><given-names>I.G.</given-names></name></person-group>
<article-title>Effect of citral, eugenol, nerolidol and &#x003b1;-terpineol on the ultrastructural changes of <italic>Trichophyton mentagrophytes</italic></article-title>
<source>Fitoterapia</source>
<year>2009</year>
<volume>80</volume>
<fpage>290</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1016/j.fitote.2009.03.007</pub-id>
<?supplied-pmid 19345255?><pub-id pub-id-type="pmid">19345255</pub-id></element-citation></ref><ref id="B17-molecules-21-00529"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Batish</surname><given-names>D.R.</given-names></name><name><surname>Singh</surname><given-names>H.P.</given-names></name><name><surname>Kohli</surname><given-names>R.K.</given-names></name><name><surname>Kaur</surname><given-names>S.</given-names></name></person-group>
<article-title>Eucalyptus essential oil as a natural pesticide</article-title>
<source>For. Ecol. Manag.</source>
<year>2008</year>
<volume>256</volume>
<fpage>2166</fpage>
<lpage>2174</lpage>
<pub-id pub-id-type="doi">10.1016/j.foreco.2008.08.008</pub-id>
</element-citation></ref><ref id="B18-molecules-21-00529"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grulova</surname><given-names>D.</given-names></name><name><surname>de Martino</surname><given-names>L.</given-names></name><name><surname>Mancini</surname><given-names>E.</given-names></name><name><surname>Salamon</surname><given-names>I.</given-names></name><name><surname>de Feo</surname><given-names>V.</given-names></name></person-group>
<article-title>Seasonal variability of the main components in essential oil of <italic>Mentha</italic> &#x000d7; <italic>piperita</italic> L.</article-title>
<source>J. Sci. Food Agric.</source>
<year>2015</year>
<volume>95</volume>
<fpage>621</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="doi">10.1002/jsfa.6802</pub-id>
<?supplied-pmid 24965379?><pub-id pub-id-type="pmid">24965379</pub-id></element-citation></ref><ref id="B19-molecules-21-00529"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marques</surname><given-names>A.M.</given-names></name><name><surname>Kaplan</surname><given-names>M.A.C.</given-names></name></person-group>
<article-title>Seasonal evaluation and chemical composition of volatile fractions from <italic>Piper claussenianum</italic> by hydrodistillation and SPME</article-title>
<source>J. Essent. Oil Res.</source>
<year>2011</year>
<volume>23</volume>
<fpage>15</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1080/10412905.2011.9700475</pub-id>
</element-citation></ref><ref id="B20-molecules-21-00529"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Sousa</surname><given-names>J.P.B.</given-names></name><name><surname>Jorge</surname><given-names>R.F.</given-names></name><name><surname>Leite</surname><given-names>M.F.</given-names></name><name><surname>Furtado</surname><given-names>N.A.J.C.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>da Silva Filho</surname><given-names>A.A.</given-names></name><name><surname>Queiroga</surname><given-names>C.L.</given-names></name><name><surname>de Magalh&#x000e3;es</surname><given-names>P.M.</given-names></name><name><surname>Soares</surname><given-names>A.E.E.</given-names></name></person-group>
<article-title>Seasonal variation of the (<italic>E</italic>)-nerolidol and other volatile compounds within ten different cultivated populations of <italic>Baccharis dracunculifolia</italic> D.C. (Asteraceae)</article-title>
<source>J. Essent. Oil Res.</source>
<year>2009</year>
<volume>21</volume>
<fpage>308</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1080/10412905.2009.9700179</pub-id>
</element-citation></ref><ref id="B21-molecules-21-00529"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>C.</given-names></name><name><surname>Qu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group>
<article-title>Determination of nerolidol in teas using headspace solid phase microextraction-gas chromatography</article-title>
<source>Food Chem.</source>
<year>2014</year>
<volume>152</volume>
<fpage>285</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="doi">10.1016/j.foodchem.2013.11.010</pub-id>
<?supplied-pmid 24444938?><pub-id pub-id-type="pmid">24444938</pub-id></element-citation></ref><ref id="B22-molecules-21-00529"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saito</surname><given-names>A.Y.</given-names></name><name><surname>Sussmann</surname><given-names>R.A.C.</given-names></name><name><surname>Kimura</surname><given-names>E.A.</given-names></name><name><surname>Cassera</surname><given-names>M.B.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Quantification of nerolidol in mouse plasma using gas chromatography-mass spectrometry</article-title>
<source>J. Pharm. Biomed. Anal.</source>
<year>2015</year>
<volume>111</volume>
<fpage>100</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpba.2015.03.030</pub-id>
<?supplied-pmid 25880240?><pub-id pub-id-type="pmid">25880240</pub-id></element-citation></ref><ref id="B23-molecules-21-00529"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>S.</given-names></name><name><surname>Kirby</surname><given-names>J.</given-names></name><name><surname>Denby</surname><given-names>C.M.</given-names></name><name><surname>Keasling</surname><given-names>J.D.</given-names></name></person-group>
<article-title>Production and quantification of sesquiterpenes in <italic>Saccharomyces cerevisiae</italic>, including extraction, detection and quantification of terpene products and key related metabolites</article-title>
<source>Nat. Protoc.</source>
<year>2014</year>
<volume>9</volume>
<fpage>1980</fpage>
<lpage>1996</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2014.132</pub-id>
<?supplied-pmid 25058645?><pub-id pub-id-type="pmid">25058645</pub-id></element-citation></ref><ref id="B24-molecules-21-00529"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pitt</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry</article-title>
<source>Clin. Biochem. Rev.</source>
<year>2009</year>
<volume>30</volume>
<fpage>19</fpage>
<lpage>34</lpage>
<?supplied-pmid 19224008?><pub-id pub-id-type="pmid">19224008</pub-id></element-citation></ref><ref id="B25-molecules-21-00529"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>Y.-S.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>B.-Y.</given-names></name><name><surname>Xu</surname><given-names>L.-H.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Qi</surname><given-names>L.-W.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Wen</surname><given-names>X.-D.</given-names></name></person-group>
<article-title>Application of a sensitive liquid chromatography-mass spectrometry method to a pharmacokinetic study of nerolidol in rat plasma</article-title>
<source>Anal. Methods</source>
<year>2016</year>
<volume>8</volume>
<fpage>785</fpage>
<lpage>789</lpage>
<pub-id pub-id-type="doi">10.1039/C5AY02575C</pub-id>
</element-citation></ref><ref id="B26-molecules-21-00529"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Znini</surname><given-names>M.</given-names></name><name><surname>Cristofari</surname><given-names>G.</given-names></name><name><surname>Majidi</surname><given-names>L.</given-names></name><name><surname>El Harrak</surname><given-names>A.</given-names></name><name><surname>Paolini</surname><given-names>J.</given-names></name><name><surname>Costa</surname><given-names>J.</given-names></name></person-group>
<article-title><italic>In vitro</italic> antifungal activity and chemical composition of <italic>Warionia saharae</italic> essential oil against 3 apple phytopathogenic fungi</article-title>
<source>Food Sci. Biotechnol.</source>
<year>2013</year>
<volume>22</volume>
<fpage>113</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1007/s10068-013-0056-2</pub-id>
</element-citation></ref><ref id="B27-molecules-21-00529"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nibret</surname><given-names>E.</given-names></name><name><surname>Wink</surname><given-names>M.</given-names></name></person-group>
<article-title>Trypanocidal and antileukaemic effects of the essential oils of <italic>Hagenia abyssinica</italic>, <italic>Leonotis ocymifolia</italic>, <italic>Moringa stenopetala</italic>, and their main individual constituents</article-title>
<source>Phytomedicine</source>
<year>2010</year>
<volume>17</volume>
<fpage>911</fpage>
<lpage>920</lpage>
<pub-id pub-id-type="doi">10.1016/j.phymed.2010.02.009</pub-id>
<?supplied-pmid 20359874?><pub-id pub-id-type="pmid">20359874</pub-id></element-citation></ref><ref id="B28-molecules-21-00529"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skaltsa</surname><given-names>H.D.</given-names></name><name><surname>Lazari</surname><given-names>D.M.</given-names></name><name><surname>Mavromati</surname><given-names>A.S.</given-names></name><name><surname>Tiligada</surname><given-names>E.A.</given-names></name><name><surname>Constantinidis</surname><given-names>T.A.</given-names></name></person-group>
<article-title>Composition and antimicrobial activity of the essential oil of <italic>Scutellaria albida</italic> ssp. albida from Greece</article-title>
<source>Planta Med.</source>
<year>2000</year>
<volume>66</volume>
<fpage>672</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="doi">10.1055/s-2000-8650</pub-id>
<?supplied-pmid 11105581?><pub-id pub-id-type="pmid">11105581</pub-id></element-citation></ref><ref id="B29-molecules-21-00529"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopes</surname><given-names>N.P.</given-names></name><name><surname>Kato</surname><given-names>M.J.</given-names></name><name><surname>Elo&#x00131;sa</surname><given-names>H.d.A.</given-names></name><name><surname>Maia</surname><given-names>J.G.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Planchart</surname><given-names>A.R.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Antimalarial use of volatile oil from leaves of <italic>Virola surinamensis</italic> (Rol.) Warb. by Waiapi Amazon Indians</article-title>
<source>J. Ethnopharmacol.</source>
<year>1999</year>
<volume>67</volume>
<fpage>313</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-8741(99)00072-0</pub-id>
<pub-id pub-id-type="pmid">10617066</pub-id></element-citation></ref><ref id="B30-molecules-21-00529"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ndung&#x02019;u</surname><given-names>M.</given-names></name><name><surname>Gitu</surname><given-names>L.</given-names></name></person-group>
<article-title>Repellent activity of the essential oil from <italic>Capparis tomentosa</italic> against maize weevil <italic>Sitophilus zeamais</italic></article-title>
<source>J. Resour. Dev. Manag.</source>
<year>2013</year>
<volume>1</volume>
<fpage>9</fpage>
<lpage>13</lpage>
</element-citation></ref><ref id="B31-molecules-21-00529"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tao</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>C.-Z.</given-names></name><name><surname>Kong</surname><given-names>Z.-W.</given-names></name></person-group>
<article-title>Antibacterial/antifungal activity and synergistic interactions between polyprenols and other lipids isolated from <italic>Ginkgo biloba</italic> L. Leaves</article-title>
<source>Molecules</source>
<year>2013</year>
<volume>18</volume>
<fpage>2166</fpage>
<lpage>2182</lpage>
<pub-id pub-id-type="doi">10.3390/molecules18022166</pub-id>
<?supplied-pmid 23434869?><pub-id pub-id-type="pmid">23434869</pub-id></element-citation></ref><ref id="B32-molecules-21-00529"><label>32.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Curvelo</surname><given-names>J.A.R.</given-names></name><name><surname>Marques</surname><given-names>A.M.</given-names></name><name><surname>Barreto</surname><given-names>A.L.S.</given-names></name><name><surname>Romanos</surname><given-names>M.T.V.</given-names></name><name><surname>Portela</surname><given-names>M.B.</given-names></name><name><surname>Kaplan</surname><given-names>M.A.C.</given-names></name><name><surname>Soares</surname><given-names>R.M.A.</given-names></name></person-group>
<article-title>A novel nerolidol-rich essential oil from <italic>Piper claussenianum</italic> modulates <italic>Candida albicans</italic> biofilm</article-title>
<source>J. Med. Microbiol.</source>
<year>2014</year>
<volume>63</volume>
<fpage>697</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.063834-0</pub-id>
<?supplied-pmid 24523158?><pub-id pub-id-type="pmid">24523158</pub-id></element-citation></ref><ref id="B33-molecules-21-00529"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Passos</surname><given-names>J.L.</given-names></name><name><surname>Barbosa</surname><given-names>L.C.A.</given-names></name><name><surname>Demuner</surname><given-names>A.J.</given-names></name><name><surname>Alvarenga</surname><given-names>E.S.</given-names></name><name><surname>Silva</surname><given-names>C.M.d.</given-names></name><name><surname>Barreto</surname><given-names>R.W.</given-names></name></person-group>
<article-title>Chemical characterization of volatile compounds of <italic>Lantana camara</italic> L. <italic>and L. radula</italic> Sw. and their antifungal activity</article-title>
<source>Molecules</source>
<year>2012</year>
<volume>17</volume>
<fpage>11447</fpage>
<lpage>11455</lpage>
<pub-id pub-id-type="doi">10.3390/molecules171011447</pub-id>
<?supplied-pmid 23018920?><pub-id pub-id-type="pmid">23018920</pub-id></element-citation></ref><ref id="B34-molecules-21-00529"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahman</surname><given-names>A.</given-names></name><name><surname>Al-Reza</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name></person-group>
<article-title>Antifungal activity of essential oil and extracts of <italic>Piper chaba</italic> Hunter against phytopathogenic fungi</article-title>
<source>J. Am. Oil Chem. Soc.</source>
<year>2011</year>
<volume>88</volume>
<fpage>573</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1007/s11746-010-1698-3</pub-id>
</element-citation></ref><ref id="B35-molecules-21-00529"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoet</surname><given-names>S.</given-names></name><name><surname>Stevigny</surname><given-names>C.</given-names></name><name><surname>H&#x000e9;rent</surname><given-names>M.-F.</given-names></name><name><surname>Quetin-Leclercq</surname><given-names>J.</given-names></name></person-group>
<article-title>Antitrypanosomal compounds from the leaf essential oil of <italic>Strychnos spinosa</italic></article-title>
<source>Planta Med.</source>
<year>2006</year>
<volume>72</volume>
<pub-id pub-id-type="doi">10.1055/s-2005-916255</pub-id>
<?supplied-pmid 16557466?><pub-id pub-id-type="pmid">16557466</pub-id></element-citation></ref><ref id="B36-molecules-21-00529"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>H.-M.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Chang</surname><given-names>K.-S.</given-names></name><name><surname>Kim</surname><given-names>B.-S.</given-names></name><name><surname>Yang</surname><given-names>Y.-J.</given-names></name><name><surname>Kim</surname><given-names>G.-H.</given-names></name><name><surname>Shin</surname><given-names>S.-C.</given-names></name><name><surname>Park</surname><given-names>I.-K.</given-names></name></person-group>
<article-title>Larvicidal activity of myrtaceae essential oils and their components against <italic>Aedes aegypti</italic>, acute toxicity on <italic>Daphnia magna</italic>, and aqueous residue</article-title>
<source>J. Med. Entomol.</source>
<year>2011</year>
<volume>48</volume>
<fpage>405</fpage>
<lpage>410</lpage>
<pub-id pub-id-type="doi">10.1603/ME10108</pub-id>
<?supplied-pmid 21485381?><pub-id pub-id-type="pmid">21485381</pub-id></element-citation></ref><ref id="B37-molecules-21-00529"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>M.C.</given-names></name><name><surname>C&#x000e2;mara</surname><given-names>C.G.</given-names></name><name><surname>Born</surname><given-names>F.</given-names></name><name><surname>Moraes</surname><given-names>M.</given-names></name><name><surname>Badji</surname><given-names>C.</given-names></name></person-group>
<article-title>Acaricidal activity and repellency of essential oil from <italic>Piper aduncum</italic> and its components against <italic>Tetranychus urticae</italic></article-title>
<source>Exp. Appl. Acarol.</source>
<year>2012</year>
<volume>57</volume>
<fpage>139</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="doi">10.1007/s10493-012-9545-x</pub-id>
<?supplied-pmid 22415244?><pub-id pub-id-type="pmid">22415244</pub-id></element-citation></ref><ref id="B38-molecules-21-00529"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>B.G.</given-names></name><name><surname>Silva</surname><given-names>A.S.B.</given-names></name><name><surname>Souza</surname><given-names>G.E.P.</given-names></name><name><surname>Figueiredo</surname><given-names>J.G.</given-names></name><name><surname>Cunha</surname><given-names>F.Q.</given-names></name><name><surname>Lahlou</surname><given-names>S.</given-names></name><name><surname>da Silva</surname><given-names>J.K.R.</given-names></name><name><surname>Maia</surname><given-names>J.G.S.</given-names></name><name><surname>Sousa</surname><given-names>P.J.C.</given-names></name></person-group>
<article-title>Chemical composition, antinociceptive and anti-inflammatory effects in rodents of the essential oil of <italic>Peperomia serpens</italic> (SW.) Loud</article-title>
<source>J. Ethnopharmacol.</source>
<year>2011</year>
<volume>138</volume>
<fpage>479</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2011.09.037</pub-id>
<?supplied-pmid 21971207?><pub-id pub-id-type="pmid">21971207</pub-id></element-citation></ref><ref id="B39-molecules-21-00529"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Costa</surname><given-names>E.V.</given-names></name><name><surname>Menezes</surname><given-names>L.R.A.</given-names></name><name><surname>Rocha</surname><given-names>S.L.A.</given-names></name><name><surname>Baliza</surname><given-names>I.R.S.</given-names></name><name><surname>Dias</surname><given-names>R.B.</given-names></name><name><surname>Rocha</surname><given-names>C.A.G.</given-names></name><name><surname>Soares</surname><given-names>M.B.P.</given-names></name><name><surname>Bezerra</surname><given-names>D.P.</given-names></name></person-group>
<article-title>Antitumor properties of the leaf essential oil of <italic>Zornia brasiliensis</italic></article-title>
<source>Planta Med.</source>
<year>2015</year>
<volume>81</volume>
<fpage>563</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="doi">10.1055/s-0035-1545842</pub-id>
<?supplied-pmid 25856436?><pub-id pub-id-type="pmid">25856436</pub-id></element-citation></ref><ref id="B40-molecules-21-00529"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ambro&#x0017e;</surname><given-names>M.</given-names></name><name><surname>Bou&#x00161;ov&#x000e1;</surname><given-names>I.</given-names></name><name><surname>Skarka</surname><given-names>A.</given-names></name><name><surname>Hanu&#x00161;ov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Kr&#x000e1;lov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Matou&#x00161;kov&#x000e1;</surname><given-names>P.</given-names></name><name><surname>Szot&#x000e1;kov&#x000e1;</surname><given-names>B.</given-names></name><name><surname>Sk&#x000e1;lov&#x000e1;</surname><given-names>L.</given-names></name></person-group>
<article-title>The influence of sesquiterpenes from <italic>Myrica rubra</italic> on the antiproliferative and pro-oxidative effects of doxorubicin and its accumulation in cancer cells</article-title>
<source>Molecules</source>
<year>2015</year>
<volume>20</volume>
<fpage>15343</fpage>
<lpage>15358</lpage>
<pub-id pub-id-type="doi">10.3390/molecules200815343</pub-id>
<?supplied-pmid 26307963?><pub-id pub-id-type="pmid">26307963</pub-id></element-citation></ref><ref id="B41-molecules-21-00529"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simionatto</surname><given-names>E.</given-names></name><name><surname>Porto</surname><given-names>C.</given-names></name><name><surname>Dalcol</surname><given-names>I.I.</given-names></name><name><surname>da Silva</surname><given-names>U.F.</given-names></name><name><surname>Morel</surname><given-names>A.F.</given-names></name></person-group>
<article-title>Essential oil from <italic>Zanthoxylum hyemale</italic></article-title>
<source>Planta Med.</source>
<year>2005</year>
<volume>71</volume>
<fpage>759</fpage>
<lpage>763</lpage>
<pub-id pub-id-type="doi">10.1055/s-2005-864184</pub-id>
<?supplied-pmid 16142642?><pub-id pub-id-type="pmid">16142642</pub-id></element-citation></ref><ref id="B42-molecules-21-00529"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tzakou</surname><given-names>O.</given-names></name><name><surname>Loukis</surname><given-names>A.</given-names></name><name><surname>Said</surname><given-names>A.</given-names></name></person-group>
<article-title>Essential oil from the flowers and leaves of <italic>Cassia fistula</italic> L.</article-title>
<source>J. Essent. Oil Res.</source>
<year>2007</year>
<volume>19</volume>
<fpage>360</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1080/10412905.2007.9699305</pub-id>
</element-citation></ref><ref id="B43-molecules-21-00529"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stashenko</surname><given-names>E.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>J.R.</given-names></name><name><surname>Medina</surname><given-names>J.D.</given-names></name><name><surname>Dur&#x000e1;n</surname><given-names>D.C.</given-names></name></person-group>
<article-title>Analysis of essential oils isolated by steam distillation from <italic>Swinglea glutinosa</italic> fruits and leaves</article-title>
<source>J. Essent. Oil Res.</source>
<year>2015</year>
<volume>27</volume>
<fpage>276</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1080/10412905.2015.1045087</pub-id>
</element-citation></ref><ref id="B44-molecules-21-00529"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garneau</surname><given-names>F.-X.</given-names></name><name><surname>Collin</surname><given-names>G.</given-names></name><name><surname>Gagnon</surname><given-names>H.</given-names></name><name><surname>Jean</surname><given-names>F.-I.</given-names></name><name><surname>Strobl</surname><given-names>H.</given-names></name><name><surname>Pichette</surname><given-names>A.</given-names></name></person-group>
<article-title>The essential oil composition of devil&#x02019;s club, <italic>Oplopanax horridus</italic> J.E. Smith Miq</article-title>
<source>Flavour. Fragr. J.</source>
<year>2006</year>
<volume>21</volume>
<fpage>792</fpage>
<lpage>794</lpage>
<pub-id pub-id-type="doi">10.1002/ffj.1716</pub-id>
</element-citation></ref><ref id="B45-molecules-21-00529"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>S.-I.</given-names></name><name><surname>Cho</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group>
<article-title>Anti-biofilm, anti-hemolysis, and anti-virulence activities of black pepper, cananga, myrrh oils, and nerolidol against <italic>Staphylococcus aureus</italic></article-title>
<source>Appl. Microbiol. Biotechnol.</source>
<year>2014</year>
<volume>98</volume>
<fpage>9447</fpage>
<lpage>9457</lpage>
<pub-id pub-id-type="doi">10.1007/s00253-014-5903-4</pub-id>
<?supplied-pmid 25027570?><pub-id pub-id-type="pmid">25027570</pub-id></element-citation></ref><ref id="B46-molecules-21-00529"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Judzentiene</surname><given-names>A.</given-names></name><name><surname>Mockut&#x000eb;</surname><given-names>D.</given-names></name></person-group>
<article-title>Chemical composition of essential oils produced by pink flower inflorescences of wild <italic>Achillea millefolium</italic> L.</article-title>
<source>Chemija</source>
<year>2004</year>
<volume>15</volume>
<fpage>28</fpage>
<lpage>32</lpage>
</element-citation></ref><ref id="B47-molecules-21-00529"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.Q.</given-names></name><name><surname>Perumalsamy</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Shu</surname><given-names>S.</given-names></name><name><surname>Ahn</surname><given-names>Y.J.</given-names></name></person-group>
<article-title>Larvicidal activity of <italic>Magnolia denudata</italic> seed hydrodistillate constituents and related compounds and liquid formulations towards two susceptible and two wild mosquito species</article-title>
<source>Pest Manag. Sci.</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.1002/ps.4064</pub-id>
</element-citation></ref><ref id="B48-molecules-21-00529"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>I.</given-names></name><name><surname>Singh</surname><given-names>B.</given-names></name><name><surname>Singh</surname><given-names>G.</given-names></name><name><surname>Isidorov</surname><given-names>V.</given-names></name><name><surname>Szczepaniak</surname><given-names>L.</given-names></name></person-group>
<article-title>Chemistry, antifungal and antioxidant activities of cardamom (<italic>Amomum subulatum</italic>) essential oil and oleoresins</article-title>
<source>Int. J. Essent. Oil Ther.</source>
<year>2008</year>
<volume>2</volume>
<fpage>29</fpage>
<lpage>40</lpage>
</element-citation></ref><ref id="B49-molecules-21-00529"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koudou</surname><given-names>J.</given-names></name><name><surname>Abena</surname><given-names>A.A.</given-names></name><name><surname>Ngaissona</surname><given-names>P.</given-names></name><name><surname>Bessi&#x000e8;re</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Chemical composition and pharmacological activity of essential oil of <italic>Canarium schweinfurthii</italic></article-title>
<source>Fitoterapia</source>
<year>2005</year>
<volume>76</volume>
<fpage>700</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="doi">10.1016/j.fitote.2005.06.004</pub-id>
<?supplied-pmid 16239074?><pub-id pub-id-type="pmid">16239074</pub-id></element-citation></ref><ref id="B50-molecules-21-00529"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tung</surname><given-names>Y.-T.</given-names></name><name><surname>Chua</surname><given-names>M.-T.</given-names></name><name><surname>Wang</surname><given-names>S.-Y.</given-names></name><name><surname>Chang</surname><given-names>S.-T.</given-names></name></person-group>
<article-title>Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (<italic>Cinnamomum osmophloeum</italic>) twigs</article-title>
<source>Bioresour. Technol.</source>
<year>2008</year>
<volume>99</volume>
<fpage>3908</fpage>
<lpage>3913</lpage>
<pub-id pub-id-type="doi">10.1016/j.biortech.2007.07.050</pub-id>
<?supplied-pmid 17826984?><pub-id pub-id-type="pmid">17826984</pub-id></element-citation></ref><ref id="B51-molecules-21-00529"><label>51.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gretchen</surname><given-names>E.P.</given-names></name><name><surname>Junwei</surname><given-names>Z.</given-names></name><name><surname>Lyric</surname><given-names>B.</given-names></name><name><surname>Joel</surname><given-names>R.C.</given-names></name></person-group>
<article-title>Amyris and siam-wood essential oils: Insect activity of sesquiterpenes</article-title>
<source>Pesticides in Household, Structural and Residential Pest Management</source>
<publisher-name>American Chemical Society</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>2009</year>
<volume>Volume 1015</volume>
<fpage>5</fpage>
<lpage>18</lpage>
</element-citation></ref><ref id="B52-molecules-21-00529"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maurer</surname><given-names>B.</given-names></name><name><surname>Hauser</surname><given-names>A.</given-names></name><name><surname>Ohloff</surname><given-names>G.</given-names></name></person-group>
<article-title>New sesquiterpenoids from cabreuva oil</article-title>
<source>Helv. Chim. Acta</source>
<year>1986</year>
<volume>69</volume>
<fpage>2026</fpage>
<lpage>2037</lpage>
<pub-id pub-id-type="doi">10.1002/hlca.19860690826</pub-id>
</element-citation></ref><ref id="B53-molecules-21-00529"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lucero</surname><given-names>M.</given-names></name><name><surname>Estell</surname><given-names>R.</given-names></name><name><surname>Tellez</surname><given-names>M.</given-names></name><name><surname>Fredrickson</surname><given-names>E.</given-names></name></person-group>
<article-title>A retention index calculator simplifies identification of plant volatile organic compounds</article-title>
<source>Phytochem. Anal.</source>
<year>2009</year>
<volume>20</volume>
<fpage>378</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1002/pca.1137</pub-id>
<?supplied-pmid 19533596?><pub-id pub-id-type="pmid">19533596</pub-id></element-citation></ref><ref id="B54-molecules-21-00529"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Babushok</surname><given-names>V.I.</given-names></name><name><surname>Zenkevich</surname><given-names>I.G.</given-names></name></person-group>
<article-title>Retention indices for most frequently reported essential oil compounds in GC</article-title>
<source>Chromatographia</source>
<year>2008</year>
<volume>69</volume>
<fpage>257</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1365/s10337-008-0872-3</pub-id>
</element-citation></ref><ref id="B55-molecules-21-00529"><label>55.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Orav</surname><given-names>A.</given-names></name></person-group>
<article-title>Identification of terpenes by gas chromatography-mass spectrometry</article-title>
<source>Current Practice of Gas Chromatography-Mass Spectrometry</source>
<publisher-name>Marcel Dekker, Inc.</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2001</year>
<fpage>483</fpage>
<lpage>494</lpage>
</element-citation></ref><ref id="B56-molecules-21-00529"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chung</surname><given-names>T.Y.</given-names></name><name><surname>Eiserich</surname><given-names>J.P.</given-names></name><name><surname>Shibamoto</surname><given-names>T.</given-names></name></person-group>
<article-title>Volatile compounds isolated from edible Korean chamchwi (<italic>Aster scaber</italic> Thunb)</article-title>
<source>J. Agric. Food Chem.</source>
<year>1993</year>
<volume>41</volume>
<fpage>1693</fpage>
<lpage>1697</lpage>
<pub-id pub-id-type="doi">10.1021/jf00034a033</pub-id>
</element-citation></ref><ref id="B57-molecules-21-00529"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choi</surname><given-names>H.-S.</given-names></name></person-group>
<article-title>Character impact odorants of citrus hallabong [(<italic>C. unshiu</italic> Marcov &#x000d7; <italic>C. sinensis</italic> Osbeck) &#x000d7; <italic>C. reticulata</italic> Blanco] cold-pressed peel oil</article-title>
<source>J. Agric. Food Chem.</source>
<year>2003</year>
<volume>51</volume>
<fpage>2687</fpage>
<lpage>2692</lpage>
<pub-id pub-id-type="doi">10.1021/jf021069o</pub-id>
<?supplied-pmid 12696958?><pub-id pub-id-type="pmid">12696958</pub-id></element-citation></ref><ref id="B58-molecules-21-00529"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Behera</surname><given-names>S.</given-names></name><name><surname>Nagarajan</surname><given-names>S.</given-names></name><name><surname>Jagan Mohan Rao</surname><given-names>L.</given-names></name></person-group>
<article-title>Microwave heating and conventional roasting of cumin seeds (<italic>Cuminum cyminum</italic> L.) and effect on chemical composition of volatiles</article-title>
<source>Food Chem.</source>
<year>2004</year>
<volume>87</volume>
<fpage>25</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.foodchem.2003.10.012</pub-id>
</element-citation></ref><ref id="B59-molecules-21-00529"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nigmatov</surname><given-names>A.G.</given-names></name><name><surname>Serebryakov</surname><given-names>&#x000e9;.P.</given-names></name><name><surname>Yanovskaya</surname><given-names>L.A.</given-names></name></person-group>
<article-title>Improved method for the isolation of geranyl esters of (4<italic>E</italic>/<italic>Z</italic>,8<italic>E</italic>)- and (4<italic>E</italic>/<italic>Z</italic>,8<italic>Z</italic>)-farnesylacetic acid</article-title>
<source>Pharm. Chem. J.</source>
<year>1987</year>
<volume>21</volume>
<fpage>529</fpage>
<lpage>533</lpage>
<pub-id pub-id-type="doi">10.1007/BF00758769</pub-id>
</element-citation></ref><ref id="B60-molecules-21-00529"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ofner</surname><given-names>A.</given-names></name><name><surname>Kimel</surname><given-names>W.</given-names></name><name><surname>Holmgren</surname><given-names>A.</given-names></name><name><surname>Forrester</surname><given-names>F.</given-names></name></person-group>
<article-title>Synthetisches nerolidol und verwandte c15-alkohole</article-title>
<source>Helv. Chim. Acta</source>
<year>1959</year>
<volume>42</volume>
<fpage>2577</fpage>
<lpage>2584</lpage>
<pub-id pub-id-type="doi">10.1002/hlca.19590420729</pub-id>
</element-citation></ref><ref id="B61-molecules-21-00529"><label>61.</label><element-citation publication-type="patent">
<person-group person-group-type="author"><name><surname>McNeil</surname><given-names>C.V.</given-names></name><name><surname>Morlacchi</surname><given-names>P.</given-names></name><name><surname>Baevich</surname><given-names>A.</given-names></name><name><surname>Matsuda</surname><given-names>S.P.T.</given-names></name></person-group>
<article-title>Nerolidol, Terpene, and Terpene Deriviative Synthesis</article-title>
<source>U.S. Patent</source>
<patent>8173405</patent>
<day>8</day>
<month>5</month>
<year>2012</year>
<publisher-name>U.S. Patent and Trademark Office</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
</element-citation></ref><ref id="B62-molecules-21-00529"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iason</surname><given-names>G.</given-names></name></person-group>
<article-title>The role of plant secondary metabolites in mammalian herbivory: Ecological perspectives</article-title>
<source>Proc. Nutr. Soc.</source>
<year>2005</year>
<volume>64</volume>
<fpage>123</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1079/PNS2004415</pub-id>
<?supplied-pmid 15877931?><pub-id pub-id-type="pmid">15877931</pub-id></element-citation></ref><ref id="B63-molecules-21-00529"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pichersky</surname><given-names>E.</given-names></name><name><surname>Gershenzon</surname><given-names>J.</given-names></name></person-group>
<article-title>The formation and function of plant volatiles: Perfumes for pollinator attraction and defense</article-title>
<source>Curr. Opin. Plant Biol.</source>
<year>2002</year>
<volume>5</volume>
<fpage>237</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="doi">10.1016/S1369-5266(02)00251-0</pub-id>
<pub-id pub-id-type="pmid">11960742</pub-id></element-citation></ref><ref id="B64-molecules-21-00529"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turlings</surname><given-names>T.C.</given-names></name><name><surname>Ton</surname><given-names>J.</given-names></name></person-group>
<article-title>Exploiting scents of distress: The prospect of manipulating herbivore-induced plant odours to enhance the control of agricultural pests</article-title>
<source>Curr. Opin. Plant Biol.</source>
<year>2006</year>
<volume>9</volume>
<fpage>421</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbi.2006.05.010</pub-id>
<?supplied-pmid 16723271?><pub-id pub-id-type="pmid">16723271</pub-id></element-citation></ref><ref id="B65-molecules-21-00529"><label>65.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dudareva</surname><given-names>N.</given-names></name><name><surname>Pichersky</surname><given-names>E.</given-names></name><name><surname>Gershenzon</surname><given-names>J.</given-names></name></person-group>
<article-title>Biochemistry of plant volatiles</article-title>
<source>Plant Physiol.</source>
<year>2004</year>
<volume>135</volume>
<fpage>1893</fpage>
<lpage>1902</lpage>
<pub-id pub-id-type="doi">10.1104/pp.104.049981</pub-id>
<?supplied-pmid 15326281?><pub-id pub-id-type="pmid">15326281</pub-id></element-citation></ref><ref id="B66-molecules-21-00529"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dudareva</surname><given-names>N.</given-names></name><name><surname>Negre</surname><given-names>F.</given-names></name><name><surname>Nagegowda</surname><given-names>D.A.</given-names></name><name><surname>Orlova</surname><given-names>I.</given-names></name></person-group>
<article-title>Plant volatiles: Recent advances and future perspectives</article-title>
<source>Crit. Rev. Plant Sci.</source>
<year>2006</year>
<volume>25</volume>
<fpage>417</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="doi">10.1080/07352680600899973</pub-id>
</element-citation></ref><ref id="B67-molecules-21-00529"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A.-X.</given-names></name><name><surname>Lou</surname><given-names>Y.-G.</given-names></name><name><surname>Mao</surname><given-names>Y.-B.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.-J.</given-names></name><name><surname>Chen</surname><given-names>X.-Y.</given-names></name></person-group>
<article-title>Plant terpenoids: Biosynthesis and ecological functions</article-title>
<source>J. Integr. Plant Biol.</source>
<year>2007</year>
<volume>49</volume>
<fpage>179</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1111/j.1744-7909.2007.00395.x</pub-id>
</element-citation></ref><ref id="B68-molecules-21-00529"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Degenhardt</surname><given-names>J.</given-names></name><name><surname>K&#x000f6;llner</surname><given-names>T.G.</given-names></name><name><surname>Gershenzon</surname><given-names>J.</given-names></name></person-group>
<article-title>Monoterpene and sesquiterpene synthases and the origin of terpene skeletal diversity in plants</article-title>
<source>Phytochemistry</source>
<year>2009</year>
<volume>70</volume>
<fpage>1621</fpage>
<lpage>1637</lpage>
<pub-id pub-id-type="doi">10.1016/j.phytochem.2009.07.030</pub-id>
<?supplied-pmid 19793600?><pub-id pub-id-type="pmid">19793600</pub-id></element-citation></ref><ref id="B69-molecules-21-00529"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagegowda</surname><given-names>D.A.</given-names></name><name><surname>Gutensohn</surname><given-names>M.</given-names></name><name><surname>Wilkerson</surname><given-names>C.G.</given-names></name><name><surname>Dudareva</surname><given-names>N.</given-names></name></person-group>
<article-title>Two nearly identical terpene synthases catalyze the formation of nerolidol and linalool in snapdragon flowers</article-title>
<source>Plant J.</source>
<year>2008</year>
<volume>55</volume>
<fpage>224</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-313X.2008.03496.x</pub-id>
<?supplied-pmid 18363779?><pub-id pub-id-type="pmid">18363779</pub-id></element-citation></ref><ref id="B70-molecules-21-00529"><label>70.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Degenhardt</surname><given-names>J.</given-names></name><name><surname>Gershenzon</surname><given-names>J.</given-names></name></person-group>
<article-title>Demonstration and characterization of (<italic>E</italic>)-nerolidol synthase from maize: A herbivore-inducible terpene synthase participating in (3<italic>E</italic>)-4,8-dimethyl-1,3,7-nonatriene biosynthesis</article-title>
<source>Planta</source>
<year>2000</year>
<volume>210</volume>
<fpage>815</fpage>
<lpage>822</lpage>
<pub-id pub-id-type="doi">10.1007/s004250050684</pub-id>
<?supplied-pmid 10805454?><pub-id pub-id-type="pmid">10805454</pub-id></element-citation></ref><ref id="B71-molecules-21-00529"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schnee</surname><given-names>C.</given-names></name><name><surname>K&#x000f6;llner</surname><given-names>T.G.</given-names></name><name><surname>Gershenzon</surname><given-names>J.</given-names></name><name><surname>Degenhardt</surname><given-names>J.</given-names></name></person-group>
<article-title>The maize gene terpene synthase 1 encodes a sesquiterpene synthase catalyzing the formation of (<italic>E</italic>)-&#x003b2;-farnesene, (<italic>E</italic>)-nerolidol, and (<italic>E</italic>,<italic>E</italic>)-farnesol after herbivore damage</article-title>
<source>Plant Physiol.</source>
<year>2002</year>
<volume>130</volume>
<fpage>2049</fpage>
<lpage>2060</lpage>
<pub-id pub-id-type="doi">10.1104/pp.008326</pub-id>
<?supplied-pmid 12481088?><pub-id pub-id-type="pmid">12481088</pub-id></element-citation></ref><ref id="B72-molecules-21-00529"><label>72.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bouwmeester</surname><given-names>H.J.</given-names></name><name><surname>Verstappen</surname><given-names>F.W.</given-names></name><name><surname>Posthumus</surname><given-names>M.A.</given-names></name><name><surname>Dicke</surname><given-names>M.</given-names></name></person-group>
<article-title>Spider mite-induced (3<italic>S</italic>)-(<italic>E</italic>)-nerolidol synthase activity in cucumber and lima bean. The first dedicated step in acyclic c11-homoterpene biosynthesis</article-title>
<source>Plant Physiol.</source>
<year>1999</year>
<volume>121</volume>
<fpage>173</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1104/pp.121.1.173</pub-id>
<?supplied-pmid 10482672?><pub-id pub-id-type="pmid">10482672</pub-id></element-citation></ref><ref id="B73-molecules-21-00529"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vinholes</surname><given-names>J.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>P.</given-names></name><name><surname>Martel</surname><given-names>F.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Rocha</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Assessment of the antioxidant and antiproliferative effects of sesquiterpenic compounds in <italic>in vitro</italic> Caco-2 cell models</article-title>
<source>Food Chem.</source>
<year>2014</year>
<volume>156</volume>
<fpage>204</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1016/j.foodchem.2014.01.106</pub-id>
<?supplied-pmid 24629959?><pub-id pub-id-type="pmid">24629959</pub-id></element-citation></ref><ref id="B74-molecules-21-00529"><label>74.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vinholes</surname><given-names>J.</given-names></name><name><surname>Rudnitskaya</surname><given-names>A.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>P.</given-names></name><name><surname>Martel</surname><given-names>F.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Rocha</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Hepatoprotection of sesquiterpenoids: A quantitative structure-activity relationship (QSAR) approach</article-title>
<source>Food Chem.</source>
<year>2014</year>
<volume>146</volume>
<fpage>78</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1016/j.foodchem.2013.09.039</pub-id>
<?supplied-pmid 24176316?><pub-id pub-id-type="pmid">24176316</pub-id></element-citation></ref><ref id="B75-molecules-21-00529"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nogueira Neto</surname><given-names>J.</given-names></name><name><surname>de Almeida</surname><given-names>A.</given-names></name><name><surname>da Silva Oliveira</surname><given-names>J.</given-names></name><name><surname>dos Santos</surname><given-names>P.</given-names></name><name><surname>de Sousa</surname><given-names>D.</given-names></name><name><surname>de Freitas</surname><given-names>R.</given-names></name></person-group>
<article-title>Antioxidant effects of nerolidol in mice hippocampus after open field test</article-title>
<source>Neurochem. Res.</source>
<year>2013</year>
<volume>38</volume>
<fpage>1861</fpage>
<lpage>1870</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-013-1092-2</pub-id>
<?supplied-pmid 23765368?><pub-id pub-id-type="pmid">23765368</pub-id></element-citation></ref><ref id="B76-molecules-21-00529"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hada</surname><given-names>T.</given-names></name><name><surname>Shiraishi</surname><given-names>A.</given-names></name><name><surname>Furuse</surname><given-names>S.</given-names></name><name><surname>Inoue</surname><given-names>Y.</given-names></name><name><surname>Hamashima</surname><given-names>H.</given-names></name><name><surname>Matsumoto</surname><given-names>Y.</given-names></name><name><surname>Masuda</surname><given-names>K.</given-names></name><name><surname>Shiojima</surname><given-names>K.</given-names></name><name><surname>Shimada</surname><given-names>J.</given-names></name></person-group>
<article-title>Inhibitory effects of terpenes on the growth of <italic>Staphylococcus aureus</italic></article-title>
<source>Nat. Med.</source>
<year>2003</year>
<volume>57</volume>
<fpage>64</fpage>
<lpage>67</lpage>
</element-citation></ref><ref id="B77-molecules-21-00529"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Inoue</surname><given-names>Y.</given-names></name><name><surname>Shiraishi</surname><given-names>A.</given-names></name><name><surname>Hada</surname><given-names>T.</given-names></name><name><surname>Hirose</surname><given-names>K.</given-names></name><name><surname>Hamashima</surname><given-names>H.</given-names></name><name><surname>Shimada</surname><given-names>J.</given-names></name></person-group>
<article-title>The antibacterial effects of terpene alcohols on <italic>Staphylococcus aureus</italic> and their mode of action</article-title>
<source>FEMS Microbiol. Lett.</source>
<year>2004</year>
<volume>237</volume>
<fpage>325</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6968.2004.tb09714.x</pub-id>
<?supplied-pmid 15321680?><pub-id pub-id-type="pmid">15321680</pub-id></element-citation></ref><ref id="B78-molecules-21-00529"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Togashi</surname><given-names>N.</given-names></name><name><surname>Hamashima</surname><given-names>H.</given-names></name><name><surname>Shiraishi</surname><given-names>A.</given-names></name><name><surname>Inoue</surname><given-names>Y.</given-names></name><name><surname>Takano</surname><given-names>A.</given-names></name></person-group>
<article-title>Antibacterial activities against <italic>Staphylococcus aureus</italic> of terpene alcohols with aliphatic carbon chains</article-title>
<source>J. Essent. Oil Res.</source>
<year>2010</year>
<volume>22</volume>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1080/10412905.2010.9700321</pub-id>
</element-citation></ref><ref id="B79-molecules-21-00529"><label>79.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Kubo</surname><given-names>I.</given-names></name></person-group>
<article-title>Antimicrobial activity of green tea flavor components</article-title>
<source>Bioactive Volatile Compounds from Plants</source>
<publisher-name>American Chemical Society</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>1993</year>
<volume>Volume 525</volume>
<fpage>57</fpage>
<lpage>70</lpage>
</element-citation></ref><ref id="B80-molecules-21-00529"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>O.</given-names></name><name><surname>Pereira</surname><given-names>R.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>F.</given-names></name><name><surname>Mendo</surname><given-names>S.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Rocha</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Evaluation of the mutagenicity of sesquiterpenic compounds and their influence on the susceptibility towards antibiotics of two clinically relevant bacterial strains</article-title>
<source>Mutat. Res. Genet. Toxicol. Environ.</source>
<year>2011</year>
<volume>723</volume>
<fpage>18</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1016/j.mrgentox.2011.03.010</pub-id>
<?supplied-pmid 21453784?><pub-id pub-id-type="pmid">21453784</pub-id></element-citation></ref><ref id="B81-molecules-21-00529"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brehm-Stecher</surname><given-names>B.F.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group>
<article-title>Sensitization of <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic> to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone</article-title>
<source>Antimicrob. Agents Chemother.</source>
<year>2003</year>
<volume>47</volume>
<fpage>3357</fpage>
<lpage>3360</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.47.10.3357-3360.2003</pub-id>
<?supplied-pmid 14506058?><pub-id pub-id-type="pmid">14506058</pub-id></element-citation></ref><ref id="B82-molecules-21-00529"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>M.</given-names></name><name><surname>Rocha</surname><given-names>S.</given-names></name><name><surname>Coimbra</surname><given-names>M.A.</given-names></name><name><surname>Vieira</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Enhancement of <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic> antibiotic susceptibility using sesquiterpenoids</article-title>
<source>Med. Chem.</source>
<year>2008</year>
<volume>4</volume>
<fpage>616</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="doi">10.2174/157340608786242016</pub-id>
<?supplied-pmid 18991747?><pub-id pub-id-type="pmid">18991747</pub-id></element-citation></ref><ref id="B83-molecules-21-00529"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.-J.</given-names></name><name><surname>Han</surname><given-names>J.-I.</given-names></name><name><surname>Lee</surname><given-names>G.-S.</given-names></name><name><surname>Park</surname><given-names>M.-J.</given-names></name><name><surname>Choi</surname><given-names>I.-G.</given-names></name><name><surname>Na</surname><given-names>K.-J.</given-names></name><name><surname>Jeung</surname><given-names>E.-B.</given-names></name></person-group>
<article-title>Antifungal effect of eugenol and nerolidol against <italic>Microsporum gypseum</italic> in a guinea pig model</article-title>
<source>Biol. Pharm. Bull.</source>
<year>2007</year>
<volume>30</volume>
<fpage>184</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1248/bpb.30.184</pub-id>
<?supplied-pmid 17202684?><pub-id pub-id-type="pmid">17202684</pub-id></element-citation></ref><ref id="B84-molecules-21-00529"><label>84.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pontin</surname><given-names>M.</given-names></name><name><surname>Bottini</surname><given-names>R.</given-names></name><name><surname>Burba</surname><given-names>J.L.</given-names></name><name><surname>Piccoli</surname><given-names>P.</given-names></name></person-group>
<article-title>Allium sativum produces terpenes with fungistatic properties in response to infection with <italic>Sclerotium cepivorum</italic></article-title>
<source>Phytochemistry</source>
<year>2015</year>
<volume>115</volume>
<fpage>152</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1016/j.phytochem.2015.02.003</pub-id>
<?supplied-pmid 25819001?><pub-id pub-id-type="pmid">25819001</pub-id></element-citation></ref><ref id="B85-molecules-21-00529"><label>85.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohd-Shukri</surname><given-names>H.</given-names></name><name><surname>Zainal-Abidin</surname><given-names>B.</given-names></name></person-group>
<article-title>The effects of nerolidol, allicin and berenil on the morphology of <italic>Trypanosoma evansi</italic> in mice: A comparative study using light and electron microscopic approaches</article-title>
<source>Malays. Appl. Biol.</source>
<year>2011</year>
<volume>40</volume>
<fpage>25</fpage>
<lpage>32</lpage>
</element-citation></ref><ref id="B86-molecules-21-00529"><label>86.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arruda</surname><given-names>D.C.</given-names></name><name><surname>D&#x02019;Alexandri</surname><given-names>F.L.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name><name><surname>Uliana</surname><given-names>S.R.B.</given-names></name></person-group>
<article-title>Antileishmanial activity of the terpene nerolidol</article-title>
<source>Antimicrob. Agents Chemother.</source>
<year>2005</year>
<volume>49</volume>
<fpage>1679</fpage>
<lpage>1687</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.49.5.1679-1687.2005</pub-id>
<?supplied-pmid 15855481?><pub-id pub-id-type="pmid">15855481</pub-id></element-citation></ref><ref id="B87-molecules-21-00529"><label>87.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Camargos</surname><given-names>H.S.</given-names></name><name><surname>Moreira</surname><given-names>R.A.</given-names></name><name><surname>Mendanha</surname><given-names>S.A.</given-names></name><name><surname>Fernandes</surname><given-names>K.S.</given-names></name><name><surname>Dorta</surname><given-names>M.L.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name></person-group>
<article-title>Terpenes increase the lipid dynamics in the <italic>Leishmania</italic> plasma membrane at concentrations similar to their IC<sub>50</sub> values</article-title>
<source>PLoS ONE</source>
<year>2014</year>
<volume>9</volume>
<elocation-id>e104429</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0104429</pub-id>
<?supplied-pmid 25101672?><pub-id pub-id-type="pmid">25101672</pub-id></element-citation></ref><ref id="B88-molecules-21-00529"><label>88.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silva</surname><given-names>M.P.</given-names></name><name><surname>Oliveira</surname><given-names>G.L.</given-names></name><name><surname>de Carvalho</surname><given-names>R.B.</given-names></name><name><surname>de Sousa</surname><given-names>D.P.</given-names></name><name><surname>Freitas</surname><given-names>R.M.</given-names></name><name><surname>Pinto</surname><given-names>P.L.</given-names></name><name><surname>de Moraes</surname><given-names>J.</given-names></name></person-group>
<article-title>Antischistosomal activity of the terpene nerolidol</article-title>
<source>Molecules</source>
<year>2014</year>
<volume>19</volume>
<fpage>3793</fpage>
<lpage>3803</lpage>
<pub-id pub-id-type="doi">10.3390/molecules19033793</pub-id>
<?supplied-pmid 24662089?><pub-id pub-id-type="pmid">24662089</pub-id></element-citation></ref><ref id="B89-molecules-21-00529"><label>89.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marques</surname><given-names>A.M.</given-names></name><name><surname>Peixoto</surname><given-names>A.C.C.</given-names></name><name><surname>de Paula</surname><given-names>R.C.</given-names></name><name><surname>Nascimento</surname><given-names>M.F.A.</given-names></name><name><surname>Soares</surname><given-names>L.F.</given-names></name><name><surname>Velozo</surname><given-names>L.S.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>E.F.</given-names></name><name><surname>Kaplan</surname><given-names>M.A.C.</given-names></name></person-group>
<article-title>Phytochemical investigation of anti-plasmodial metabolites from Brazilian Native Piper species</article-title>
<source>J. Essent. Oil Bear. Plants</source>
<year>2015</year>
<volume>18</volume>
<fpage>74</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1080/0972060X.2014.974075</pub-id>
</element-citation></ref><ref id="B90-molecules-21-00529"><label>90.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodrigues Goulart</surname><given-names>H.</given-names></name><name><surname>Kimura</surname><given-names>E.A.</given-names></name><name><surname>Peres</surname><given-names>V.J.</given-names></name><name><surname>Couto</surname><given-names>A.S.</given-names></name><name><surname>Aquino Duarte</surname><given-names>F.A.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in <italic>Plasmodium falciparum</italic></article-title>
<source>Antimicrob. Agents Chemother.</source>
<year>2004</year>
<volume>48</volume>
<fpage>2502</fpage>
<lpage>2509</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.48.7.2502-2509.2004</pub-id>
<?supplied-pmid 15215101?><pub-id pub-id-type="pmid">15215101</pub-id></element-citation></ref><ref id="B91-molecules-21-00529"><label>91.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Macedo</surname><given-names>C.S.</given-names></name><name><surname>Uhrig</surname><given-names>M.L.</given-names></name><name><surname>Kimura</surname><given-names>E.A.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Characterization of the isoprenoid chain of coenzyme Q in <italic>Plasmodium falciparum</italic></article-title>
<source>FEMS Microbiol. Lett.</source>
<year>2002</year>
<volume>207</volume>
<fpage>13</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6968.2002.tb11021.x</pub-id>
<?supplied-pmid 11886744?><pub-id pub-id-type="pmid">11886744</pub-id></element-citation></ref><ref id="B92-molecules-21-00529"><label>92.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>M.F.</given-names></name><name><surname>Saito</surname><given-names>A.Y.</given-names></name><name><surname>Peres</surname><given-names>V.J.</given-names></name><name><surname>Oliveira</surname><given-names>A.C.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name></person-group>
<article-title><italic>In vitro</italic> antimalarial activity of different inhibitors of the plasmodial isoprenoid synthesis pathway</article-title>
<source>Antimicrob. Agents Chemother.</source>
<year>2015</year>
<volume>59</volume>
<fpage>5084</fpage>
<lpage>5087</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.04161-14</pub-id>
<?supplied-pmid 26055383?><pub-id pub-id-type="pmid">26055383</pub-id></element-citation></ref><ref id="B93-molecules-21-00529"><label>93.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>AbouLaila</surname><given-names>M.</given-names></name><name><surname>Sivakumar</surname><given-names>T.</given-names></name><name><surname>Yokoyama</surname><given-names>N.</given-names></name><name><surname>Igarashi</surname><given-names>I.</given-names></name></person-group>
<article-title>Inhibitory effect of terpene nerolidol on the growth of <italic>Babesia</italic> parasites</article-title>
<source>Parasitol. Int.</source>
<year>2010</year>
<volume>59</volume>
<fpage>278</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1016/j.parint.2010.02.006</pub-id>
<?supplied-pmid 20178862?><pub-id pub-id-type="pmid">20178862</pub-id></element-citation></ref><ref id="B94-molecules-21-00529"><label>94.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abdel-Rahman</surname><given-names>F.H.</given-names></name><name><surname>Alaniz</surname><given-names>N.M.</given-names></name><name><surname>Saleh</surname><given-names>M.A.</given-names></name></person-group>
<article-title>Nematicidal activity of terpenoids</article-title>
<source>J. Environ. Sci. Health B</source>
<year>2013</year>
<volume>48</volume>
<fpage>16</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1080/03601234.2012.716686</pub-id>
<?supplied-pmid 23030436?><pub-id pub-id-type="pmid">23030436</pub-id></element-citation></ref><ref id="B95-molecules-21-00529"><label>95.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Navarro-Moll</surname><given-names>M.C.</given-names></name><name><surname>Romero</surname><given-names>M.C.</given-names></name><name><surname>Montilla</surname><given-names>M.P.</given-names></name><name><surname>Valero</surname><given-names>A.</given-names></name></person-group>
<article-title><italic>In vitro</italic> and <italic>in vivo</italic> activity of three sesquiterpenes against L<sub>3</sub> larvae of <italic>Anisakis</italic> type I</article-title>
<source>Exp. Parasitol.</source>
<year>2011</year>
<volume>127</volume>
<fpage>405</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1016/j.exppara.2010.09.008</pub-id>
<?supplied-pmid 20932829?><pub-id pub-id-type="pmid">20932829</pub-id></element-citation></ref><ref id="B96-molecules-21-00529"><label>96.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Di Campli</surname><given-names>E.</given-names></name><name><surname>di Bartolomeo</surname><given-names>S.</given-names></name><name><surname>Delli Pizzi</surname><given-names>P.</given-names></name><name><surname>Di Giulio</surname><given-names>M.</given-names></name><name><surname>Grande</surname><given-names>R.</given-names></name><name><surname>Nostro</surname><given-names>A.</given-names></name><name><surname>Cellini</surname><given-names>L.</given-names></name></person-group>
<article-title>Activity of tea tree oil and nerolidol alone or in combination against <italic>Pediculus capitis</italic> (head lice) and its eggs</article-title>
<source>Parasitol. Res.</source>
<year>2012</year>
<volume>111</volume>
<fpage>1985</fpage>
<lpage>1992</lpage>
<pub-id pub-id-type="doi">10.1007/s00436-012-3045-0</pub-id>
<?supplied-pmid 22847279?><pub-id pub-id-type="pmid">22847279</pub-id></element-citation></ref><ref id="B97-molecules-21-00529"><label>97.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Assis Lage</surname><given-names>T.C.</given-names></name><name><surname>Montanari</surname><given-names>R.M.</given-names></name><name><surname>Fernandes</surname><given-names>S.A.</given-names></name><name><surname>de Oliveira Monteiro</surname><given-names>C.M.</given-names></name><name><surname>de Oliveira Souza Senra</surname><given-names>T.</given-names></name><name><surname>Zeringota</surname><given-names>V.</given-names></name><name><surname>da Silva Matos</surname><given-names>R.</given-names></name><name><surname>Daemon</surname><given-names>E.</given-names></name></person-group>
<article-title>Chemical composition and acaricidal activity of the essential oil of <italic>Baccharis dracunculifolia</italic> De Candole (1836) and its constituents nerolidol and limonene on larvae and engorged females of <italic>Rhipicephalus microplus</italic> (Acari: Ixodidae)</article-title>
<source>Exp. Parasitol.</source>
<year>2015</year>
<volume>148</volume>
<fpage>24</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.exppara.2014.10.011</pub-id>
<?supplied-pmid 25448290?><pub-id pub-id-type="pmid">25448290</pub-id></element-citation></ref><ref id="B98-molecules-21-00529"><label>98.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klopell</surname><given-names>F.C.</given-names></name><name><surname>Lemos</surname><given-names>M.</given-names></name><name><surname>Sousa</surname><given-names>J.P.B.</given-names></name><name><surname>Comunello</surname><given-names>E.</given-names></name><name><surname>Maistro</surname><given-names>E.L.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>Andrade</surname><given-names>S.F.d.</given-names></name></person-group>
<article-title>Nerolidol, an antiulcer constituent from the essential oil of <italic>Baccharis dracunculifolia</italic> DC (Asteraceae)</article-title>
<source>Z. Naturforsch. C</source>
<year>2007</year>
<volume>62</volume>
<fpage>537</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1515/znc-2007-7-812</pub-id>
<?supplied-pmid 17913068?><pub-id pub-id-type="pmid">17913068</pub-id></element-citation></ref><ref id="B99-molecules-21-00529"><label>99.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cornwell</surname><given-names>P.A.</given-names></name><name><surname>Barry</surname><given-names>B.W.</given-names></name></person-group>
<article-title>Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil</article-title>
<source>J. Pharm. Pharmacol.</source>
<year>1994</year>
<volume>46</volume>
<fpage>261</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1111/j.2042-7158.1994.tb03791.x</pub-id>
<?supplied-pmid 8051608?><pub-id pub-id-type="pmid">8051608</pub-id></element-citation></ref><ref id="B100-molecules-21-00529"><label>100.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prasanthi</surname><given-names>D.</given-names></name><name><surname>Lakshmi</surname><given-names>P.K.</given-names></name></person-group>
<article-title>Terpenes: Effect of lipophilicity in enhancing transdermal delivery of alfuzosin hydrochloride</article-title>
<source>J. Adv. Pharm. Technol. Res.</source>
<year>2012</year>
<volume>3</volume>
<fpage>216</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.4103/2231-4040.104712</pub-id>
<?supplied-pmid 23378942?><pub-id pub-id-type="pmid">23378942</pub-id></element-citation></ref><ref id="B101-molecules-21-00529"><label>101.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krishnaiah</surname><given-names>Y.S.</given-names></name><name><surname>Al-Saidan</surname><given-names>S.M.</given-names></name><name><surname>Jayaram</surname><given-names>B.</given-names></name></person-group>
<article-title>Effect of nerodilol, carvone and anethole on the <italic>in vitro</italic> transdermal delivery of selegiline hydrochloride</article-title>
<source>Pharmazie</source>
<year>2006</year>
<volume>61</volume>
<fpage>46</fpage>
<lpage>53</lpage>
<?supplied-pmid 16454206?><pub-id pub-id-type="pmid">16454206</pub-id></element-citation></ref><ref id="B102-molecules-21-00529"><label>102.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El-Kattan</surname><given-names>A.F.</given-names></name><name><surname>Asbill</surname><given-names>C.S.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Michniak</surname><given-names>B.B.</given-names></name></person-group>
<article-title>The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities</article-title>
<source>Int. J. Pharm.</source>
<year>2001</year>
<volume>215</volume>
<fpage>229</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-5173(00)00699-2</pub-id>
<pub-id pub-id-type="pmid">11250108</pub-id></element-citation></ref><ref id="B103-molecules-21-00529"><label>103.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fons&#x000ea;ca</surname><given-names>D.V.</given-names></name><name><surname>Salgado</surname><given-names>P.R.R.</given-names></name><name><surname>de Carvalho</surname><given-names>F.L.</given-names></name><name><surname>Salvadori</surname><given-names>M.G.S.S.</given-names></name><name><surname>Penha</surname><given-names>A.R.S.</given-names></name><name><surname>Leite</surname><given-names>F.C.</given-names></name><name><surname>Borges</surname><given-names>C.J.S.</given-names></name><name><surname>Piuvezam</surname><given-names>M.R.</given-names></name><name><surname>Pordeus</surname><given-names>L.C.d.M.</given-names></name><name><surname>Sousa</surname><given-names>D.P.</given-names></name><etal/></person-group>
<article-title>Nerolidol exhibits antinociceptive and anti-inflammatory activity: Involvement of the GABAergic system and proinflammatory cytokines</article-title>
<source>Fundam. Clin. Pharmacol.</source>
<year>2015</year>
<volume>30</volume>
<fpage>14</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1111/fcp.12166</pub-id>
<?supplied-pmid 26791997?><pub-id pub-id-type="pmid">26791997</pub-id></element-citation></ref><ref id="B104-molecules-21-00529"><label>104.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ryabchenko</surname><given-names>B.</given-names></name><name><surname>Tulupova</surname><given-names>E.</given-names></name><name><surname>Schmidt</surname><given-names>E.</given-names></name><name><surname>Wlcek</surname><given-names>K.</given-names></name><name><surname>Buchbauer</surname><given-names>G.</given-names></name><name><surname>Jirovetz</surname><given-names>L.</given-names></name></person-group>
<article-title>Investigation of anticancer and antiviral properties of selected aroma samples</article-title>
<source>Nat. Prod. Commun.</source>
<year>2008</year>
<volume>3</volume>
<fpage>1085</fpage>
<lpage>1088</lpage>
</element-citation></ref><ref id="B105-molecules-21-00529"><label>105.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boris</surname><given-names>R.</given-names></name><name><surname>Elena</surname><given-names>T.</given-names></name><name><surname>Erich</surname><given-names>S.</given-names></name><name><surname>Walter</surname><given-names>J.</given-names></name><name><surname>Gerhard</surname><given-names>B.</given-names></name><name><surname>Leopold</surname><given-names>J.</given-names></name></person-group>
<article-title>Cytotoxic properties of selected sesquiterpene alcohols on human cervix carcinoma cell lines</article-title>
<source>J. Essent. Oil Bear. Plants</source>
<year>2011</year>
<volume>14</volume>
<fpage>316</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1080/0972060X.2011.10643940</pub-id>
</element-citation></ref><ref id="B106-molecules-21-00529"><label>106.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kubo</surname><given-names>I.</given-names></name><name><surname>Morimitsu</surname><given-names>Y.</given-names></name></person-group>
<article-title>Cytotoxicity of green tea flavor compounds against two solid tumor cells</article-title>
<source>J. Agric. Food Chem.</source>
<year>1995</year>
<volume>43</volume>
<fpage>1626</fpage>
<lpage>1628</lpage>
<pub-id pub-id-type="doi">10.1021/jf00054a039</pub-id>
</element-citation></ref><ref id="B107-molecules-21-00529"><label>107.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wattenberg</surname><given-names>L.W.</given-names></name></person-group>
<article-title>Inhibition of azoxymethane-induced neoplasia of the large bowel by 3-hydroxy-3,7,11-trimethyl-l,6,10-dodecatriene (nerolidol)</article-title>
<source>Carcinogenesis</source>
<year>1991</year>
<volume>12</volume>
<fpage>151</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1093/carcin/12.1.151</pub-id>
<?supplied-pmid 1988176?><pub-id pub-id-type="pmid">1988176</pub-id></element-citation></ref><ref id="B108-molecules-21-00529"><label>108.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tatman</surname><given-names>D.</given-names></name><name><surname>Mo</surname><given-names>H.</given-names></name></person-group>
<article-title>Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells</article-title>
<source>Cancer Lett.</source>
<year>2002</year>
<volume>175</volume>
<fpage>129</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3835(01)00723-6</pub-id>
<pub-id pub-id-type="pmid">11741740</pub-id></element-citation></ref><ref id="B109-molecules-21-00529"><label>109.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanu&#x00161;ov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Sk&#x000e1;lov&#x000e1;</surname><given-names>L.</given-names></name><name><surname>Ambro&#x0017e;</surname><given-names>M.</given-names></name><name><surname>Kr&#x000e1;lov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Langhansov&#x000e1;</surname><given-names>L.</given-names></name><name><surname>Matou&#x00161;kov&#x000e1;</surname><given-names>P.</given-names></name></person-group>
<article-title>The effect of <italic>Myrica rubra</italic> essential oil and its components &#x003b1;-humulene and <italic>trans</italic>-nerolidol on adhesion and apoptosis of colorectal cancer cells</article-title>
<source>Cancer Cell Microenviron.</source>
<year>2015</year>
<volume>2</volume>
<pub-id pub-id-type="doi">10.14800/ccm.1058</pub-id>
</element-citation></ref><ref id="B110-molecules-21-00529"><label>110.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lushchak</surname><given-names>V.I.</given-names></name></person-group>
<article-title>Free radicals, reactive oxygen species, oxidative stress and its classification</article-title>
<source>Chem. Biol. Interact.</source>
<year>2014</year>
<volume>224</volume>
<fpage>164</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbi.2014.10.016</pub-id>
<?supplied-pmid 25452175?><pub-id pub-id-type="pmid">25452175</pub-id></element-citation></ref><ref id="B111-molecules-21-00529"><label>111.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahman</surname><given-names>K.</given-names></name></person-group>
<article-title>Studies on free radicals, antioxidants, and co-factors</article-title>
<source>Clin. Interv. Aging</source>
<year>2007</year>
<volume>2</volume>
<fpage>219</fpage>
<lpage>236</lpage>
<?supplied-pmid 18044138?><pub-id pub-id-type="pmid">18044138</pub-id></element-citation></ref><ref id="B112-molecules-21-00529"><label>112.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uttara</surname><given-names>B.</given-names></name><name><surname>Singh</surname><given-names>A.V.</given-names></name><name><surname>Zamboni</surname><given-names>P.</given-names></name><name><surname>Mahajan</surname><given-names>R.T.</given-names></name></person-group>
<article-title>Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options</article-title>
<source>Curr. Neuropharmacol.</source>
<year>2009</year>
<volume>7</volume>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.2174/157015909787602823</pub-id>
<?supplied-pmid 19721819?><pub-id pub-id-type="pmid">19721819</pub-id></element-citation></ref><ref id="B113-molecules-21-00529"><label>113.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hana</surname><given-names>B.</given-names></name><name><surname>Veronika</surname><given-names>H.</given-names></name><name><surname>Lenka</surname><given-names>S.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name><name><surname>Iva</surname><given-names>B.</given-names></name></person-group>
<article-title>Antioxidant, pro-oxidant and other biological activities of sesquiterpenes</article-title>
<source>Curr. Top. Med. Chem.</source>
<year>2014</year>
<volume>14</volume>
<fpage>2478</fpage>
<lpage>2494</lpage>
<pub-id pub-id-type="pmid">25478887</pub-id></element-citation></ref><ref id="B114-molecules-21-00529"><label>114.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gonzalez-Burgos</surname><given-names>E.</given-names></name><name><surname>Gomez-Serranillos</surname><given-names>M.P.</given-names></name></person-group>
<article-title>Terpene compounds in nature: A review of their potential antioxidant activity</article-title>
<source>Curr. Med. Chem.</source>
<year>2012</year>
<volume>19</volume>
<fpage>5319</fpage>
<lpage>5341</lpage>
<pub-id pub-id-type="doi">10.2174/092986712803833335</pub-id>
<?supplied-pmid 22963623?><pub-id pub-id-type="pmid">22963623</pub-id></element-citation></ref><ref id="B115-molecules-21-00529"><label>115.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B.</given-names></name></person-group>
<article-title>Antioxidants in human health and disease</article-title>
<source>Annu. Rev. Nutr.</source>
<year>1996</year>
<volume>16</volume>
<fpage>33</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.nu.16.070196.000341</pub-id>
<?supplied-pmid 8839918?><pub-id pub-id-type="pmid">8839918</pub-id></element-citation></ref><ref id="B116-molecules-21-00529"><label>116.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.Y.</given-names></name><name><surname>Wang</surname><given-names>S.Y.</given-names></name><name><surname>Chen</surname><given-names>C.T.</given-names></name></person-group>
<article-title>Increasing antioxidant activity and reducing decay of blueberries by essential oils</article-title>
<source>J. Agric. Food Chem.</source>
<year>2008</year>
<volume>56</volume>
<fpage>3587</fpage>
<lpage>3592</lpage>
<pub-id pub-id-type="doi">10.1021/jf7037696</pub-id>
<?supplied-pmid 18442248?><pub-id pub-id-type="pmid">18442248</pub-id></element-citation></ref><ref id="B117-molecules-21-00529"><label>117.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blair</surname><given-names>J.M.A.</given-names></name><name><surname>Webber</surname><given-names>M.A.</given-names></name><name><surname>Baylay</surname><given-names>A.J.</given-names></name><name><surname>Ogbolu</surname><given-names>D.O.</given-names></name><name><surname>Piddock</surname><given-names>L.J.V.</given-names></name></person-group>
<article-title>Molecular mechanisms of antibiotic resistance</article-title>
<source>Nat. Rev. Microbiol.</source>
<year>2015</year>
<volume>13</volume>
<fpage>42</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro3380</pub-id>
<?supplied-pmid 25435309?><pub-id pub-id-type="pmid">25435309</pub-id></element-citation></ref><ref id="B118-molecules-21-00529"><label>118.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kubo</surname><given-names>I.</given-names></name><name><surname>Muroi</surname><given-names>H.</given-names></name><name><surname>Masaki</surname><given-names>H.</given-names></name><name><surname>Kubo</surname><given-names>A.</given-names></name></person-group>
<article-title>Antibacterial activity of long-chain alcohols: The role of hydrophobic alkyl groups</article-title>
<source>Bioorg. Med. Chem. Lett.</source>
<year>1993</year>
<volume>3</volume>
<fpage>1305</fpage>
<lpage>1308</lpage>
<pub-id pub-id-type="doi">10.1016/S0960-894X(00)80336-4</pub-id>
</element-citation></ref><ref id="B119-molecules-21-00529"><label>119.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Donlan</surname><given-names>R.M.</given-names></name></person-group>
<article-title>Biofilms: Microbial life on surfaces</article-title>
<source>Emerg. Infect. Dis.</source>
<year>2002</year>
<volume>8</volume>
<fpage>881</fpage>
<lpage>890</lpage>
<pub-id pub-id-type="doi">10.3201/eid0809.020063</pub-id>
<?supplied-pmid 12194761?><pub-id pub-id-type="pmid">12194761</pub-id></element-citation></ref><ref id="B120-molecules-21-00529"><label>120.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ashley</surname><given-names>E.S.D.</given-names></name><name><surname>Lewis</surname><given-names>R.</given-names></name><name><surname>Lewis</surname><given-names>J.S.</given-names></name><name><surname>Martin</surname><given-names>C.</given-names></name><name><surname>Andes</surname><given-names>D.</given-names></name></person-group>
<article-title>Pharmacology of systemic antifungal agents</article-title>
<source>Clin. Infect. Dis.</source>
<year>2006</year>
<volume>43</volume>
<fpage>S28</fpage>
<lpage>S39</lpage>
<pub-id pub-id-type="doi">10.1086/504492</pub-id>
</element-citation></ref><ref id="B121-molecules-21-00529"><label>121.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kalemba</surname><given-names>D.</given-names></name><name><surname>Kunicka</surname><given-names>A.</given-names></name></person-group>
<article-title>Antibacterial and antifungal properties of essential oils</article-title>
<source>Curr. Med. Chem.</source>
<year>2003</year>
<volume>10</volume>
<fpage>813</fpage>
<lpage>829</lpage>
<pub-id pub-id-type="doi">10.2174/0929867033457719</pub-id>
<?supplied-pmid 12678685?><pub-id pub-id-type="pmid">12678685</pub-id></element-citation></ref><ref id="B122-molecules-21-00529"><label>122.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pattnaik</surname><given-names>S.</given-names></name><name><surname>Subramanyam</surname><given-names>V.R.</given-names></name><name><surname>Kole</surname><given-names>C.</given-names></name></person-group>
<article-title>Antibacterial and antifungal activity of ten essential oils <italic>in vitro</italic></article-title>
<source>Microbios</source>
<year>1996</year>
<volume>86</volume>
<fpage>237</fpage>
<lpage>246</lpage>
<?supplied-pmid 8893526?><pub-id pub-id-type="pmid">8893526</pub-id></element-citation></ref><ref id="B123-molecules-21-00529"><label>123.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Renslo</surname><given-names>A.R.</given-names></name><name><surname>McKerrow</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Drug discovery and development for neglected parasitic diseases</article-title>
<source>Nat. Chem. Biol.</source>
<year>2006</year>
<volume>2</volume>
<fpage>701</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="doi">10.1038/nchembio837</pub-id>
<?supplied-pmid 17108988?><pub-id pub-id-type="pmid">17108988</pub-id></element-citation></ref><ref id="B124-molecules-21-00529"><label>124.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anthony</surname><given-names>J.P.</given-names></name><name><surname>Fyfe</surname><given-names>L.</given-names></name><name><surname>Smith</surname><given-names>H.</given-names></name></person-group>
<article-title>Plant active components&#x02014;A resource for antiparasitic agents?</article-title>
<source>Trends Parasitol.</source>
<year>2005</year>
<volume>21</volume>
<fpage>462</fpage>
<lpage>468</lpage>
<pub-id pub-id-type="doi">10.1016/j.pt.2005.08.004</pub-id>
<?supplied-pmid 16099722?><pub-id pub-id-type="pmid">16099722</pub-id></element-citation></ref><ref id="B125-molecules-21-00529"><label>125.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaye</surname><given-names>P.</given-names></name><name><surname>Scott</surname><given-names>P.</given-names></name></person-group>
<article-title>Leishmaniasis: Complexity at the host-pathogen interface</article-title>
<source>Nat. Rev. Microbiol.</source>
<year>2011</year>
<volume>9</volume>
<fpage>604</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2608</pub-id>
<?supplied-pmid 21747391?><pub-id pub-id-type="pmid">21747391</pub-id></element-citation></ref><ref id="B126-molecules-21-00529"><label>126.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tiuman</surname><given-names>T.S.</given-names></name><name><surname>Santos</surname><given-names>A.O.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Filho</surname><given-names>B.P.D.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name></person-group>
<article-title>Recent advances in leishmaniasis treatment</article-title>
<source>Int. J. Infect. Dis.</source>
<year>2011</year>
<volume>15</volume>
<fpage>e525</fpage>
<lpage>e532</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijid.2011.03.021</pub-id>
<?supplied-pmid 21605997?><pub-id pub-id-type="pmid">21605997</pub-id></element-citation></ref><ref id="B127-molecules-21-00529"><label>127.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Couto</surname><given-names>A.S.</given-names></name><name><surname>Kimura</surname><given-names>E.A.</given-names></name><name><surname>Peres</surname><given-names>V.J.</given-names></name><name><surname>Uhrig</surname><given-names>M.L.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Active isoprenoid pathway in the intra-erythrocytic stages of <italic>Plasmodium falciparum</italic>: Presence of dolichols of 11 and 12 isoprene units</article-title>
<source>Biochem. J.</source>
<year>1999</year>
<volume>341</volume>
<fpage>629</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="doi">10.1042/0264-6021:3410629</pub-id>
<?supplied-pmid 10417326?><pub-id pub-id-type="pmid">10417326</pub-id></element-citation></ref><ref id="B128-molecules-21-00529"><label>128.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mendanha</surname><given-names>S.A.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name></person-group>
<article-title>Effects of terpenes on fluidity and lipid extraction in phospholipid membranes</article-title>
<source>Biophys. Chem.</source>
<year>2015</year>
<volume>198</volume>
<fpage>45</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/j.bpc.2015.02.001</pub-id>
<?supplied-pmid 25687600?><pub-id pub-id-type="pmid">25687600</pub-id></element-citation></ref><ref id="B129-molecules-21-00529"><label>129.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>T.</given-names></name><name><surname>Esmat</surname><given-names>G.</given-names></name></person-group>
<article-title>Hepatic and intestinal schistosomiasis: Review</article-title>
<source>J. Adv. Res.</source>
<year>2013</year>
<volume>4</volume>
<fpage>445</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1016/j.jare.2012.12.001</pub-id>
<?supplied-pmid 25685451?><pub-id pub-id-type="pmid">25685451</pub-id></element-citation></ref><ref id="B130-molecules-21-00529"><label>130.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ross</surname><given-names>A.G.P.</given-names></name><name><surname>Bartley</surname><given-names>P.B.</given-names></name><name><surname>Sleigh</surname><given-names>A.C.</given-names></name><name><surname>Olds</surname><given-names>G.R.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Williams</surname><given-names>G.M.</given-names></name><name><surname>McManus</surname><given-names>D.P.</given-names></name></person-group>
<article-title>Schistosomiasis</article-title>
<source>N. Engl. J. Med.</source>
<year>2002</year>
<volume>346</volume>
<fpage>1212</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra012396</pub-id>
<?supplied-pmid 11961151?><pub-id pub-id-type="pmid">11961151</pub-id></element-citation></ref><ref id="B131-molecules-21-00529"><label>131.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tangpukdee</surname><given-names>N.</given-names></name><name><surname>Duangdee</surname><given-names>C.</given-names></name><name><surname>Wilairatana</surname><given-names>P.</given-names></name><name><surname>Krudsood</surname><given-names>S.</given-names></name></person-group>
<article-title>Malaria diagnosis: A brief review</article-title>
<source>Korean. J. Parasitol.</source>
<year>2009</year>
<volume>47</volume>
<fpage>93</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.3347/kjp.2009.47.2.93</pub-id>
<?supplied-pmid 19488414?><pub-id pub-id-type="pmid">19488414</pub-id></element-citation></ref><ref id="B132-molecules-21-00529"><label>132.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tonhosolo</surname><given-names>R.</given-names></name><name><surname>D&#x02019;Alexandri</surname><given-names>F.L.</given-names></name><name><surname>Genta</surname><given-names>F.A.</given-names></name><name><surname>Wunderlich</surname><given-names>G.</given-names></name><name><surname>Gozzo</surname><given-names>F.C.</given-names></name><name><surname>Eberlin</surname><given-names>M.N.</given-names></name><name><surname>Peres</surname><given-names>V.J.</given-names></name><name><surname>Kimura</surname><given-names>E.A.</given-names></name><name><surname>Katzin</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Identification, molecular cloning and functional characterization of an octaprenyl pyrophosphate synthase in intra-erythrocytic stages of <italic>Plasmodium falciparum</italic></article-title>
<source>Biochem. J.</source>
<year>2005</year>
<volume>392</volume>
<fpage>117</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20050441</pub-id>
<?supplied-pmid 15984931?><pub-id pub-id-type="pmid">15984931</pub-id></element-citation></ref><ref id="B133-molecules-21-00529"><label>133.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ukeh</surname><given-names>D.A.</given-names></name><name><surname>Birkett</surname><given-names>M.A.</given-names></name><name><surname>Pickett</surname><given-names>J.A.</given-names></name><name><surname>Bowman</surname><given-names>A.S.</given-names></name><name><surname>Jennifer Mordue</surname><given-names>A.</given-names></name></person-group>
<article-title>Repellent activity of alligator pepper, <italic>Aframomum melegueta</italic>, and ginger, <italic>Zingiber officinale</italic>, against the maize weevil, <italic>Sitophilus zeamais</italic></article-title>
<source>Phytochemistry</source>
<year>2009</year>
<volume>70</volume>
<fpage>751</fpage>
<lpage>758</lpage>
<pub-id pub-id-type="doi">10.1016/j.phytochem.2009.03.012</pub-id>
<?supplied-pmid 19394981?><pub-id pub-id-type="pmid">19394981</pub-id></element-citation></ref><ref id="B134-molecules-21-00529"><label>134.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Isman</surname><given-names>M.B.</given-names></name></person-group>
<article-title>Plant essential oils for pest and disease management</article-title>
<source>Crop Prot.</source>
<year>2000</year>
<volume>19</volume>
<fpage>603</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.1016/S0261-2194(00)00079-X</pub-id>
</element-citation></ref><ref id="B135-molecules-21-00529"><label>135.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prajapati</surname><given-names>V.</given-names></name><name><surname>Tripathi</surname><given-names>A.K.</given-names></name><name><surname>Aggarwal</surname><given-names>K.K.</given-names></name><name><surname>Khanuja</surname><given-names>S.P.S.</given-names></name></person-group>
<article-title>Insecticidal, repellent and oviposition-deterrent activity of selected essential oils against <italic>Anopheles stephensi</italic>, <italic>Aedes aegypti</italic> and <italic>Culex quinquefasciatus</italic></article-title>
<source>Bioresour. Technol.</source>
<year>2005</year>
<volume>96</volume>
<fpage>1749</fpage>
<lpage>1757</lpage>
<pub-id pub-id-type="doi">10.1016/j.biortech.2005.01.007</pub-id>
<?supplied-pmid 16051081?><pub-id pub-id-type="pmid">16051081</pub-id></element-citation></ref><ref id="B136-molecules-21-00529"><label>136.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chan</surname><given-names>F.K.L.</given-names></name><name><surname>Leung</surname><given-names>W.K.</given-names></name></person-group>
<article-title>Peptic-ulcer disease</article-title>
<source>Lancet</source>
<year>2002</year>
<volume>360</volume>
<fpage>933</fpage>
<lpage>941</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(02)11030-0</pub-id>
<pub-id pub-id-type="pmid">12354485</pub-id></element-citation></ref><ref id="B137-molecules-21-00529"><label>137.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prausnitz</surname><given-names>M.R.</given-names></name><name><surname>Mitragotri</surname><given-names>S.</given-names></name><name><surname>Langer</surname><given-names>R.</given-names></name></person-group>
<article-title>Current status and future potential of transdermal drug delivery</article-title>
<source>Nat. Rev. Drug Discov.</source>
<year>2004</year>
<volume>3</volume>
<fpage>115</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1038/nrd1304</pub-id>
<?supplied-pmid 15040576?><pub-id pub-id-type="pmid">15040576</pub-id></element-citation></ref><ref id="B138-molecules-21-00529"><label>138.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fang</surname><given-names>J.-Y.</given-names></name><name><surname>Leu</surname><given-names>Y.-L.</given-names></name><name><surname>Hwang</surname><given-names>T.-L.</given-names></name><name><surname>Cheng</surname><given-names>H.-C.</given-names></name><name><surname>Hung</surname><given-names>C.-F.</given-names></name></person-group>
<article-title>Development of sesquiterpenes from <italic>Alpinia oxyphylla</italic> as novel skin permeation enhancers</article-title>
<source>Eur. J. Pharm. Sci.</source>
<year>2003</year>
<volume>19</volume>
<fpage>253</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1016/S0928-0987(03)00118-0</pub-id>
<pub-id pub-id-type="pmid">12885390</pub-id></element-citation></ref><ref id="B139-molecules-21-00529"><label>139.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name></person-group>
<article-title><italic>In vitro</italic> percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes</article-title>
<source>J. Control. Release</source>
<year>1998</year>
<volume>51</volume>
<fpage>193</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1016/S0168-3659(97)00168-5</pub-id>
<pub-id pub-id-type="pmid">9685917</pub-id></element-citation></ref><ref id="B140-molecules-21-00529"><label>140.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riedel</surname><given-names>W.</given-names></name><name><surname>Neeck</surname><given-names>G.</given-names></name></person-group>
<article-title>Nociception, pain, and antinociception: Current concepts</article-title>
<source>Z. Rheumatol.</source>
<year>2001</year>
<volume>60</volume>
<fpage>404</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.1007/s003930170003</pub-id>
<?supplied-pmid 11826734?><pub-id pub-id-type="pmid">11826734</pub-id></element-citation></ref><ref id="B141-molecules-21-00529"><label>141.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kidd</surname><given-names>B.L.</given-names></name><name><surname>Urban</surname><given-names>L.A.</given-names></name></person-group>
<article-title>Mechanisms of inflammatory pain</article-title>
<source>Br. J. Anaesth.</source>
<year>2001</year>
<volume>87</volume>
<fpage>3</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1093/bja/87.1.3</pub-id>
<?supplied-pmid 11460811?><pub-id pub-id-type="pmid">11460811</pub-id></element-citation></ref><ref id="B142-molecules-21-00529"><label>142.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liew</surname><given-names>F.Y.</given-names></name></person-group>
<article-title>The role of innate cytokines in inflammatory response</article-title>
<source>Immunol. Lett.</source>
<year>2003</year>
<volume>85</volume>
<fpage>131</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-2478(02)00238-9</pub-id>
<pub-id pub-id-type="pmid">12527218</pub-id></element-citation></ref><ref id="B143-molecules-21-00529"><label>143.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maroon</surname><given-names>J.C.</given-names></name><name><surname>Bost</surname><given-names>J.W.</given-names></name><name><surname>Maroon</surname><given-names>A.</given-names></name></person-group>
<article-title>Natural anti-inflammatory agents for pain relief</article-title>
<source>Surg. Neurol. Int.</source>
<year>2010</year>
<volume>1</volume>
<pub-id pub-id-type="doi">10.4103/2152-7806.73804</pub-id>
</element-citation></ref><ref id="B144-molecules-21-00529"><label>144.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chan</surname><given-names>C.K.</given-names></name><name><surname>Supriady</surname><given-names>H.</given-names></name><name><surname>Goh</surname><given-names>B.H.</given-names></name><name><surname>Kadir</surname><given-names>H.A.</given-names></name></person-group>
<article-title><italic>Elephantopus scaber</italic> induces apoptosis through ROS-dependent mitochondrial signaling pathway in HCT116 human colorectal carcinoma cells</article-title>
<source>J. Ethnopharmacol.</source>
<year>2015</year>
<volume>168</volume>
<fpage>291</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2015.03.072</pub-id>
<?supplied-pmid 25861953?><pub-id pub-id-type="pmid">25861953</pub-id></element-citation></ref><ref id="B145-molecules-21-00529"><label>145.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name></person-group>
<article-title>Ocular adverse effects of anti-cancer chemotherapy</article-title>
<source>J. Cancer Ther. Res.</source>
<year>2012</year>
<volume>1</volume>
<pub-id pub-id-type="doi">10.7243/2049-7962-1-5</pub-id>
</element-citation></ref><ref id="B146-molecules-21-00529"><label>146.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>R.W.</given-names></name><name><surname>Ruefli</surname><given-names>A.A.</given-names></name><name><surname>Lowe</surname><given-names>S.W.</given-names></name></person-group>
<article-title>Apoptosis: A link between cancer genetics and chemotherapy</article-title>
<source>Cell</source>
<year>2002</year>
<volume>108</volume>
<fpage>153</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00625-6</pub-id>
<pub-id pub-id-type="pmid">11832206</pub-id></element-citation></ref><ref id="B147-molecules-21-00529"><label>147.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gautam</surname><given-names>N.</given-names></name><name><surname>Mantha</surname><given-names>A.K.</given-names></name><name><surname>Mittal</surname><given-names>S.</given-names></name></person-group>
<article-title>Essential oils and their constituents as anticancer agents: A mechanistic view</article-title>
<source>Biomed. Res. Int.</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1155/2014/154106</pub-id>
<?supplied-pmid 25003106?><pub-id pub-id-type="pmid">25003106</pub-id></element-citation></ref><ref id="B148-molecules-21-00529"><label>148.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goh</surname><given-names>B.H.</given-names></name><name><surname>Chan</surname><given-names>C.K.</given-names></name><name><surname>Kamarudin</surname><given-names>M.N.A.</given-names></name><name><surname>Abdul Kadir</surname><given-names>H.</given-names></name></person-group>
<article-title><italic>Swietenia macrophylla</italic> King induces mitochondrial-mediated apoptosis through p53 upregulation in HCT116 colorectal carcinoma cells</article-title>
<source>J. Ethnopharmacol.</source>
<year>2014</year>
<volume>153</volume>
<fpage>375</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2014.02.036</pub-id>
<?supplied-pmid 24613274?><pub-id pub-id-type="pmid">24613274</pub-id></element-citation></ref><ref id="B149-molecules-21-00529"><label>149.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sylvestre</surname><given-names>M.</given-names></name><name><surname>Pichette</surname><given-names>A.</given-names></name><name><surname>Lavoie</surname><given-names>S.</given-names></name><name><surname>Longtin</surname><given-names>A.</given-names></name><name><surname>Legault</surname><given-names>J.</given-names></name></person-group>
<article-title>Composition and cytotoxic activity of the leaf essential oil of <italic>Comptonia peregrina</italic> (L.) Coulter</article-title>
<source>Phytother. Res.</source>
<year>2007</year>
<volume>21</volume>
<fpage>536</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1002/ptr.2095</pub-id>
<?supplied-pmid 17326040?><pub-id pub-id-type="pmid">17326040</pub-id></element-citation></ref><ref id="B150-molecules-21-00529"><label>150.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Golias</surname><given-names>C.</given-names></name><name><surname>Tsoutsi</surname><given-names>E.</given-names></name><name><surname>Matziridis</surname><given-names>A.</given-names></name><name><surname>Makridis</surname><given-names>P.</given-names></name><name><surname>Batistatou</surname><given-names>A.</given-names></name><name><surname>Charalabopoulos</surname><given-names>K.</given-names></name></person-group>
<article-title>Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease</article-title>
<source>In Vivo</source>
<year>2007</year>
<volume>21</volume>
<fpage>757</fpage>
<lpage>769</lpage>
<?supplied-pmid 18019409?><pub-id pub-id-type="pmid">18019409</pub-id></element-citation></ref><ref id="B151-molecules-21-00529"><label>151.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Casey</surname><given-names>P.J.</given-names></name><name><surname>Solski</surname><given-names>P.A.</given-names></name><name><surname>Der</surname><given-names>C.J.</given-names></name><name><surname>Buss</surname><given-names>J.E.</given-names></name></person-group>
<article-title>p21ras is modified by a farnesyl isoprenoid</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>1989</year>
<volume>86</volume>
<fpage>8323</fpage>
<lpage>8327</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.86.21.8323</pub-id>
<?supplied-pmid 2682646?><pub-id pub-id-type="pmid">2682646</pub-id></element-citation></ref><ref id="B152-molecules-21-00529"><label>152.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Smet</surname><given-names>P.A.G.M.</given-names></name></person-group>
<article-title>Clinical risk management of herb-drug interactions</article-title>
<source>Br. J. Clin. Pharmacol.</source>
<year>2007</year>
<volume>63</volume>
<fpage>258</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2125.2006.02797.x</pub-id>
<?supplied-pmid 17116126?><pub-id pub-id-type="pmid">17116126</pub-id></element-citation></ref><ref id="B153-molecules-21-00529"><label>153.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>King</surname><given-names>A.J.</given-names></name><name><surname>Dickinson</surname><given-names>J.R.</given-names></name></person-group>
<article-title>Biotransformation of hop aroma terpenoids by ale and lager yeasts</article-title>
<source>FEMS Yeast Res.</source>
<year>2003</year>
<volume>3</volume>
<fpage>53</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1111/j.1567-1364.2003.tb00138.x</pub-id>
<?supplied-pmid 12702246?><pub-id pub-id-type="pmid">12702246</pub-id></element-citation></ref><ref id="B154-molecules-21-00529"><label>154.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Longenecker</surname><given-names>H.E.</given-names></name><name><surname>Musulin</surname><given-names>R.R.</given-names></name><name><surname>Tully</surname><given-names>R.H.</given-names></name><name><surname>King</surname><given-names>C.G.</given-names></name></person-group>
<article-title>An acceleration of Vitamin C synthesis and excretion by feeding known organic compounds to rats</article-title>
<source>J. Biol. Chem.</source>
<year>1939</year>
<volume>129</volume>
<fpage>445</fpage>
<lpage>453</lpage>
</element-citation></ref><ref id="B155-molecules-21-00529"><label>155.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mendanha</surname><given-names>S.A.</given-names></name><name><surname>Moura</surname><given-names>S.S.</given-names></name><name><surname>Anjos</surname><given-names>J.L.V.</given-names></name><name><surname>Valadares</surname><given-names>M.C.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name></person-group>
<article-title>Toxicity of terpenes on fibroblast cells compared to their hemolytic potential and increase in erythrocyte membrane fluidity</article-title>
<source>Toxicol. In Vitro</source>
<year>2013</year>
<volume>27</volume>
<fpage>323</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1016/j.tiv.2012.08.022</pub-id>
<?supplied-pmid 22944593?><pub-id pub-id-type="pmid">22944593</pub-id></element-citation></ref><ref id="B156-molecules-21-00529"><label>156.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reagan-Shaw</surname><given-names>S.</given-names></name><name><surname>Nihal</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name></person-group>
<article-title>Dose translation from animal to human studies revisited</article-title>
<source>FASEB J.</source>
<year>2008</year>
<volume>22</volume>
<fpage>659</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="doi">10.1096/fj.07-9574LSF</pub-id>
<?supplied-pmid 17942826?><pub-id pub-id-type="pmid">17942826</pub-id></element-citation></ref><ref id="B157-molecules-21-00529"><label>157.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>S.</given-names></name></person-group>
<article-title>Drug administration, absorption, and bioavailability</article-title>
<source>Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook and Computer Simulations</source>
<edition>1st ed.</edition>
<publisher-name>John Wiley &#x00026; Sons, Inc.</publisher-name>
<publisher-loc>Hoboken, NJ, USA</publisher-loc>
<year>2011</year>
<fpage>36</fpage>
<lpage>59</lpage>
</element-citation></ref><ref id="B158-molecules-21-00529"><label>158.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Jambhekar</surname><given-names>S.S.</given-names></name><name><surname>Breen</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Bioavailability/bioequivalence</article-title>
<source>Basic Pharmacokinetics</source>
<edition>2nd ed.</edition>
<publisher-name>Pharmaceutical Press</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>2012</year>
<fpage>137</fpage>
<lpage>159</lpage>
</element-citation></ref><ref id="B159-molecules-21-00529"><label>159.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bunel</surname><given-names>V.</given-names></name><name><surname>Ouedraogo</surname><given-names>M.</given-names></name><name><surname>Nguyen</surname><given-names>A.T.</given-names></name><name><surname>St&#x000e9;vigny</surname><given-names>C.</given-names></name><name><surname>Duez</surname><given-names>P.</given-names></name></person-group>
<article-title>Methods applied to the <italic>in vitro</italic> primary toxicology testing of natural products: State of the art, strengths, and limits</article-title>
<source>Planta Med.</source>
<year>2014</year>
<volume>80</volume>
<fpage>1210</fpage>
<lpage>1226</lpage>
<pub-id pub-id-type="doi">10.1055/s-0033-1360273</pub-id>
<?supplied-pmid 24431017?><pub-id pub-id-type="pmid">24431017</pub-id></element-citation></ref><ref id="B160-molecules-21-00529"><label>160.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hausen</surname><given-names>B.M.</given-names></name><name><surname>Evers</surname><given-names>P.</given-names></name><name><surname>St&#x000fc;we</surname><given-names>H.T.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>W.A.</given-names></name><name><surname>Wollenweber</surname><given-names>E.</given-names></name></person-group>
<article-title>Propolis allergy (IV) studies with further sensitizers from propolis and constituents common to propolis, poplar buds and Balsam of Peru</article-title>
<source>Contact Dermat.</source>
<year>1992</year>
<volume>26</volume>
<fpage>34</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0536.1992.tb00865.x</pub-id>
</element-citation></ref><ref id="B161-molecules-21-00529"><label>161.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hausen</surname><given-names>B.M.</given-names></name><name><surname>Simatupang</surname><given-names>T.</given-names></name><name><surname>Bruhn</surname><given-names>G.</given-names></name><name><surname>Evers</surname><given-names>P.</given-names></name><name><surname>Koenig</surname><given-names>W.A.</given-names></name></person-group>
<article-title>Identification of new allergenic constituents and proof of evidence for coniferyl benzoate in Balsam of Peru</article-title>
<source>Am. J. Contact Dermat.</source>
<year>1995</year>
<volume>6</volume>
<fpage>199</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1016/1046-199X(95)90043-8</pub-id>
</element-citation></ref><ref id="B162-molecules-21-00529"><label>162.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Belsito</surname><given-names>D.</given-names></name><name><surname>Bickers</surname><given-names>D.</given-names></name><name><surname>Bruze</surname><given-names>M.</given-names></name><name><surname>Calow</surname><given-names>P.</given-names></name><name><surname>Greim</surname><given-names>H.</given-names></name><name><surname>Hanifin</surname><given-names>J.M.</given-names></name><name><surname>Rogers</surname><given-names>A.E.</given-names></name><name><surname>Saurat</surname><given-names>J.H.</given-names></name><name><surname>Sipes</surname><given-names>I.G.</given-names></name><name><surname>Tagami</surname><given-names>H.</given-names></name></person-group>
<article-title>A safety assessment of non-cyclic alcohols with unsaturated branched chain when used as fragrance ingredients: The RIFM expert panel</article-title>
<source>Food Chem. Toxicol.</source>
<year>2010</year>
<volume>48</volume>
<issue>Suppl. 3</issue>
<fpage>S1</fpage>
<lpage>S42</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2009.11.007</pub-id>
<?supplied-pmid 20659630?><pub-id pub-id-type="pmid">20659630</pub-id></element-citation></ref><ref id="B163-molecules-21-00529"><label>163.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanley</surname><given-names>K.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Crumrine</surname><given-names>D.</given-names></name><name><surname>Bass</surname><given-names>N.M.</given-names></name><name><surname>Appel</surname><given-names>R.</given-names></name><name><surname>Elias</surname><given-names>P.M.</given-names></name><name><surname>Williams</surname><given-names>M.L.</given-names></name><name><surname>Feingold</surname><given-names>K.R.</given-names></name></person-group>
<article-title>Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier</article-title>
<source>J. Clin. Investig.</source>
<year>1997</year>
<volume>100</volume>
<fpage>705</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1172/JCI119583</pub-id>
<?supplied-pmid 9239419?><pub-id pub-id-type="pmid">9239419</pub-id></element-citation></ref><ref id="B164-molecules-21-00529"><label>164.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brand</surname><given-names>M.D.</given-names></name><name><surname>Nicholls</surname><given-names>D.G.</given-names></name></person-group>
<article-title>Assessing mitochondrial dysfunction in cells</article-title>
<source>Biochem. J.</source>
<year>2011</year>
<volume>435</volume>
<fpage>297</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20110162</pub-id>
<?supplied-pmid 21726199?><pub-id pub-id-type="pmid">21726199</pub-id></element-citation></ref><ref id="B165-molecules-21-00529"><label>165.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>P&#x000e9;res</surname><given-names>V.F.</given-names></name><name><surname>Moura</surname><given-names>D.J.</given-names></name><name><surname>Sperotto</surname><given-names>A.R.M.</given-names></name><name><surname>Damasceno</surname><given-names>F.C.</given-names></name><name><surname>Caram&#x000e3;o</surname><given-names>E.B.</given-names></name><name><surname>Zini</surname><given-names>C.A.</given-names></name><name><surname>Saffi</surname><given-names>J.</given-names></name></person-group>
<article-title>Chemical composition and cytotoxic, mutagenic and genotoxic activities of the essential oil from <italic>Piper gaudichaudianum</italic> Kunth leaves</article-title>
<source>Food Chem. Toxicol.</source>
<year>2009</year>
<volume>47</volume>
<fpage>2389</fpage>
<lpage>2395</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2009.06.035</pub-id>
<?supplied-pmid 19563855?><pub-id pub-id-type="pmid">19563855</pub-id></element-citation></ref><ref id="B166-molecules-21-00529"><label>166.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sperotto</surname><given-names>A.R.M.</given-names></name><name><surname>Moura</surname><given-names>D.J.</given-names></name><name><surname>P&#x000e9;res</surname><given-names>V.F.</given-names></name><name><surname>Damasceno</surname><given-names>F.C.</given-names></name><name><surname>Caram&#x000e3;o</surname><given-names>E.B.</given-names></name><name><surname>Henriques</surname><given-names>J.A.P.</given-names></name><name><surname>Saffi</surname><given-names>J.</given-names></name></person-group>
<article-title>Cytotoxic mechanism of <italic>Piper gaudichaudianum</italic> Kunth essential oil and its major compound nerolidol</article-title>
<source>Food Chem. Toxicol.</source>
<year>2013</year>
<volume>57</volume>
<fpage>57</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2013.03.013</pub-id>
<?supplied-pmid 23523831?><pub-id pub-id-type="pmid">23523831</pub-id></element-citation></ref><ref id="B167-molecules-21-00529"><label>167.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heijne</surname><given-names>W.H.M.</given-names></name><name><surname>Kienhuis</surname><given-names>A.S.</given-names></name><name><surname>van Ommen</surname><given-names>B.</given-names></name><name><surname>Stierum</surname><given-names>R.H.</given-names></name><name><surname>Groten</surname><given-names>J.P.</given-names></name></person-group>
<article-title>Systems toxicology: Applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology</article-title>
<source>Expert Rev. Proteom.</source>
<year>2005</year>
<volume>2</volume>
<fpage>767</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="doi">10.1586/14789450.2.5.767</pub-id>
<?supplied-pmid 16209655?><pub-id pub-id-type="pmid">16209655</pub-id></element-citation></ref><ref id="B168-molecules-21-00529"><label>168.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Youns</surname><given-names>M.</given-names></name><name><surname>Hoheisel</surname><given-names>J.D.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group>
<article-title>Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine</article-title>
<source>Planta Med.</source>
<year>2010</year>
<volume>76</volume>
<fpage>2019</fpage>
<lpage>2025</lpage>
<pub-id pub-id-type="doi">10.1055/s-0030-1250432</pub-id>
<?supplied-pmid 20957595?><pub-id pub-id-type="pmid">20957595</pub-id></element-citation></ref><ref id="B169-molecules-21-00529"><label>169.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>P&#x000ed;culo</surname><given-names>F.</given-names></name><name><surname>Guiraldeli Macedo</surname><given-names>C.</given-names></name><name><surname>de Andrade</surname><given-names>S.F.</given-names></name><name><surname>Luis Maistro</surname><given-names>E.</given-names></name></person-group>
<article-title><italic>In vivo</italic> genotoxicity assessment of nerolidol</article-title>
<source>J. Appl. Toxicol.</source>
<year>2011</year>
<volume>31</volume>
<fpage>633</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1002/jat.1607</pub-id>
<?supplied-pmid 21089164?><pub-id pub-id-type="pmid">21089164</pub-id></element-citation></ref></ref-list><sec sec-type="display-objects"><title>Figures, Schemes and Tables</title><fig id="molecules-21-00529-f001" position="float"><label>Figure 1</label><caption><p>Chemical structures of the two enantiomers both for <italic>cis</italic>- and <italic>trans</italic>-isomers of nerolidol.</p></caption><graphic xlink:href="molecules-21-00529-g001"/></fig><fig id="molecules-21-00529-sch001" position="float"><object-id pub-id-type="pii">molecules-21-00529-sch001_Scheme 1</object-id><label>Scheme 1</label><caption><p>The overall chemical synthesis pathway of nerolidol to fulfill the demand of nerolidol in the industrial sector.</p></caption><graphic xlink:href="molecules-21-00529-sch001"/></fig><fig id="molecules-21-00529-sch002" position="float"><object-id pub-id-type="pii">molecules-21-00529-sch002_Scheme 2</object-id><label>Scheme 2</label><caption><p>The biosynthesis pathway of (3<italic>S</italic>)-(<italic>E</italic>)-nerolidol as an intermediate product for the production of DMNT as an herbivore-induced volatile to protect the plant against herbivore damage.</p></caption><graphic xlink:href="molecules-21-00529-sch002"/></fig><fig id="molecules-21-00529-f002" position="float"><label>Figure 2</label><caption><p>The source of extraction of nerolidol and an overview of the biological activities of nerolidol.</p></caption><graphic xlink:href="molecules-21-00529-g002"/></fig><table-wrap id="molecules-21-00529-t001" position="float"><object-id pub-id-type="pii">molecules-21-00529-t001_Table 1</object-id><label>Table 1</label><caption><p>Synonyms of <italic>cis</italic>- and <italic>trans</italic>-nerolidol.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cis</italic>-Nerolidol</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trans</italic>-Nerolidol</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">(i) (&#x000b1;)-<italic>cis</italic>-nerolidol</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) (&#x000b1;)-<italic>trans</italic>-nerolidol</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) (6<italic>Z</italic>)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol</td><td align="left" valign="middle" rowspan="1" colspan="1">(ii) (6<italic>E</italic>)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(iii) (6<italic>Z</italic>)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol</td><td align="left" valign="middle" rowspan="1" colspan="1">(iii) (6<italic>E</italic>)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(iv) (6<italic>Z</italic>)-nerolidol</td><td align="left" valign="middle" rowspan="1" colspan="1">(iv) (6<italic>E</italic>)-nerolidol</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(v) 1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (6<italic>Z</italic>)-</td><td align="left" valign="middle" rowspan="1" colspan="1">(v) 1,6,10-dodecatrien-3-ol, 3,7,11-trimethyl-, (6<italic>E</italic>)-</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(vi) (<italic>Z</italic>)-nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(vi) (<italic>E</italic>)-nerolidol</td></tr></tbody></table></table-wrap><table-wrap id="molecules-21-00529-t002" position="float"><object-id pub-id-type="pii">molecules-21-00529-t002_Table 2</object-id><label>Table 2</label><caption><p>Plant sources of nerolidol along with its percentage of nerolidol and extraction method.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Part</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Nerolidol Found in the Essential Oil</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol Purified from the Essential Oil of the Respective Plants (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extraction Method</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Aerial parts</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-nerolidol</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) <italic>Warionia saharae</italic> ex Benth. &#x00026; Coss. (23.0%)</td><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B10-molecules-21-00529" ref-type="bibr">10</xref>,<xref rid="B26-molecules-21-00529" ref-type="bibr">26</xref>,<xref rid="B27-molecules-21-00529" ref-type="bibr">27</xref>,<xref rid="B28-molecules-21-00529" ref-type="bibr">28</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) <italic>Scutellaria abida</italic> L. ssp. <italic>albida</italic> (9.03%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(iii) <italic>Piper aleyreanum</italic> C. DC (1.2%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iv) <italic>Leonotis ocymifolia</italic> (Burm.f.) Iwarsson (0.41%)</td></tr><tr><td rowspan="17" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Leaf</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) <italic>Capparis tomentosa</italic> Lam. (5.14%)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B29-molecules-21-00529" ref-type="bibr">29</xref>,<xref rid="B30-molecules-21-00529" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) <italic>Virola surinamensis</italic> (Rol. ex Rottb.) Warb. (3.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ginkgo biloba</italic> L. (0.12%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Molecular distillation at a feed temperature of 60 &#x000b0;C, distillation temperature of 280 &#x000b0;C, feed flow rate of 180 mL per hour, scraper rate of 300 rpm, and operating pressure of 0.1&#x02013;0.5 Pa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-molecules-21-00529" ref-type="bibr">31</xref>]</td></tr><tr><td rowspan="14" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) <italic>Baccharis dracunculifolia</italic> DC. (33.51%)</td><td rowspan="14" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td rowspan="14" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B8-molecules-21-00529" ref-type="bibr">8</xref>,<xref rid="B9-molecules-21-00529" ref-type="bibr">9</xref>,<xref rid="B32-molecules-21-00529" ref-type="bibr">32</xref>,<xref rid="B33-molecules-21-00529" ref-type="bibr">33</xref>,<xref rid="B34-molecules-21-00529" ref-type="bibr">34</xref>,<xref rid="B35-molecules-21-00529" ref-type="bibr">35</xref>,<xref rid="B36-molecules-21-00529" ref-type="bibr">36</xref>,<xref rid="B37-molecules-21-00529" ref-type="bibr">37</xref>,<xref rid="B38-molecules-21-00529" ref-type="bibr">38</xref>,<xref rid="B39-molecules-21-00529" ref-type="bibr">39</xref>,<xref rid="B40-molecules-21-00529" ref-type="bibr">40</xref>,<xref rid="B41-molecules-21-00529" ref-type="bibr">41</xref>,<xref rid="B42-molecules-21-00529" ref-type="bibr">42</xref>,<xref rid="B43-molecules-21-00529" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) <italic>Cassia fistula</italic> L. (2.2%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(iii) <italic>Comptonia peregrina</italic> (L.) Coult. (2.11% and 3.43% after 0&#x02013;30 min fraction and 30&#x02013;60 min fraction respectively)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(iv) <italic>Melaleuca quinquenervia</italic> (Cav.) S.T.Blake (24.19%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(v) <italic>Myrica rubra</italic> (Lour.) Siebold &#x00026; Zucc. (2%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(vi) <italic>Lantana radula</italic> Sw. (19.0%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(vii) <italic>Peperomia serpens</italic> (Sw.) Loudon (38.0%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(viii) <italic>Piper aduncum</italic> L. (0.2%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ix) <italic>Piper chaba</italic> Hunter (5.1%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(x) <italic>Piper claussenianum</italic> (Miq.) C. DC. (81.4%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(xi) <italic>Strychnos spinosa</italic> Lam. (0.7%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(xii) <italic>Swinglea glutinosa</italic> (Blanco) Merr. (28.4%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(xiii) <italic>Zanthoxylum hyemale</italic> A.St.-Hil. (51.0%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(xiv) <italic>Zornia brasiliensis</italic> Vogel (48.0%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stem</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Oplopanax horridus</italic> (Sm.) Miq. (54.5%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Steam distillation using a low pressure system with an external steam source</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-molecules-21-00529" ref-type="bibr">44</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Flower</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) <italic>Achillea millefolium</italic> L. (11.6%&#x02013;31.9%)</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B42-molecules-21-00529" ref-type="bibr">42</xref>,<xref rid="B45-molecules-21-00529" ref-type="bibr">45</xref>,<xref rid="B46-molecules-21-00529" ref-type="bibr">46</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) <italic>Cananga odorata</italic> (Lam.) Hook.f. &#x00026; Thomson (0.32%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iii) <italic>Cassia fistula</italic> L. (38.0%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Oplopanax horridus</italic> (Sm.) Miq. (54.6%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Steam distillation using a low pressure system with an external steam source</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-molecules-21-00529" ref-type="bibr">44</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Seed/grain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Magnolia denudata</italic> Desr. (2.18%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-molecules-21-00529" ref-type="bibr">47</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) <italic>Elettaria cardamomum</italic> (L.) Maton (3.6%)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B7-molecules-21-00529" ref-type="bibr">7</xref>,<xref rid="B48-molecules-21-00529" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) <italic>Momordica charantia</italic> L. (61.6%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fruit</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Swinglea glutinosa</italic> (Blanco) Merr. (19.1%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-molecules-21-00529" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Canarium schweinfurthii</italic> Engl. (14%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-molecules-21-00529" ref-type="bibr">49</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Twig/wood</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cinnamomum osmophloeum</italic> Kaneh. (1.05%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-molecules-21-00529" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Fokienia hodginsii</italic> (Dunn) A.Henry &#x00026; H H.Thomas (34.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solid-phase microextraction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-molecules-21-00529" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>cis-</italic>Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Myrocarpus fastigiatus</italic> Allemao (80.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydrodistillation technique using the Clevenger-type apparatus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-molecules-21-00529" ref-type="bibr">52</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Key: n.s. = not specified.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-21-00529-t003" position="float"><object-id pub-id-type="pii">molecules-21-00529-t003_Table 3</object-id><label>Table 3</label><caption><p>Retention indices of different chromatographic columns of GC and major peaks of mass spectrometry to differentiate <italic>cis</italic>- and <italic>trans</italic>-nerolidol.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Types of Column/Equipment Used</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cis</italic>-Nerolidol</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trans</italic>-Nerolidol</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>(A) Retention time of different chromatographic columns of GC (minutes)</bold></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) A-100 or 154-C column</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) DB-5 capillary column</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B21-molecules-21-00529" ref-type="bibr">21</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iii) TR-5MS capillary column</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>(B) Retention time of different chromatographic columns of LC (minutes)</bold></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) Hypersil BDS C18 column</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-molecules-21-00529" ref-type="bibr">25</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>(C) Major peaks of mass spectrometry (MS) (m/z)</bold></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) M-80B gas chromatograph double focusing mass spectrometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41, 69, 134, 91, 93, 79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69, 41, 93, 43, 71, 55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-molecules-21-00529" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Y2K ion trap (MS) PolarisQ System mass spectrometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93, 91, 67, 107, 79, 161, 121, 133, 55, 147, 189, 175</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93, 121, 67, 107, 79, 161, 136, 55, 189, 148, 175</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>]</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><bold>(D) Retention indices of different chromatographic columns of GC</bold></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) HP-101</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1564</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-molecules-21-00529" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) HP-20M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-molecules-21-00529" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iii) HP-FFAP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2055</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-molecules-21-00529" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iv) Fused silica capillary column coated with DB-5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1564</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-molecules-21-00529" ref-type="bibr">29</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(v) OV-101</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1549</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-molecules-21-00529" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(vi) PEG 20M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2028</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2035</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-molecules-21-00529" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(vii) DB-5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1565</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1539</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-molecules-21-00529" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(viii) DB-Wax</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2054</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-molecules-21-00529" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ix) SPB-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1543</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-molecules-21-00529" ref-type="bibr">58</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(x) Dimethylsilicone (DIMS)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1524.4 (a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1550.1 (a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-molecules-21-00529" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(xi) Dimethylsilicone with 5% phenyl groups (DIMS5P)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1543.6 (a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1560.9 (a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-molecules-21-00529" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(xii) Polyethylene glycol (PEG)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007.3 (a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2036.3 (a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-molecules-21-00529" ref-type="bibr">54</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Key: (a) = average value; n.a. = not available.</p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-21-00529-t004" position="float"><object-id pub-id-type="pii">molecules-21-00529-t004_Table 4</object-id><label>Table 4</label><caption><p>A summary of pharmacological and biological activities of nerolidol.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactivity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Nerolidol</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant and Part of Plant Used (If Any)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target Organism(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Screening Assay and Methods Used</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Possible Mechanisms of Action</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="6" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Antioxidant activity</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>cis</italic>-Nerolidol (Aldrich Chemical Co., Milwaukee, WI, USA)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">DPPH and hydroxyl radical scavenging activity</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Exhibited DPPH radical scavenging activity</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Mediates antioxidant activities via free radical scavenging activity</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B73-molecules-21-00529" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Exhibited scavenging activity against hydroxyl radical with IC<sub>50</sub> = 1.48 mM</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>cis</italic>-Nerolidol (Sigma-Aldrich, St. Louis, MO, USA)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Thiobarbituric acid reactive substances (TBARS) assay</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Demonstrated 25.60% &#x000b1; 0.98% malonaldehyde (MDA) reduction in hepatocytes at 1 mM under physiological conditions</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Mediates antioxidant activity via lipid peroxidation inhibitory effect</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B74-molecules-21-00529" ref-type="bibr">74</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Demonstrated higher MDA reduction with value of 36.50% &#x000b1; 4.47% at 1 mM in hepatocytes under oxidative stress induced by <italic>tert</italic>-BuOOH</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (Sigma Chemical Company, St. Louis, MO, USA)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">TBARS assay, nitrite assay, superoxide dismutase (SOD) activity and catalase activity</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) At doses of 25, 50 and 75 mg/kg of nerolidol caused a significant decrease in lipid peroxidation by 59.97%, 74.79% and 91.31% respectively when compared to negative control</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">(i) Suggested to prevent oxidation of polyunsaturated fatty acids</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"/></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) At doses of 25, 50 and 75 mg/kg of nerolidol caused a significant decrease in nitrite level by 71.1%, 66.6% and 63.35 % respectively when compared to negative control</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">(iii) At doses of 25, 50 and 75 mg/kg of nerolidol increased superoxide dismutase activity by 31.1%, 34.8% and 66.1%, respectively when compared to negative control</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">(ii) Suggested to inactivate the enzyme nitric oxide synthase</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B75-molecules-21-00529" ref-type="bibr">75</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iv) At doses of 25, 50 and 75 mg/kg of nerolidol increased catalase enzymatic activity by 109%, 148% and 177.7%, respectively when compared to negative control</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (Sigma Chemical Company, St. Louis, MO, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic> FDA 209P, 14 strains of methicillin-susceptible <italic>S. aureus</italic> (MSSA) and 20 strains of methicillin-resistant <italic>S. aureus</italic> (MRSA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth-dilution with shaking method (BDS)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited dose-related inhibition against 34 clinical isolates of <italic>S. aureus.</italic> Inhibitory dose 50% (ID<sub>50</sub>) ranged from 5.0 to 22.0 &#x003bc;g/mL and from 2.6 to 10.6 &#x003bc;g/mL against MSSA and MRSA respectively.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suggested the aliphatic chain of nerolidol mediates the antibacterial activity by damaging the bacterial cell membrane</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-molecules-21-00529" ref-type="bibr">76</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (Sigma Chemical Company, (St. Louis, MO, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic> FDA209P</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth dilution with shaking (BDS) method and quantitation of the leakage of K<sup>+</sup> ions using K<sup>+</sup>-selective electrode</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment of nerolidol caused a dose-dependent increase in amount of K<sup>+</sup> ions leakage from bacterial cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mediates the antibacterial activity via cell membrane-distrupting mechanism and hence resulting in the leakage of K<sup>+</sup> ions from bacterial cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-molecules-21-00529" ref-type="bibr">77</xref>]</td></tr><tr><td rowspan="8" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (Sigma Chemical Company, St. Louis, MO, USA)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Staphylococcus aureus</italic> FDA209P</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Broth dilution with shaking (BDS) method and quantitation of the leakage of K<sup>+</sup> ions using K<sup>+</sup>-selective electrode</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Caused a dose-dependent increase in K+ ions leakage from bacterial cells</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B78-molecules-21-00529" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Exhibited minimum inhibitory concentration at 40 &#x003bc;g/mL</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Momordica charantia</italic> L., seed</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic> ATCC 6538</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth microdilution method (MIC)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) Exhibited anti-microbial activity with MIC ranged from 125&#x02013;500 &#x003bc;g/mL.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B7-molecules-21-00529" ref-type="bibr">7</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Camellia sinensis</italic> (L.) Kuntze, leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic> and <italic>Streptococcus mutans</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth dilution method</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited antibacterial activity against <italic>S. aureus</italic> and <italic>S. mutans</italic> with MIC measured at 200 and 25 &#x003bc;g/mL respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-molecules-21-00529" ref-type="bibr">79</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ginkgo biloba</italic> L., leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Salmonella enterica, Staphylococcus aureus</italic> and <italic>Aspergillus niger</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disc-diffusion and broth dilution methods</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) Exhibited antibacterial activity against <italic>S. enterica</italic>, <italic>S. aureus</italic> and <italic>A. niger</italic> with MIC, MBC and MFC values measured ranging from 3.9&#x02013;15.6 &#x003bc;g/mL, 31.3&#x02013;62.5 &#x003bc;g/mL and 62.5 &#x003bc;g/mL respectively.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-molecules-21-00529" ref-type="bibr">31</xref>]</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>cis</italic>-Nerolidol and the racemic mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (Aldrich Chemical Co., Milwaukee, WI, USA)</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic></td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Agar-disc diffusion assay</td><td align="left" valign="middle" rowspan="1" colspan="1">Nerolidol (<italic>cis</italic>-nerolidol and the racemic mixture of <italic>cis</italic>- and <italic>trans</italic>-isomers) potentiated the action of antibiotics:</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B80-molecules-21-00529" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(i) amoxicillin/clavulanic acid against <italic>S. aureus</italic> and</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) amoxicilline/clavulanic acid, ceftadizine and imipenem against <italic>E. coli</italic></td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol (n.s.) (Sigma, St. Louis, MO, USA)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Escherichia coli</italic> ATCC 25922 and <italic>Staphylococcus aureus</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Disc-diffusion assay</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Nerolidol concentrations ranged from 0.5 to 2 mM enhanced the susceptibility of <italic>S. aureus</italic> to ciprofloxacin, clindamycin, erythromycin, gentamicin, tetracycline, and vancomycin</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B81-molecules-21-00529" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Nerolidol (1 mM) enhanced the susceptibility of <italic>E. coli</italic> to polymyxin B</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Racemic mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (1:1) (Aldrich, Madrid, Spain)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Escherichia coli</italic> ATCC 25922 and <italic>Staphylococcus aureus</italic> ATCC 25923</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic disc assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (20 mM) potentiated the susceptibility of <italic>E. coli</italic> and <italic>S. aureus</italic> towards ciprofloxacin, erythromycin, gentamicin and vancomycin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-molecules-21-00529" ref-type="bibr">82</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-biofilm activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Black pepper, cananga, and myrrh EOs (Berj&#x000e9; (Bloomfield, NJ, USA), Jin Aromatics (Anyang, Gyeonggi Province, Korea) and Sigma-Aldrich (St. Louis, USA))</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crystal violet biofilm assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cis</italic>-nerolidol at 0.01% (<italic>v</italic>/<italic>v</italic>) inhibited <italic>S. aureus</italic> biofilm formation by &#x0003e; 80 %; <italic>trans</italic>-nerolidol at similar concentration exerted 45% inhibition</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-molecules-21-00529" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper claussenianum</italic> (Miq.) C. DC., leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Candida albicans</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MTT assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Concentrations of 0.06%&#x02013;1.0% inhibited biofilm formation by 30% and 50% after 24 and 48 h incubation respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-molecules-21-00529" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>cis,trans-</italic>Nerolidol and <italic>cis-</italic>nerolidol (Sigma Aldrich)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Candida albicans</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MTT assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0% of <italic>cis,trans-</italic>nerolidol exerted 76.1% reduction in the viability of pre-formed biofilm while only 67.0% reduction observed from 1.0% <italic>cis</italic>-nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-molecules-21-00529" ref-type="bibr">32</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-fungal activity</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol (n.s.)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Chamaecyparis obtusa</italic> (Siebold &#x00026; Zucc.) Endl. (Japanese cypress)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Microsporum gypseum</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Broth microdilution method Skin lesion scoring in guinea pig model</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Exhibited MIC concentrations of 0.5%&#x02013;2% against <italic>M. gypseum</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B83-molecules-21-00529" ref-type="bibr">83</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Nerolidol-treated group exhibited a significant improvement (<italic>p &#x0003c;</italic> 0.05) in lesion as compared to eugenol and econazole (positive control) treated groups</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Piper claussenianum</italic> (Miq.) C. DC., Piperaceae, leaves</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Candida albicans</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Broth microdilution and trypan blue exclusion method</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Exhibited anti-fungal activity with MIC values ranging from 0.24% to 1.26%.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B32-molecules-21-00529" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Exhibited inhibitory effect on yeast-to-hyphae transition by 81%</td></tr><tr><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Sigma-Aldrich, Yongin, Korea)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Trichophyton mentagrophytes</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Agar dilution method</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the hyphal growth of <italic>T. mentagrophytes</italic> at the concentration of 0.4 mg/mL.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B16-molecules-21-00529" ref-type="bibr">16</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Camellia sinensis</italic> (L.) Kuntze, leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broth dilution method</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the growth of <italic>T. mentagrophytes</italic> at 12.5 &#x003bc;g/mL</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-molecules-21-00529" ref-type="bibr">79</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Lantana radula</italic> Sw., leaves</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Corynespora cassiicola</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Poison food (PF) technique</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) <italic>L. radula</italic> EO at the concentration of 1000 mg/L and 3000 mg/L inhibited the growth of <italic>C.</italic>
<italic>cassiicola</italic> by 17.2% and 40.6% respectively</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B33-molecules-21-00529" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) <italic>L. radula</italic> EO at the concentration of 5000 mg/L and 10,000 mg/L completely inhibited the growth of <italic>C.</italic>
<italic>cassiicola</italic></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper chaba</italic> Hunter, leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Fusarium oxysporum</italic>, <italic>Phytophthora capsici</italic>, <italic>Colletotrichum capsici</italic>, <italic>Fusarium solani</italic> and <italic>Rhizoctonia solani</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spore germination assay and agar dilution method</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caused 55.1%&#x02013;70.3% growth inhibition at concentration ranging from 125 to 500 &#x000b5;g/mL.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B34-molecules-21-00529" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Warionia saharae</italic> ex Benth. &#x00026; Coss., aerial part</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Alternaria</italic> sp., <italic>Penicillium expansum</italic> and <italic>Rhizopus stolonifer</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poisoned food (PF) technique and volatile activity (VA) assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the fungal spore production of <italic>Alternaria</italic> sp., <italic>P. expansum</italic> and <italic>R. stolonifera</italic> at 1, 2 and 2 &#x000b5;L/mL air respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-molecules-21-00529" ref-type="bibr">26</xref>]</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Allium sativum</italic> L., bulb</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Sclerotium cepivorum</italic></td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Disc diffusion method; scanning electron microscopy</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Nerolidol ranged from 2.0 to 5.0 &#x000b5;g/disc displayed fungistatic property by inhibiting mycelial growth by ~85%</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B84-molecules-21-00529" ref-type="bibr">84</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) Nerolidol ranged from 2.0 to 5.0 &#x000b5;g/disc inhibited the production of sclerotial by ~84%</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Nerolidol at 4.0 &#x000b5;g/disc caused morphological alterations such as shorter branching, hyphal shrinkage and partial distortion</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-trypanosomal activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Strychnos spinosa</italic> Lam., leaves</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Trypanosoma brucei</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alamar Blue&#x02122; assay.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited anti-trypanosomal activity with IC<sub>50</sub> measured at 1.7 &#x000b5;g/mL (7.6 &#x000b5;M)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-molecules-21-00529" ref-type="bibr">35</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>cis</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Leonotis ocymifolia</italic> (Burm.f.) Iwarsson, aerial part</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trypanocidal and cytotoxic assays</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited anti-trypanosomal activity with IC<sub>50</sub> measured at 15.78 &#x000b5;g/mL</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-molecules-21-00529" ref-type="bibr">27</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" colspan="1"/><td rowspan="2" align="left" valign="middle" colspan="1">Mixture of &#x000b1;40% <italic>cis</italic>-nerolidol and &#x000b1;55% of <italic>trans</italic>-nerolidol (Merck, Darmstadt, Germany)</td><td rowspan="2" align="left" valign="middle" colspan="1">-</td><td rowspan="2" align="left" valign="middle" colspan="1"><italic>Trypanosoma evansi</italic></td><td rowspan="2" align="left" valign="middle" colspan="1">Collection of blood samples from <italic>T. evansi</italic>-infected mice for observation using light and electron microscopes</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Adverse morphological changes observed in nerolidol-treated group. The parasites lost their undulating membrane after 23 day post-treatment.</td><td rowspan="2" align="left" valign="middle" colspan="1">-</td><td rowspan="2" align="center" valign="middle" colspan="1">[<xref rid="B85-molecules-21-00529" ref-type="bibr">85</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) Total disfigurement observed after 27 day post-treatment</td></tr><tr><td rowspan="5" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Anti-leishmanial activity</td><td rowspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">A mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol</td><td rowspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic>Leishmania</italic> (L.) <italic>amazonensis</italic>, <italic>L. braziliensis</italic>, and <italic>L. chagasi</italic></td><td rowspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">MTT assay and metabolic labeling with [2-<sup>14</sup>C] mevalonic acid, [1-<sup>14</sup>C] acetic acid, [1(n)-<sup>3</sup>H] farnesyl pyrophosphate and <sc>l</sc>-[<sup>35</sup>S]methionine</td><td align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">(i) Inhibited the growth of <italic>L. amazonensis, L. braziliensis</italic> and <italic>L. chagasi</italic> promastigotes, and <italic>L. amazonensis</italic> amastigotes with IC<sub>50</sub> of 85, 74, 75, and 67 &#x000b5;M respectively</td><td rowspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Inhibition of the isoprenoid biosynthesis pathway</td><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">[<xref rid="B86-molecules-21-00529" ref-type="bibr">86</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Nerolidol at 100 &#x000b5;M reduced the percentage of intracellular parasitism of <italic>L. amazonensis</italic> by 95% from the pre-infected macrophages culture</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Baccharis dracunculifolia</italic> DC., leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Leishmania donovani</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parasite lactate dehydrogenase (pLDH) assay, antileishmanial assay, schistosomicidal assay and cytotoxicity assay using the mammalian cells <italic>Vero</italic>.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited anti-leishmanial activity against promastigotes of <italic>L. donovani</italic> with IC<sub>50</sub> and IC<sub>90</sub> values of 42 and 85 &#x000b5;g/mL respectively.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B8-molecules-21-00529" ref-type="bibr">8</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Piper claussenianum</italic> (Miq.) C. DC., Piperaceae, leaves</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Leishmania amazonensis</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Protozoal arginase activity, nitrite determination and cytotoxicity assay using L929 fibroblast cells (mouse) and Raw cells (mouse macrophages)</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Nerolidol inhibited the arginase activity by 62.17% in the promastigotes of <italic>Leishmania amazonensis</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Interferes with parasite-host cell interaction</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B9-molecules-21-00529" ref-type="bibr">9</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Nerolidol caused an increase in NO production (20.5%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Acros Organics, Geel, Belgium)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promastigotes of <italic>Leishmania amazonensis</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-proliferative activity assay and electron paramagnetic resonance (EPR) spectroscopy of the spin-labeled 5-doxyl stearic acid</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol modulated the molecular dynamics of the lipid component in the <italic>Leishmania</italic> plasma membrane</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Insertion of nerolidol into the lipid bilayer increased the fluidity of membranes, thus causing leakage of cytoplasmic content and eventually the death of <italic>Leishmania</italic> cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-molecules-21-00529" ref-type="bibr">87</xref>]</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-schistosomal activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Baccharis dracunculifolia</italic> DC. (Asteraceae), leaves</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Schistosoma mansoni</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Schistosomicidal assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100% mortality of <italic>S. mansoni</italic> adult worms after 24 h incubation with 10 to 100 mg/mL of EO containing nerolidol as the main constituent</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B8-molecules-21-00529" ref-type="bibr">8</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Racemic mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (1:1) (Sigma-Aldrich, St. Louis, MO, USA)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>In vitro</italic> anti-schistosomal assay and microscopy studies</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Exhibited anti-schistosomal activity by reducing worm motor activity and caused 100% mortality of male and female schistosomes at concentration of 31.2 and 62.5 &#x000b5;M respectively</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Induced severe tegumental damage in adult schistosomes.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B88-molecules-21-00529" ref-type="bibr">88</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Caused alterations on the tubercles of male parasites</td></tr><tr><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-malarial activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Virola surinamensis</italic> (Rol. ex Rottb.) Warb., leaves</td><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Plasmodium falciparum</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>In vitro</italic> anti-plasmodial assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment with 100 &#x000b5;g/mL of nerolidol caused 100% inhibition in the development of young trophozoite to the schizont stage after 48 h</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-molecules-21-00529" ref-type="bibr">29</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans-</italic>Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper claussenianum</italic> (Miq.) C. DC., leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exerted anti-malarial activity with IC<sub>50</sub> of 11.1 &#x003bc;g/mL</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-molecules-21-00529" ref-type="bibr">89</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Sigma, St. Louis, MO, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunoprecipitation assays and metabolic labeling</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited inhibitory activity on the biosynthesis of the isoprenic side chain of the benzoquinone ring in ubiquinones during the schizont stage</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Interferes with the elongation of isoprenic chains via inhibition of isoprenyl diphosphate synthases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-molecules-21-00529" ref-type="bibr">90</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Sigma, St. Louis, MO, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol at 50 nM inhibited the synthesis of the isoprenic chain attached to coenzyme Q at all intraerythrocytic stages</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-molecules-21-00529" ref-type="bibr">91</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isobolographic analysis</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol mediated supra-additive (the sum of the fractions of IC<sub>50</sub> of &#x0003c; 1) interaction with fosmidomycin and squalestatin with average IC<sub>50</sub> values of 0.57 and 0.62 &#x000b5;M, respectively in the inhibition of plasmodial isoprenoid pathway</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-molecules-21-00529" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Other anti-parasite activities</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (Sigma-Aldrich, St. Louis, MO, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Four <italic>Babesia</italic> species (<italic>B. bovis, B. bigemina, B. ovata,</italic> and <italic>B. caballi</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>In vitro</italic> growth inhibition assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited <italic>in vitro</italic> growth of <italic>B. bovis</italic>, <italic>B. bigemina</italic>, <italic>B. ovata</italic>, and <italic>B. caballi</italic> with IC<sub>50</sub> values of 21 &#x000b1; 1, 29.6 &#x000b1; 3, 26.9 &#x000b1; 2, and 23.1 &#x000b1; 1 &#x000b5;M respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the isoprenoid biosynthesis pathway in a similar mechanism with that of <italic>P. falciparum</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-molecules-21-00529" ref-type="bibr">93</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (Sigma Chemical Company, St. Louis, MO, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Caenorhabditis elegans</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mortality assay against <italic>Caenorhabditis elegans</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caused 74.0% mortality of <italic>C. elegans</italic> at 50 &#x000b5;g/mL</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-molecules-21-00529" ref-type="bibr">94</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol (n.s.)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">L<sub>3</sub> larvae of <italic>Anisakis</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>In vitro</italic> and <italic>in vivo</italic> larvicidal activity</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Nerolidol at both 31.5 and 62.5 &#x000b5;g/mL resulted in 100% mortality of L<sub>3</sub> larvae of <italic>Anisakis</italic> type I after 4 h.</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B95-molecules-21-00529" ref-type="bibr">95</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Only 20% of nerolidol-treated rats were affected by gastric wall lesions caused by <italic>Anisakis</italic> larvae in comparison to 86% of the control rats</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Insecticidal activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siam-wood (<italic>Fokienia hodginsii</italic> (Dunn) A.Henry &#x00026; H H.Thomas), wood</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mosquito and house flies</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">House fly toxicity test</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited insecticidal activity with LD<sub>50</sub> measured at 0.17 &#x000b5;mol/fly</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-molecules-21-00529" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Combination of nerolidol (n.s.) and linalool</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Capparis tomentosa</italic>, leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maize weevil (<italic>Sitophilus zeamais</italic>)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Repellency assay using a glass Y-tube Olfactometer</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited mean repellency value of 58.23% &#x000b1; 2.95% against <italic>S. zeamais</italic> at 2 &#x000b5;L</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-molecules-21-00529" ref-type="bibr">30</xref>]</td></tr><tr><td rowspan="6" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Moellhausen SpA,Vimercate, Milano, Italy)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Melaleuca alternifolia</italic> (Maiden &#x00026; Betche) Cheel (tea tree oil)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pediculus capitis</italic> (head lice) and its eggs</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pediculicidal and ovicidal activities</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol in combination with tea tree oil with ratio of 1:2 (tea tree oil 0.5% plus nerolidol 1%), exerted a total killing effect of lice within 30 min and abortive effect of louse eggs after 5 days.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-molecules-21-00529" ref-type="bibr">96</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Magnolia denudata</italic> Desr., seeds</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Culex pipiens</italic> pallens, <italic>Aedes aegypti</italic>, <italic>Aedes albopictus and Anopheles sinensis</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Direct-contact mortality bioassay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exerted larvacidal activity against <italic>Culex pipiens pallens</italic>, <italic>Aedes aegypti</italic>, <italic>Aedes albopictus</italic> and <italic>Anopheles sinensis</italic> with LD<sub>50</sub> value of 9.84, 13.85, 16.34 and 20.84 mg/L respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-molecules-21-00529" ref-type="bibr">47</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Melaleuca quinquenervia</italic> (Cav.) S.T.Blake, leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aedes aegypti</italic></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Larvicidal activity test</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exerted larvicidal activity with &#x02265; 95% and &#x0003e; 80% mortality of <italic>A. aegypti</italic> at 0.1 mg/mL and 0.05mg/mL respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B36-molecules-21-00529" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper aduncum</italic> L., leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tetranychus urticae</italic> Koch</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fumigant, contact, repellency and two-choice assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exerted acaricidal activity with repellency value of 83.2% &#x000b1; 0.59 % at 9.8 &#x000b5;g/mL</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-molecules-21-00529" ref-type="bibr">37</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol (n.s.)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Baccharis dracunculifolia</italic> DC., leaves</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Rhipicephalus microplus</italic></td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Larval packet test (LPT) and engorged female immersion test</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Exerted acaricidal activity when concentration more than 5mg/mL and 100% mortality of larvae at 15 mg/mL</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B97-molecules-21-00529" ref-type="bibr">97</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Reduced the quality of the egg and larval hatching rate with increasing concentration from 20 to 50 mg/mL</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiulcer activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Baccharis dracunculifolia</italic> DC., leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>In vivo</italic> antiulcer activity in male Wistar rat ulcer models induced with ethanol, indomethacin and stress</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol displayed gastroprotective activity by inhibiting the formation of ulcers induced by all physical and chemical agents in dose-dependent manner (50, 250, 500 mg/kg)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-molecules-21-00529" ref-type="bibr">98</xref>]</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Skin penetration enhancer activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Aldrich, Gillingham, UK)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>In vitro</italic> diffusion studies and stratum corneum-water partitioning studies</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased diffusion rate by over 20-fold for transdermal delivery of drugs such as 5-fluorouracil</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol exhibits a chemical structure that allows it to align within the lipid lamellae of the stratum corneum in order to disrupt the organization of stratum corneum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-molecules-21-00529" ref-type="bibr">99</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Alfa Aesar Ltd., Haverhill, MA, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Solubility studies, <italic>ex vivo</italic> permeation studies and histopathological studies</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The enhancement effect is increased with the increasing lipophilicity; the rank of order (nerolidol &#x0003e; farnesol &#x0003e; limonene &#x0003e; linalool &#x0003e; geraniol &#x0003e; carvone &#x0003e; fenchone &#x0003e; menthol) in facilitating transdermal delivery of alfuzosin hydrochloride</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-molecules-21-00529" ref-type="bibr">100</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Merck-Schuchardt, Hohenbrunn, Germany)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>In vitro</italic> permeation studies</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited the highest permeation enhancing ability with a 3.2-fold increase in permeation of selegiline hydrochloride across the rat skin, followed by the effect of carvone (2.8-fold increase) and anethole (2.6-fold increase)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-molecules-21-00529" ref-type="bibr">101</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Aldrich Chemical Co. Milwaukee, WI, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>In vitro</italic> skin permeability studies</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Most effective terpene enhancer for percutaneous permeation of four different drug models (nicardipine hydrochloride, hydrocortisone, carbamazepine, and tamoxifen) when compared to fenchone, thymol and limonene</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-molecules-21-00529" ref-type="bibr">102</xref>]</td></tr><tr><td rowspan="6" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-nociceptive and anti-inflammatory activities</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Peperomia serpens</italic> (Sw.) Loudon, leaves</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Chemical (acetic acid and formalin) and thermal (hot plate) models of nociception</td><td rowspan="6" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans-</italic>Nerolidol could be responsible for the anti-inflammatory and anti-nociceptive effects displayed by essential oils of both <italic>Peperomia serpens</italic> (Sw.) Loudon and <italic>Piper aleyreanum</italic> C. DC</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B38-molecules-21-00529" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) Carrageenan- and dextran-induced paw edema tests in rats croton oil-induced ear edema</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iii) Cell migration, rolling and adhesion activities</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans</italic>-Nerolidol</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Piper aleyreanum</italic> C. DC, aerial parts</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Nociception induced by formalin</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B10-molecules-21-00529" ref-type="bibr">10</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) Evaluation of locomotor activity</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iii) Induction of acute gastric lesions</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.) (Sigma, St. Louis, MO, USA)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) Rotarod, acetic acid-induced writhing, formalin and hot-plate tests <break/>(ii) Involvement of ATP-sensitive opioid and GABAergic K<sup>+</sup> channels <break/>(iii)Carrageenan-induced paw edema <break/>(iv) Analysis of leukocytes, tumor necrosis factor (TNF-&#x003b1;), interleukin 1 beta (IL-1&#x003b2;) and interleukin 6 in peritoneal lavage</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) For acetic acid-induced writhing test, at the doses of 200, 300 and 400 mg/kg, nerolidol reduced the frequency of acetic acid-induced writhing at all three doses tested compared to the mice in the control group (55% &#x000b1; 1.1%, 53% &#x000b1; 4.5%, and 41% &#x000b1; 2.4%, respectively) <break/>(ii) For formalin test, at the doses of 200, 300 and 400 mg/kg, nerolidol significantly inhibited licking time by 20% &#x000b1; 3.3%, 33% &#x000b1; 5.9% and 37% &#x000b1; 4.8%, respectively when compared to the control mice. <break/>(iii) For hot-plate test, no increase in the reaction time to painful stimulation in the mice treated with nerolidol when compared to the control mice. <break/>(iv) Reduced leukocytes level by 51% &#x000b1; 0.7%, 37% &#x000b1; 0.5% and 57% &#x000b1; 0.4% at doses of 200, 300 and 400 mg/kg respectively <break/>(v) Reduced the level of tumor necrosis factor (TNF-&#x003b1;) at doses of 300 (59.3% &#x000b1; 30.2%) and 400 (62.2% &#x000b1; 13.7%) in peritoneal lavage. <break/>(vi) IL-1&#x003b2; production was inhibited after treatment with nerolidol (1, 10, 50 and 100 &#x000b5;M) whereas IL-6 level was unchanged</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(i) Anti-nociceptive activtity of nerolidol was indicated to be mediated by GABA<sub>A</sub> receptors, as the use of bicuculline, a GABA<sub>A</sub> antagonist inhibited the effect of nerolidol in reducing the paw licking times <break/>(ii) Anti-inflammatory activity of nerolidol was suggested to be mediated by inhibiting the production or the activity of pro-inflammatory cytokines such as TNF-&#x003b1; analgesic and IL-1&#x003b2;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-molecules-21-00529" ref-type="bibr">103</xref>]</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-cancer or anti-tumor activity</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (a combination of <italic>cis</italic>-nerolidol 40.7%, <italic>trans</italic>-nerolidol 58.3%, <italic>cis</italic>-dihydronerolidol 0.4% and <italic>trans</italic>-dihydro-nerolidol) (Kurt Kitzing Co. Wallerstein, Germany)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity assay on HeLa cell lines using CytoTox-96<sup>&#x000ae;</sup>-assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited anticancer effect against HeLa cells with CC<sub>50</sub> value at 1.5 &#x000b1; 0.7 &#x000b5;M</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-molecules-21-00529" ref-type="bibr">104</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>cis</italic>-Nerolidol (Charabot S.A. Grasse, France)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity and cytoproliferative activity on HeLa cell lines using Cytotoxicity Detection Kit (LDH) and the Cell Proliferation Reagent WST-1, respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited cytotoxic effect (16.5 &#x000b1; 6.7 &#x003bc;M) against HeLa cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-molecules-21-00529" ref-type="bibr">105</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Camellia sinensis</italic> (L.) Kuntze, leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MTT assay</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibited cytotoxic effect with IC<sub>50</sub> value of 2.96 and 3.02 &#x000b5;g/mL against BT-20 breast carcinoma and HeLa cells respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-molecules-21-00529" ref-type="bibr">106</xref>]</td></tr><tr><td rowspan="9" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"/><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans-</italic>Nerolidol</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Zornia brasiliensis</italic> Vogel, leaves</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>In vitro</italic> cytotoxic activity assay using Alamar blue assay, and <italic>in vivo</italic> antitumor activity assay</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) <italic>trans</italic>-Nerolidol induced cytotoxic effect on B16-F10, HepG2, HL-60 and K562 cells with IC<sub>50</sub> value of &#x0003e;25, &#x0003e;25, 21.99 and 17.58 &#x000b5;g/mL respectively</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B39-molecules-21-00529" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) The EO at dose of 100 mg/kg containing <italic>trans</italic>-nerolidol as major constituent reduced the weight of tumor in mice injected with B16-F10 melanoma by 38.61%</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Myrica rubra</italic> (Lour.) Siebold &#x00026; Zucc.<italic>,</italic> leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutral red uptake (NRU) test, MTT assay and 2&#x02032;,7&#x02032;-dichlorodihydrofluorescein-diacetate (H2DCF-DA) oxidation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potentiated the action of doxorubicin, an anticancer drug in the modulation of CaCo-2 cancer cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-molecules-21-00529" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol (n.s.) (Sigma Aldrich Chemical Company)</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>In vivo</italic> anti-cancer study</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Reduction of incidence of intestinal neoplasia from 82% to 33% in rats fed with nerolidol</td><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Modulation of nerolidol on protein prenylation which responsible for the formation of cancer</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B107-molecules-21-00529" ref-type="bibr">107</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(ii) Reduction of number of tumors/rat from 1.5 to 0.7 in rats fed with nerolidol</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Combination of farnesol and nerolidol (n.s.)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>In vitro</italic> anti-cancer study</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The combination suppressed the proliferation of human HL-60 acute promyelocytic leukemia (HL-60) cells by 20%. Meanwhile, farnesol isomers (2.5 &#x000b5;mol/L) and nerolidol (5 &#x000b5;mol/L) individually suppressed the proliferation of HL-60 cells by 4 and 9%, respectively</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nerolidol induced cell cycle arrest at the G<sub>0</sub>-G<sub>1</sub>/S interphase in HL-60 cells and eventually lead to apoptotic cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B108-molecules-21-00529" ref-type="bibr">108</xref>]</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>trans-</italic>Nerolidol</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1"><italic>Myrica rubra</italic> (Lour.) Siebold &#x00026; Zucc.<italic>,</italic> leaves</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">-</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Cell adhesion and apoptosis luminescent assays</td><td align="left" valign="middle" rowspan="1" colspan="1">(i) Reduced adhesion of HT29 to collagen.</td><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">Nerolidol induced apoptosis in cancer cells</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B109-molecules-21-00529" ref-type="bibr">109</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">(ii) Suppressed cell adhesion of HT29 cells in the presence TNF&#x003b1; cytokines</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(iii) Decreasing the phosphorylation of NF-&#x003ba;B and increased the activity of caspases</td></tr></tbody></table><table-wrap-foot><fn><p>Key: n.s. = not specified<bold>.</bold></p></fn></table-wrap-foot></table-wrap><table-wrap id="molecules-21-00529-t005" position="float"><object-id pub-id-type="pii">molecules-21-00529-t005_Table 5</object-id><label>Table 5</label><caption><p>Comparison of pharmacokinetic studies of nerolidol conducted by Saito <italic>et al.</italic> and He <italic>et al.</italic> [<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>,<xref rid="B25-molecules-21-00529" ref-type="bibr">25</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameters</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Saito <italic>et al.</italic> [<xref rid="B22-molecules-21-00529" ref-type="bibr">22</xref>]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">He <italic>et al.</italic> [<xref rid="B25-molecules-21-00529" ref-type="bibr">25</xref>]</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Type of nerolidol</td><td align="center" valign="middle" rowspan="1" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (1:3)</td><td align="center" valign="middle" rowspan="1" colspan="1">Mixture of <italic>cis</italic>- and <italic>trans</italic>-nerolidol (2:3)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Analytical method used</td><td align="center" valign="middle" rowspan="1" colspan="1">GC-MS</td><td align="center" valign="middle" rowspan="1" colspan="1">LC-MS</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Animal used</td><td align="center" valign="middle" rowspan="1" colspan="1">BALB/c mice</td><td align="center" valign="middle" rowspan="1" colspan="1">Sprague-Dawley rats</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Route of administration</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral</td><td align="center" valign="middle" rowspan="1" colspan="1">Intraperitoneal injection</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dosage (mg/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">1000 </td><td align="center" valign="middle" rowspan="1" colspan="1">25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Type of sample used</td><td colspan="2" align="center" valign="middle" rowspan="1">Plasma</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Time collection taken (min)</td><td align="center" valign="middle" rowspan="1" colspan="1">30, 60, 120, 180, 240, 300, 360, 480 and 720</td><td align="center" valign="middle" rowspan="1" colspan="1">10, 20, 30, 60, 90, 120, 240 and 360</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Peak plasma concentration (C<sub>max</sub>) (&#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">~0.27 &#x000b1; 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">8.30 &#x000b1; 1.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Peak time (T<sub>max</sub>) (min)</td><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Elimination half life (T<sub>1/2</sub>) (min)</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" rowspan="1" colspan="1">20.98 &#x000b1; 7.71</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mean residence time (MRT) (min)</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" rowspan="1" colspan="1">27.72 &#x000b1; 2.14</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Clearance (L/min/kg)</td><td align="center" valign="middle" rowspan="1" colspan="1">n.a.</td><td align="center" valign="middle" rowspan="1" colspan="1">0.082 &#x000b1; 0.012</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Time for drug to be eliminated to almost near zero</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">~2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human equivalent dose <sup>a</sup> (HED) (mg/kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.05</td></tr></tbody></table><table-wrap-foot><fn><p>Key: (i) n.a. = data not available; (ii) a = HED values were calculated based on the formula for dose translation based on body surface area (BSA) [<xref rid="B156-molecules-21-00529" ref-type="bibr">156</xref>] as follows: Human equivalent dose (HED) (mg/kg) = Animal dose (mg/kg) &#x000d7; <inline-formula><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>A</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>K</mml:mi><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>K</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:mfrac><mml:mo>;</mml:mo><mml:mo>&#x000a0;</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>with adult human, rat and mouse K<sub>m</sub> factors of 37, 6 and 3 respectively [<xref rid="B156-molecules-21-00529" ref-type="bibr">156</xref>].</p></fn></table-wrap-foot></table-wrap></sec></back></article>